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Introduction
The first consumption of fermented products by humans can be found as early as 7000BC in 
ancient Egypt [1]. Only in 1907, the concept that fermented foods can bring beneficial health 
effects to consumers was introduced by Elie Metchnikoff [2]. The definition of probiotics has 
evolved ever since and is currently coined as ‘live microorganisms which when administered 
in adequate amounts confer a health benefit on the host’ [3]. In current commercial products 
lactobacilli are predominant [4, 5] and are Gram-positive, non-sporeforming, rod-shaped bacteria. 
This genus currently contains over 200 species, which can be found in various habitats ranging 
from raw and fermented dairy products, fresh and fermented plant materials, and digestive 
tracts and reproductive systems of humans and animals [5, 6]. Their ability to produce high levels 
of lactic acid lowers the pH of their environments and suppresses the growth of many other 
bacteria [6]. The taxonomical complexity mirrors the phenotypic diversity of the members of the 
Lactobacillus genus, which was initially divided into three phylogenetic groups: the Lactobacillus 
delbrueckii group, the Lactobacillus casei-Pediococcus group, and the Leuconostoc group. Based on 
subsequent phylogenetic analyses on basis of 16S rRNA sequences, the Leuconostoc group are now 
reclassified as species of the genera Leuconostoc or Weissella. The L. delbrueckii group was renamed 
the Lactobacillus acidophilus group, and the L. casei-Pediococcus group was split into further subgroups 
(L. salivarius group, L. reuteri group, L. buchneri group, and L. plantarum group) and the new genus 
Pediococcus [6, 7]. 
Genomic and genetic tools facilitate current probiotic researches
During the last decades, the growing collections of genomic sequences opened new avenues to 
obtain molecular insights in probiotic functionality and to decipher functional properties in bacteria 
and their hosts [5, 8]. With the access to genetic information available in the genome sequences in 
combination with comparative genomics, there is the possibility to correlate genotypic variation, 
to the presence and absence of a relevant probiotic function to identify potential probiotic effector 
genes and molecules involved in host-probiotic interactions. Successful strategies are exemplified 
by the identification of the gene encoding the mannose-specific adhesin in L. plantarum [9, 10] 
and the gene cluster encoding a pilin-like surface structure of Lactobacillus rhamnosus GG [11], 
which are both involved in intestinal adherence. Moreover, sequenced genomes can be employed 
in functional genomics approaches, including microarray-based transcriptional profiling that can 
provide comprehensive information on the transcriptional adaptation of a bacterium towards 
changes in its environment [12]. These transcriptomic profiles can provide associations of the 
expression of conserved genes to specific functional traits, which cannot be deduced from 
comparative genomic analysis. For example, such transcriptome-trait matching approach has 
been employed to identify genetic biomarkers of gastrointestinal (GI) survival, which facilitated 
the optimization of probiotic culture condition to improve their intestinal delivery in a viable 
form [13]. Moreover, annotated Lactobacillus genomes and in silico metabolic pathway prediction 
models provide comprehensive information about candidate effector genes to further identify key 
biological pathways that are important for the observed probiotic functions [12]. 
Functional validation is required to establish the link between specific phenotypes and the candidate 
genes selected from genome/transcriptome-trait matching approaches. Such validation is often 
achieved by genetic engineering, using targeted gene disruption by insertion or replacement 
through homologous recombination [12]. Alternatively, bacteriophage derived recombination 
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elements can also be employed for site-specific integration and provide high efficacy genetic 
engineering methodology [14, 15]. Alternative to gene disruption, (controlled) gene expression 
systems are also often employed in the validation of gene-function relations. Among the controlled 
expression systems, the nisin-controlled gene expression (NICE) system has been widely applied 
in Lactobacillus [12], but also other systems are available, including the sakacin-[16] and lactose-
inducible [17] expression systems. Finally, besides controlled expression, in certain approaches 
constitutive gene expression systems are preferred and can be developed on basis of known 
constitutive promoters, such as the L-lactate dehydrogenase (ldhL) promoter [18, 19]. 
Lactobacillus plantarum WCFS1 as a model probiotic organism
L. plantarum is found in various environmental habitats, including a plethora of fermentations, 
ranging from dairy to meat and vegetables [20, 21]. Besides this dietary abundance, this species 
is frequently encountered as a natural inhabitant of the GI tract and specific strains are marketed 
as probiotics [22]. The genome sequence of several L. plantarum strains is available in the public 
domain, allowing the effective investigation of the genes and regulatory mechanisms underlying 
the observed GI tract persistence of the different members of this species [23, 24]. The L. 
plantarum genome appears to be the largest among the lactic acid bacteria genomes sequenced 
to date [25] , and contains a large amount of genes involved in carbon metabolism, as well as in 
regulatory and (sugar) transport functions. The overrepresentation of these functions reflects the 
flexibility and versatility of this species that can readily adapt to diverse environmental niches 
and the corresponding physicochemical conditions [24]. L. plantarum WCFS1 is a single isolate of 
strain NCIMB8826, which was originally isolated from human saliva [24]. The genome sequence 
of the WCFS1 strain was the first Lactobacillus genome to be published and is predicted to contain 
3042 protein-encoding genes [24, 26]. The genome is well annotated and analyzed, including 
a comprehensive overview of secretome [27, 28], a genome-scale metabolic model [29], and 
reconstructed regulatory networks based on transcriptome data [30]. Moreover, established 
genetic tools for L. plantarum WCFS1 include gene deletion [31] and overexpression systems [16, 
32], which provide the genetic engineering capacity for experimental validations of predicted 
gene functions. The combination of these available tools, makes this species and in particular the 
WCFS1 strain a suitable model for probiotic lactobacilli for the purpose of in depth investigation 
of the molecular mechanisms underlying probiotic functions. 
Survival and persistence of L. plantarum WCFS1 in gastrointestinal tract 
Consumption of probiotic bacteria is mostly achieved through the ingestion of freshly fermented 
foods or dried bacterial products in the form of dietary supplements. During passage of the GI tract, 
probiotic bacteria encounter various stresses, including acidity in the stomach, bile and digestive 
enzymes in the intestine, as well as osmotic stress and oxygen gradient throughout the digestive 
tract (Figure 1). The human stomach is a harsh environment where the pH can vary from 1 during 
fasting to 5 following food intakes [33]. The low pH in the environment results in intracellular 
acidification, which reduces the proton motive force, the energy source for transmembrane 
transport, and can damage acid-sensitive enzymes and DNA [34]. Bile is the main challenge for 
probiotics in the small intestine [35]; it is harmful to cells due to its detergent properties and also 
can cause oxidative damage by the generation of free radicals. Additionally, especially the glycine-
conjugated bile acids are thought to dissipate membrane potential in a similar way as weak organic 
acids, and thereby can have antimicrobial activity [36]. The protonated forms of conjugated bile 
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acids can freely cross cell membranes and once inside the cell release protons [34], which leads 
to reduction of the intracellular pH, dissipating membrane potential, and thus acting similarly as 
organic acids. 
Figure 1. Stresses encountered by probiotics in the host GI tract (adapted from [28]). Probiotics experience 
acid stress in the stomach, bile and digestive enzymes in the small intestine and high osmolarity in the 
colon, as well as a highly variable oxygen concentration throughout the GI tract.
L. plantarum NCIMB8826 (alias WCFS1) was demonstrated to effectively survive passage of the 
human stomach, reach the ileum in high numbers, and could be detected in the colon [37]. A 
survival assay of 42 L. plantarum strains in a GI-tract mimicking environment illustrated a large 
diversity of the GI tract surviving capacity within this species [38]. Among the tested strains, 
WCFS1 was one of the better survivors and could persist at pH 2.3 for at least an hour and also 
displayed a strong tolerance to bile stress [38]. Notably, the in vitro GI survival assays employed 
in these studies was later shown to be in qualitative agreement with the GI persistence in a trial 
using healthy human volunteers [38]. Besides the survival capacity, L. plantarum WCFS1 adheres 
to intestinal molecules, including collagen I, Type II mucine, and fibronectin [39], which can also 
contribute to its persistence in the GI tract. The persistence of L. plantarum in the GI tract of 
healthy human volunteers enables its detection up to 3 days post-consumption, but after 7 days the 
levels of viable bacteria tended to decline below detection limits [37, 38], which is in agreement 
with the observation that probiotics are generally temporary inhabitants of the GI tract and do not 
exhibit long-term colonization [40].
Interaction of L. plantarum WCFS1 and host mucosa
After reaching the intestine, probiotic bacteria encounter the host intestinal microbiota and 
mucosal cells, including the activity of the mucosal immune system. The interaction between 
probiotics and immune cells is considered one of the core mechanisms to confer probiotic 
health-beneficial effects [41, 42]. In vitro studies have demonstrated that L. plantarum WCFS1 
elicits an intermediate level of immune responses when co-culture with human peripheral blood 
mononuclear cells (PBMCs) [43] and dendritic cells (DCs) [44], in comparison to several other 
strains of the same species, of which some are substantially more or less immunomodulatory 
as compared to the WCFS1 strain. The WCFS1 strain stimulates moderate production levels of 
the pro-inflammatory cytokines interleukin (IL)-12 and tumor necrosis factor alpha (TNF-α), as 
well as the anti-inflammatory cytokine IL-10. In healthy mice, this strain was shown to increase 
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regulatory DCs and regulatory T cell frequencies in the spleen and tune the systemic immunity 
toward a more regulatory status [45]. In vivo mucosal responses elicited by the WCFS1 strain were 
also determined in healthy volunteers, by determination of the gene transcription responses in 
the small intestinal mucosa after exposure to L. plantarum WCFS1 [46, 47]. Troost et al. employed 
an intestinal perfusion technique to study the direct exposure of L. plantarum WCFS1 to proximal 
small intestine for 1-hour or 6-hour periods [46]. Their results show that the exposure has the 
most impact on lipid metabolism, cellular proliferation, cell death and survival and immune 
responses. The data show that L. plantarum WCFS1 inhibited lipid metabolism and cell proliferation 
after 1-hour exposure but these pathways were upregulated after 6-hour exposure, illustrating the 
dynamic response of the mucosa to microbial stimuli. Regulatory pathways associated with cell 
death and inflammation were also triggered, but did not appear to lead to complete activated of 
the corresponding cellular response networks [46]. Samples obtained from this same study [46] 
were also subjected to studies targeting the epithelial barrier function, showing that tight junction 
related proteins (scaffold protein zonula occludens 1 and transmembrane protein occludin) were 
significantly increase in the vicinity of the tight junction structures within duodenal tissues after 
6-hour exposure to L. plantarum WCFS1 [48]. A parallel in vitro experiment using the Caco-2 
epithelial cell line showed that this enhancement in tight junction function by L. plantarum WCFS1 
is mediated through Toll-like receptor (TLR) 2 [48]. Other studies performed by van Baarlen et 
al. reported on the impact of L. plantarum WCFS1 consumption on the proximal duodenum of 
healthy adults [47]. The gene expression profiles of duodenal tissues were analyzed after 6-hour 
consumption of L. plantarum WCFS1. The results show that L. plantarum WCFS1 modulates innate 
and adaptive immune responses of small intestine, mainly genes associated with a NF-κB-related 
regulatory network. However, no signatures were detected of active triggering of pro-inflammatory 
responses, such as local immune cells infiltration [47]. Moreover, this study highlighted the distinct 
responses in duodenal mucosa elicited by consumption of L. plantarum WCFS1 bacteria harvested 
at specific time points during the bacterial growth (mid-logarithmic phase of growth, stationary 
phase of growth, or heat-killed stationary phase cells). Only consumption of stationary phase 
derived L. plantarum (live or heat-killed) leads to activation of the observed NF-κB network 
[47], whereas mid-logarithmic phase of growth derived cells induced pathways related to cell 
proliferation and biogenesis [47]. The authors pointed out that major changes take place in cell 
envelope component composition during transition from mid-logarithmic to stationary phase of 
growth which could play a critical role in the observed differential mucosal responses, which 
forms one of the fundaments of the work presented in this thesis [47].  
Current challenges 
Throughout the studies of the mechanisms underlying probiotic activity, it became apparent 
that the probiotic effects are often species and/or strain specific [49-52]. This situation has led 
more researchers to focus on the molecular characteristics of probiotic strains intending to link 
specific molecular structures to specific probiotic functions, and thereby deduce the mechanisms 
of molecular communication of probiotics. Molecules on the bacterial cell surface, such as 
peptidoglycan, teichoic acids, proteins and extracellular polysaccharides, not only play important 
roles in bacterial physiology where they are important to maintain cell integrity and morphology, 
but also are considered to be key-players in the interaction with the host mucosa through pattern 
recognition receptors (PRRs) expressed by the host cells [41, 52, 53]. These molecules are 
commonly present in Gram-positive bacteria, yet their structural properties can be substantially 
12
Chapter 1
1
diverse between species and also between strains of the same species, raising the core question 
to what extent these structural differences can influence the interaction between these bacteria 
and the host cells. To date, this question largely remains unanswered, where the majority of our 
working models of host-microbe molecular interaction are built on basis of research performed 
with exemplary strains of a species, rather than considering the diversity among strains as an 
important factor of variation.   
Outline of the thesis 
This thesis focuses on potential cell envelope effector molecules involved in interaction with the 
mammalian host cells, including lipoteichoic acids, lipo- and glyco-proteins, and extracellular 
polysaccharides, of L. plantarum WCFS1, a probiotic model strain. The contribution of these 
molecules to bacterial physiology and immunomodulatory properties were assessed by 
gene deletion strategies and functional genomics-based approaches in order to enhance our 
understanding of molecular mechanisms of host-bacterial interactions.
Chapter 2 presents an overview of existing research regarding the potential roles in probiotic 
functionality of Lactobacillus surface molecules, including peptidoglycan, teichoic acids, surface 
polysaccharides and proteins. Biosynthesis pathways and structure variations as well as interaction 
with host PRRs and immunomodulatory properties of these molecules are summarized and 
compared among Lactobacillus species/strains. With this review of the current state-of-the-art in 
probiotic effector molecule research, the subsequent chapters focus on specific molecules that 
reside in the cell envelope of L. plantarum WCFS1, and study their role in bacterial physiology, as 
well as their role as ligands in TLR2 signaling and immunomodulatory properties using human-
cell co-incubation models.   
In chapter 3 we focus on the lipoteichoic acid (LTA) of L. plantarum WCFS1. LTA is generally 
considered to signal through TLR2 and elicit pro-inflammatory responses in human cells, including 
epithelial as well as immune system cells. However, inconsistent results have been reported on 
this subject when using LTA molecules obtained from different Gram-positive bacteria. In our 
studies, two lipoteichoic acid synthase genes (ltaS1 and ltaS2) were disrupted in the WCFS1 model 
strain, allowing the confirmation of their requirement in LTA biosynthesis by this bacterium. The 
deficiency of LTA also had a drastic impact on cell division, cell morphology and growth, and 
LTA-deficient cells elicited more pro-inflammatory responses in PBMCs rather than the expected 
loss of pro-inflammatory capacity as was observed with similar mutants of L. acidophilus NCFM. 
Further studies on the signaling capacity of the purified LTA from L. plantarum WCFS1 showed 
that these molecules failed to trigger TLR2 dependent responses, which is in clear contrast to the 
highly potent TLR2 stimulatory capacity of LTA obtained from Bacillus subtilis. These results imply 
that structural differences of the LTA produced by different bacteria are prominent determinants 
for their TLR2 signaling capacity and immunomodulatory properties. 
Chapter 4 focuses on lipoproteins of L. plantarum WCFS1. Bacterial lipoproteins can be divided 
into two types, di-acyl and tri-acyl lipoproteins, which are recognized by TLR2/6 and TLR1/2 
respectively. Despite being well-recognized TLR2 ligands, lipoproteins have mainly been studied 
in pathogenic bacteria and their role in probiotic functions has barely been addressed. In chapter 
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4, a WCFS1 derivative was constructed that is deficient in prolipoprotein diacylglyceryltransferase 
(Lgt), which transfers acyl chains moiety onto lipoproteins. This deletion mutant displayed 
normal growth and cell morphology, but released substantially more lipoproteins into its culture 
supernatant as compared to the wild type strain. Moreover, lipidation deficiency of lipoproteins 
resulted in significant reduction of TLR1/2 signaling capacity but left TLR2/6 signaling unaffected, 
suggesting that lipoproteins of L. plantarum WCFS1 are predominantly (if not exclusively) tri-
acylated. The lgt deficient strain elicited more pro-inflammatory responses in PBMCs as compared 
to the wild type, indicating that the native lipoproteins could play a prominent role in dampening 
inflammation upon host-probiotic interaction.       
Chapter 5 explores the protein glycosylation machinery in L. plantarum WCFS1. Glycosylation is 
an important post-translational modification for proteins, yet has only been discovered relatively 
recent in bacteria. In order to explore protein glycosylation in probiotics, we set out to identify 
glycosyltransferases responsible for the major autolysin (Acm2) of L. plantarum WCFS1, which was 
recently found to be O-glycosylated with N-acetylhexosamine conjugates [54]. Using sequence 
similarity searches with a glycosylation associated protein found in Streptococcus parasanguinis as 
a query sequence, 6 candidate glycosyltransferase genes were identified in the WCFS1 genome 
that could play a role in protein glycosylation but were annotated to play a role in glycosylation of 
teichoic acids rather than proteins. Using gene deletion and complementation in combination with 
a lectin-based glycan detection and mass spectrometry analysis, two glycosyltransferases, GtfA and 
GtfB (formerly TagE5 and TagE6, respectively), were shown to be required for the glycosylation of 
Acm2 and other unidentified L. plantarum WCFS1 proteins. These results provide the first example 
of a general protein-glycosylation machinery in a Lactobacillus species. Furthermore, the lectin-
based detection revealed similar patterns of protein bands among 9 different L. plantarum strains, 
suggesting conserved protein glycosylation machineries in this species. 
Chapter 6 focuses on extracellular polysaccharides (EPS) in L. plantarum. Two L. plantarum strains 
SF2A35B and Lp90 display an obvious ropy phenotype, implying much higher EPS production 
levels as compared to the model strain WCFS1. Based on genome sequence comparison, both of 
the ropy strains SF2A35B and Lp90 were found to possess their own, unique polysaccharide gene 
clusters. These gene clusters were deleted and the resulting mutants were shown to have lost the 
capacity to produce large amounts of EPS, and were studied in relation to their properties in host-
bacteria interaction. The latter analyses included the comparative determination of bacterial surface 
properties and survival under GI-tract mimicking conditions, in EPS-mutants in comparison 
to their corresponding parent strains. Additionally, TLR2 signaling and immunomodulatory 
capacities of the mutant strains were compared with those obtained with their cognate wild 
type. The results illustrate strain-specific and variable impacts of the removal of the EPS in the 
background of individual L. plantarum strains, supporting the importance to evaluate and study the 
role of these cell-envelope associated molecules within the context of their producing host rather 
than in purified form.
Chapter 7 discusses the main findings of the thesis in the context of structural variations 
between bacteria and their relevance to strain specificity in host interaction.   
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Abstract
Pharmaceutical agents are widely applied for the treatment of gastrointestinal (and systemic) 
disorders and their role as modulators of host cell responses is relatively well characterized. 
By contrast, we are only beginning to understand the molecular mechanisms by which health-
promoting, probiotic bacteria act as host cell modulators. The last decade has seen a rapid 
development of the genomics field for the widely applied probiotic genus Lactobacillus, and nowadays 
dozens of full genome sequences are available, as well as sophisticated post genomic and genetic 
engineering tools. This development has enabled comparative (functional) genomics approaches 
to identify the bacterial effector molecules involved in molecular communication with the host 
system that may underlie the probiotic effects observed. These efforts can also be complemented 
with dedicated mutagenesis approaches to eliminate or alter these effector molecules, followed by 
assessment of the host interaction consequences thereof, allowing the elucidation of the molecular 
mechanisms involved in probiotic health effects. Many of these approaches have pinpointed that the 
Lactobacillus cell envelope contains several effector molecules that are pivotal in the direct signaling 
capacity of these bacteria that underlies their immunomodulatory effects, including lipoteichoic 
acid, peptidoglycan, and (glyco)proteins. Moreover, the cell envelope contains several compounds 
such as wall teichoic acid and capsular polysaccharides that may not be involved in direct signaling 
to the host cell, but still affect signaling through shielding of other bacterial effector molecules. 
Initial structural studies revealed subtle strain-and species-specific biochemical differences in the 
canonical cell envelope compounds that are involved in these host interactions. These biochemical 
variations include the degree and positioning of d-alanyl and glycosyl substitution in lipoteichoic 
acids, and acetylation of peptidoglycan. Furthermore, specific peptides derived from peptidoglycan 
and envelope associated (glyco)proteins were recently identified as potent immunomodulators. 
These findings are exciting in the light of the possibility of more pharmacological application of 
these bioactive probiotic molecules, and especially cost-effective production and targeted delivery 
of bioactive peptides seems to emerge as a feasible strategy to harness this knowledge.
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Introduction
The word ‘probiotic’ is derived from the two Greek words ‘προ’ (pro) and ‘βιοτος’ (biotic), which 
translates to ‘for life’ [1]. Nowadays, probiotics are defined as “live microorganisms which when 
administered in adequate amounts confer a health benefit on the host” [2]. The most extensively 
commercialized probiotic genera are those of Lactobacillus and Bifidobacterium [3-5], although other 
microorganisms are also employed, including the Gram-negative bacterium Escherichia coli str. 
Nissle 1917 [6, 7] and the yeast Saccharomyces boulardii [8, 9]. 
A variety of health benefits has been proposed to be associated with the consumption of probiotics, 
which are frequently related to prophylactic or therapeutic effects in specific disorders and 
diseases. Several of the proposed health benefits have been observed relatively consistently in 
clinical studies that targeted (intestinal) diseases, including the prevention of antibiotic associated 
diarrhea [10], prevention of Clostridium difficile-associated diseases [11], prevention of pouchitis 
after ileal pouch anal anastomosis [12], increased eradication rates of anti-Helicobacter pylori 
therapy [13], prevention of severe necrotizing enterocolitis [14], symptom alleviation in irritable 
bowel syndrome [15], and reduction of respiratory tract infection incidence [16]. By contrast, 
other diseases that were targeted by probiotic supplementation have generated less consistent 
clinical results and/or were less reliably observed in different studies, including prevention of 
atopic dermatitis in infants [17], extension or induction of remission periods in Irritable Bowel 
Disease patients [18-20], Traveler’s diarrhea [21], reduction of duration of active diarrhea [22], 
and relieve of childhood constipation [23].  Importantly, accurate comparison of these clinical 
studies is often hampered by substantial differences in study design, including the probiotic strain 
and dosage tested, the duration of intervention, the clinical read-outs employed to assess the 
intervention efficacy, and the target population included in the intervention. Therefore, at this 
stage it is virtually impossible to draw general conclusions on the health impact of probiotics. 
Additionally, although some health benefits may be less dependent on the probiotic strain used, 
many of the beneficial effects of probiotics are expected to be strain specific, implying that the 
proposed efficacy of a particular strain cannot be extrapolated to other probiotic strains or species 
[24]. Analogously, many of the referred meta-analyses conclude that further studies are needed to 
draw strong conclusions. As a consequence, the European Food Safety Agency (EFSA) has deemed 
the vast majority of probiotic health claims as insufficient, in probiotic strain characterization and/
or the lack of biomarkers to demonstrate a cause-effect relationship [25]. This situation has fueled 
the ambitions of the industrial and scientific community to unravel the molecular characteristics 
of probiotics and identify the effector molecules underlying the (strain-specific) clinical effects of 
probiotics. 
Probiotic modes of action 
Probiotics can potentially influence gastrointestinal and systemic health in various ways. 
One of their modes of action may be indirectly elicited via their influence on the endogenous 
microbiota of the gastrointestinal tract [26]. For example, probiotics can protect the host from 
pathogens by competitive exclusion, thereby hindering the adhesion on the intestinal surface and 
subsequent infection by pathogens [27]. Probiotics can also inhibit pathogens by acidification of 
the gut microenvironment through production of organic acids or by secretion of antimicrobial 
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compounds [28, 29]. The latter concept has elegantly been evidenced for a bacteriocin produced 
by Lactobacillus salivarius which was shown to be solely responsible for the efficient reduction of 
Listeria monocytogenes infection in mice [30]. 
Probiotics may also directly interact with the different cell lineages that reside in the intestinal 
tract mucosa. These interactions may involve epithelial cell lineages like enterocytes, Goblet cells 
and / or entero-endocrine cells (Figure 1), which play various roles in controlling local innate 
immune activity as well as in systemic control of defense-associated responses [4, 5, 31, 32]. 
Additionally, probiotics may interact with the adaptive immune system of the intestinal tract, 
which is contained predominantly in the gut-associated lymphoid tissues (GALT) of the lamina 
propria [5, 31, 33]. The small intestine lymphoid tissues are especially dominant in the Peyer’s 
patches (Figure 1), which are regions that contain follicle centers that are covered by specific, 
follicle-associated epithelium composed of ‘M’-cells that play a role as primary portal for antigen-
entry into follicle centers. Besides these dedicated follicle centers, the lamina propria of the 
mucosa is populated by various immune cells, including macrophages, dendritic cells (DCs), and 
T-cells, but are predominated by antigen presenting B cells that produce antibodies (Figure 1) [5, 
31, 33]. Among the T-cells the most important classes of lamina propria associated T cells in the 
context of probiotic function belong to the T helper (Th) and regulatory T (Treg) cells [5]. Tregs 
are the major producers of the anti-inflammatory interleukin (IL)-10, and play a key-role in the 
control of appropriate T cell responses, which includes the suppression of auto-reactive T cells and 
maintenance of tolerance [34]. The role of macrophages and DCs is related to their phagocytotic 
capacity, where macrophages are important for the removal of cell-debris and pathogens [35] 
and DCs act as dedicated antigen presenting cells that control both adaptive and innate immune 
responses [5]. Immature DCs are present in the lamina propria throughout the intestinal mucosa 
as well as in the Peyer’s Patches that upon stimulation with microbes or other factors (e.g., diet 
derived) can mature via activation of the nuclear factor (NF)-κB pathway and in their activated 
form can modulate T-cell activity via T-cell clonal expansion and/or differentiation [36, 37]. These 
direct interactions of probiotics with different cell lineages within the mucosa of the intestine are 
considered to involve direct molecular recognition of specific microbial components, designated 
Microbe Associated Molecular Patterns (MAMPs) that are recognized by corresponding Pattern 
Recognition Receptors (PRRs) expressed by host cells (Figure 2). These PRRs include Toll-Like 
Receptors (TLRs), Nucleotide Oligomerization Domain (NOD)-Like Receptors (NLRs) and 
C-type Lectin Receptors (CLRs) [4, 5, 38].  
In a healthy situation, the integrated interactions of the endogenous intestinal microbiota with 
the mucosal tissue leads to a state of homeostasis that sustains an adequate and balanced mucosal 
barrier function and prevents excessive immune responses. This homeostasis or balance involves all 
components of the mucosal defense systems, including mucin production, antimicrobial activities 
produced by the innate immune system, and specific responses elicited in the adaptive immune 
system [5, 31, 32]. However, this situation may be (transiently) compromised, for example 
by excessive abundance of certain microbial groups in the endogenous microbiota or specific 
pathogens [5, 39]. This state is referred to as dysbiosis, in which defense responses are unbalanced 
and may eventually lead to disease [5, 40]. Direct interactions between probiotic bacteria and 
the mucosa of the intestine may play a role in restoration and / or maintenance of homeostasis 
or prevention of deterioration of barrier functions in dysbiosis situations that can eventually 
contribute to the prevention of disease development [41]. Therefore, it is of great importance 
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to better understand the precise biochemical nature of the interactions between the probiotic 
MAMPs or effector molecules and their cognate PRRs. Especially the molecular mechanisms and 
corresponding effector molecules (MAMPs) that underlie strain specific probiotic effects in the 
mucosa remain largely unknown. Moreover, it is also poorly understood how the multi-factorial 
PRR-MAMP interactions that trigger a complex network of signal transduction cascades is 
integrated into the overall response that they elicit in terms of changed transcriptional patterns in 
the cell nucleus, which are the ultimate determinant of the host (immunomodulatory) responses. 
It is generally considered plausible that a prominent fraction of the probiotic effector molecules 
resides in the bacterial cell envelope, as this part of the microbial cell is the first to interact 
with intestinal host cells [4, 31, 38]. Analogously, several PRRs have been reported to specifically 
recognize certain microbial cell envelope components or fragments thereof, including 
lipopolysaccharides, peptidoglycan, teichoic acids, lipoproteins or other surface (glyco)proteins, 
and cell envelope associated polysaccharides [38]. The remainder of this review will focus on the 
state-of-the-art knowledge on Lactobacillus-derived cell envelope associated components that may 
vary in terms of their biochemistry and structural properties and as a consequence may play 
distinct roles as probiotic effector molecules in different probiotic strains and species which might 
provide the molecular basis to explain the strain- and species-specific probiotic effects observed. 
Figure 1. The intestinal mucosa tissue (Modified from [5]). The intestinal mucosa consists of a one-cell-
thick epithelium layer, separating the highly colonized intestinal lumen from the lamina propria. Specialized 
epithelial cells, including mucin-producing Goblet cells and antimicrobial-protein-secreting Paneth cells, 
limit the exposure of mucosa tissue to the bacteria. The small intestine lymphoid tissues are dominant in the 
Peyer’s patch, which is a region containing follicle centres covered by follicle-associated epithelium. The 
follicle-associated epithelium contains Microfold (M) cells, which transports microbial antigen across the 
epithelial barrier to antigen-presenting cells, such as dendritic cells (DC) and macrophages underneath. 
The lamina propria of the mucosa is populated by various immune cells, including macrophages, DCs, 
T-cells (T) and predominately the antibody-producing B-cells (B). slgA: secreted IgA.
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Probiotic surface effector molecules
Peptidoglycan
The cell wall of Gram-positive bacteria, including lactobacilli, consists of a thick peptidoglycan 
layer, which is a multilayered, cross-linked glycan chain with a repeating unit of β-1,4-linked 
N-acetlyglucosamine (GlcNAc)and N-acetylmuramic acid (MurNAc) [4, 42]. These multilayered 
and stacked glycan strands are linked via peptide bridges and form a rigid structure to maintain 
the integrity of the underlying protoplast against internal turgor pressure [38, 42-44].  This layer 
also serves as a platform for the anchoring of cell surface molecules (Figure 2), such as wall 
teichoic acids (WTA), wall polysaccharides and surface proteins [38, 42, 45]. In lactobacilli, 
the disaccharide unit of peptidoglycan can undergo a wide range of modifications, which have 
important consequences for bacterial physiology. For example, N-deacetylation of GlcNAc 
and/or MurNAc in Lactobacillus fermentum [46] and 6-O-acetylation of MurNAc in Lactobacillus 
casei, L. acidophilus and L. fermentum [38, 42, 47] have been described. The N-deacetylation and 
6-O-acetylation in GlcNAc/MurNAc have shown to reduce the susceptibility for autolysis by 
lysozyme, which is a bacteriolytic enzyme present in the host innate immune system [38, 47]. An 
in silico analysis of the complete genome sequences of 12 Lactobacillus species showed that most 
lactobacilli lack the pgdA gene, encoding a peptidoglycan GlcNAc deacetylase [48], but 10 out of 
the 12 species have at least one copy a peptidoglycan O-acetyltransferase gene, oatA [38, 49]. This 
analysis implies that O-acetylation of peptidoglycan occurs in the majority of Lactobacillus species. 
Figure 2. Molecular interaction of Lactobacillus surface components and epithelial Pattern Recognition 
Receptors (PRRs). (Modified from [5] and [57]). The Lactobacillus cell envelope components or fragments 
thereof, such as polysaccharides, peptidoglycan (PG), teichoic acids, lipoproteins or surface (glyco)
proteins, have been reported to be specifically recognized by PRRs, including Toll-like receptors (TLRs), 
Nucleotide Oligomerization Domain (NOD)-Like Receptors (NLRs), and C-type Lectin Receptors 
(CLRs). Pentapeptides derived from PG autolysis or enzymatic degradation as well as lipoproteins are 
signaling through TLR2. Lipoteichoic acid (LTA) commonly contains di-acyl and/or tri-acyl glycolipids, 
which are proposed to signal through heterodimers TLR2/6 and TLR2/1, respectively. The capability of 
wall teichoic acid (WTA) to induce TLR2 signaling still remains debated yet it is thought WTA might shield 
other surface molecules from recognition and / or signaling. Glycoproteins might be recognized and signal 
through C-type Lectin Receptors (CLRs). Lactobacillus surface polysaccharides are thought to contribute 
by a shielding effect for other microorganism-associated molecular patterns (MAMPs).
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There are two paralogues of O-acetyltransferase found in L. plantarum WCFS1 and L. sakei 23K 
[38]. Bernard et al. found that in L. plantarum WCFS1 these O-acetyltransferases, OatA and OatB, 
are responsible for O-acetylation of MurNAc and GlcNAc, and consequently results in resistance 
against lysozyme and endogenous autolysins, respectively. More specifically, OatB reduces the 
peptidoglycan autolysis by inhibiting the activity of the acm2-encoded N-acetylglucosaminidase, 
the major L. plantarum autolysin [50]. The impact of these two modifications on peptidoglycan 
degradation and remodeling, as well as immunomodulation still remain to be determined.
The peptide bridge of peptidoglycan consists of a pentapeptide chain, containing l- and d-amino 
acids and one diamino acid (either l-Lys or meso-diaminopimelic acid) to allow cross-linkage. In 
most lactobacilli, the peptide chain consist of l-Ala-d-Glu-l-Lys-d-Ala-d-Asp (position 1 to 5), and 
the l-Lys at position 3 is cross-linked to d-Asp of an adjacent stem peptide (Figure 3A). Other types 
of peptide bridges have also been found, for example the linkage via l-Orn (l-ornithine), instead of 
l-Lys (Figure 3A), with d-Asp in L. fermentum and Lactobacillus cellobiosus or direct linkage through 
meso-diaminopimelic acid (meso-A2pm) in L. plantarum (Figure 3B) [38, 44, 51]. The l-Lys/l-Orn-
d-Asp bridge first requires RacD, an aspartate racemase, to generate d-Asp from l-Asp, followed 
by cross-linking that is catalyzed by a ligase, AslA [52, 53]. The analysis of sequenced Lactobacillus 
genomes confirms that orthologues of RacD and AslA are found in all l-Lys/l-Orn-d-Asp types 
lactobacilli, but AslA is absent in L. plantarum strains that harbor peptidoglycan containing meso-
A2pm. The racD gene, however, is also found in meso-A2pm type species, suggesting that d-Asp 
might have a metabolic function besides peptidoglycan biosynthesis [38]. Another important 
feature of the peptide stems of many Lactobacillus species, including L. casei and L. plantarum, 
is the substitution of the terminal d-Ala with d-lactate [38, 42]. This determines the bacterial 
resistance to vancomycin, which acts as an antibiotic by binding to d-Ala containing peptidoglycan 
precursors, thereby preventing the proper assembly of peptidoglycan. The d-lactate containing 
peptidoglycan precursors displays a 1000-fold decreased affinity to vancomycin as compared to 
d-Ala-containing peptidoglycan [42]. Besides the compositions and linkage types of the peptide 
bridges, post-assembly modifications allow even more diversity in peptidoglycan structures, 
including amidations of d-Glu, meso-A2pm and d-Asp which have been reported in L. casei and L. 
plantarum [54, 55]. An asparagines synthase, encoded by asnH, has recently been identified and 
predicted to be involved in d-Asp amidation in Lactococcus lactis [56]. Homologues of asnH are found 
in sequenced Lactobacillus genomes, even in the meso-A2pm type L. plantarum, which indicates d-Asp 
amidation is a general feature of lactobacilli and AsnH might also be responsible for amidation 
other than d-Asp in pentapeptide bridges of peptidoglycan (such as meso-A2pm or d-Glu) [38]. 
Figure 3. Two types of peptide bridge of 
peptidoglycan in Lactobacillus. (A) The 
peptide chain in most lactobacilli consists 
of l-Ala-d-Glu-l-Lys-d-Ala-d-Asp with 
l-Lys cross-linked to d-Asp of an adjacent 
stem peptide. However, the linkage via 
l-Orn (l-ornithine), instead of l-Lys, 
with d-Asp has been found in Lactobacillus 
fermentum and Lactobacillus cellobiosus. (B) 
Another type of peptide bridge, present 
in L. plantarum, is directly linked through 
meso-diaminopimelic acid (meso-A2pm).
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The precise role of amidation remains to be established. However, the degree of d-Asp amidation 
strongly affects the sensitivity of the bacterium to endogenous autolysins but also to lysozyme 
and the cationic antimicrobial nisin [56]. Taken together, these studies underline the notion that 
despite the universal conservation of peptidoglycan in Gram-positive bacteria, its composition, 
cross-linking and modification varies considerably among different Lactobacillus species [42, 44, 
45, 51, 54, 55]. Moreover, it requires further investigation to determine whether these variations 
also occur among different strains of the same species. Importantly, the biochemical differences in 
peptidoglycan affect the susceptibility to lysozyme and endogenous autolysins, which affects the 
formation of fragments recognizable by the host immune system (see below). 
It has been suggested that specific small fragments of peptidoglycan derived from enzymatic 
processing of peptidoglycan or normal cell wall remodeling, are recognized by TLR2 and NLRs 
of the host innate immune system [38, 55]. Highly O-acetylated peptidoglycan has been shown to 
be more resistant to hydrolysis by human lysozyme [56], thereby reducing the release of NLRs 
recognizable peptidoglycan fragments which may result in altered innate immune responses of 
antigen presenting cells, such as DCs and macrophages [57]. One example is the sensitivity of 
peptidoglycan to N-acetylmuramidase that is negatively correlated to the ability of Lactobacillus 
strains to induce IL-12 in mouse-derived macrophages [58]. Moreover, peptidoglycan from 
N-acetylmuramidase sensitive strains was demonstrated to be able to inhibit the IL-12 production 
induced by L. casei peptidoglycan, which is a strain insensitive to N-acetylmuramidase, in a TLR2-
dependent- and independent manner [59]. The fact that the suppression of IL-12 production was 
also observed in TLR2-deficient macrophages suggests that NLRP2 (NOD-, LRR- and pyrin 
domain-containing 2) is also involved in this inhibitory mechanism [59]. Furthermore, host 
receptors have different affinities to distinct structures of peptidoglycan fragments. It has been 
established that TLR2 binds more favorably to A2pm-containing peptidoglycan fragments than to 
lysine-containing ones [55, 60]. However, other studies debate that peptidoglycan fragments can 
induce TLR2 signaling [61]. In this respect our view might be blurred by minute contaminations in 
isolated peptidoglycan with other highly immunogenic cell wall components, such as lipoproteins 
[62]. 
It is more generally accepted that peptidoglycan fragments are recognized by NLRs after 
internalization into host cells [61, 63]. The NLR protein NLRP1 (NOD-, LRR- and pyrin domain-
containing 1) recognizes γ-d-glutamyl-meso-A2pm, which is present in all Gram-negative bacteria 
and specific Gram-positive probiotics (e.g. L. plantarum), while NLRP2 interacts with muramyl 
dipeptides (MurNAc-l-Ala-d-Glu), which are found universally in all peptidoglycan variants 
[31, 42]. NLRP1 and NLRP2 belong to the NLR family, which is composed of cytoplasmic 
proteins and characterized by a C-terminal domain with leucine-rich repeats, nucleotide-
binding oligomerization domain, and an N-terminal caspase-recruitment domain [64]. An 
elegant study illustrated an NLRP2-dependent anti-inflammatory capacity of peptidoglycan-
derived muropeptides (MurNAc-l-Ala-d-Glu-l-Lys) from Lactobacillus salivarius Ls33 [63]. The 
peptidoglycan purified from the strain Ls33 displayed a protective effect in a trinitrobenzene 
sulfonic acid (TNBS)-induced colitis mouse model, whereas peptidoglycan isolated from L. 
acidophilus NCFM lacked this capacity. This protective effect appeared mediated by local IL-10 
production [63, 65]. This distinct property could be pinpointed to the difference of muropeptides 
released from peptidoglycan of these strains, even though they possess the same l-Lys-d-Asn 
type linkage. While NCFM released the muropeptide GlcNAc-MurNAc-l-Ala-d-Glu-l-Lys-d-Asn 
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exclusively, carrying an epsilon-linked d-Asn, Ls33 produced an additional muropeptide without 
d-Asn (GlcNAc-MurNAc-l-Ala-d-Glu-l-Lys). Both muropeptides were chemically synthesized, 
confirming that this strain-specific immunomodulatory property is determined by the subtle 
difference in the structure of the muropeptides [63, 65]. The authors proposed that different 
peptidoglycan turnover, in relation to amidases and γ-d-glutaminyl-Lysine endopeptidase, might 
be the reason of the observed differentiated release of muropeptides. In addition, the peptide 
transporters, such as PepT1 or PepT2, might influence the internalization of muropeptides, which 
is required for the intracellular NLRP2 recognition. Interestingly, the mutations in leucine-rich 
repeats of NLRP2 are associated with Crohn’s disease [66]. These mutations also defect the NLRP2 
recognition of muramyl dipeptide [67]. This hints towards a connection between peptidoglycan 
and probiotic effects in Crohn’s disease. Taken together, these studies clearly demonstrate the 
important roles of Lactobacillus peptidoglycan components in host NLR signaling, as well as the 
significant impact of species-specific variations in peptidoglycan on its immunomodulatory effects, 
and consequently on probiotic functionality of lactobacilli [5, 63, 65].  
Teichoic acid
Lactobacilli and most other Gram-positive bacteria synthesize teichoic acids (TAs) which are 
anionic polymers consisting of repeating units of alditol-phosphate. TAs are typically present in 
substantial amounts in the cell envelope and provide a net anionic charge at the cell surface, 
contributing to the mechanical strength of the cell wall together with peptidoglycan [38, 42]. 
The anionic charge of TAs is also involved in functional aspects of the cell wall, e.g. playing a 
role in processes such as cell division [68], metal cation homeostasis (particularly Mg2+) [69, 
70], and resistance toward antimicrobial substances [71, 72]. TAs are produced in two distinct 
forms, lipoteichoic acid (LTA) and wall teichoic acid (WTA). LTA is anchored in the cytoplasmic 
membrane through a terminal glycolipid moiety, whereas WTA is covalently linked to MurNAc of 
peptidoglycan via a disaccharide linkage unit [73]. The LTA polymer typically consists of glycerol-
phosphate (Gro-P) repeating units, whereas WTA of lactobacilli is commonly composed of either 
Gro-P or ribitol-phosphate (Rbo-P) repeating units [74-76]. The backbone polymer of both WTA 
and LTA can be substituted with D-Alanine and glycosyl moieties. These glycosylations can involve 
various glycosyl residues, e.g. glucose, galactose, rhamnose, GlcNAc, and GalNAc in either α- or 
β-configurations [77, 78]. 
Despite the structural similarity of the backbone of both molecules, the LTA and WTA backbone 
polymers are synthesized via independent pathways using different precursor molecules [77, 79]. 
LTA is directly polymerized on a glycolipid carrier, typically a di- or trihexosyldiacylglycerol, 
in which the composition and conformation of the glycoside moiety may vary between species 
[80-82]. The biosynthetic pathway of LTA is well established [83-86]. First, glycolipid anchors 
are synthesized in the cytoplasm, followed by translocation from the inner to the outer face of 
the cytoplasmic membrane by a flippase, encoded by ltaA [83]. The subsequent generation of the 
poly(Gro-P) chain  involves a primase (LtaP) that adds the initial Gro-P residue, and a polymerase 
(LtaS) that polymerizes the Gro-P backbone using phosphatidylglycerol as substrate [79, 86]. The 
presence of at least one ltaS homologous in all completed Lactobacillus genomes suggests that LTA 
is present universally among these species [38]. Recently, an ltaS deletion mutant was constructed 
in L. acidophilus NCFM and its LTA-deficient phenotype confirmed the involvement of ltaS in 
LTA biosynthesis. The structure of LTA has been determined in L. casei, L. rhamnosus, L. delbrueckii, 
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and L. plantarum and all these polymers are composed of 1,3-linked poly(Gro-P) and contain 
a glycolipid anchor which consists of Glc-β-1→6Gal-α-1→2Glc-α-1→3-diacylglycerol (Figure 
4A) [82, 87-89]. The LTA isolated from L. plantarum KCTC 10887BP contains an extra acyl chain 
attached to the C6 carbon of the glucose linked to di-acyl chains [82]. Similarly, the L. casei LTA 
was also shown to contain a lipid anchor which is partially substituted with an additional, third 
fatty acid connected at the same position [87]. This additional acyl chain is thought to be important 
for TLR2 signaling, as the acyl chains of lipopeptides interact with the hydrophobic pocket in 
the extracellular domain of TLR2 [57, 82, 90]. The diacyl lipid chains are recognized by TLR2/6 
heterodimers, whereas triacylated lipoproteins are recognized by TLR2/1 heterodimers [57, 90]. 
However, how this structural difference in LTA contributes to immunomodulatory effects is not 
determined yet. 
Although the LTA backbone polymer structure appears conserved in lactobacilli, it is likely that 
the LTA molecules produced vary between different species or even strains of the same species. 
Structural variations are anticipated to include different glycolipid anchors, chain length, and the 
degree and composition of the polymer substitutions with glycosyl moieties and d-alanyl residues 
[38, 77, 91-95]. As an illustration of these variations, the LTA polymer contains 20-22 Gro-P 
residues in L. plantarum [96] and L. reuteri [97], but has 37-44 residues in L. casei DSM20221 [87], 
and 33 and 50 residues in L. delbrueckii [88] and L. rhamnosus [89], respectively. Moreover, the LTAs 
of different strains of L. delbrueckii appeared to vary in their α-glucosyl- and D-alanyl-substitution 
level, which impacted on strain specific phage sensitivity, suggesting a role for LTA as a phage-
docking molecule [88]. The dltABCD genes have been demonstrated to be responsible for D-alanine 
activation, transport, and substitution to LTA [77, 79]. The dlt operon is highly conserved among 
lactobacilli, and the genetic and enzymatic characteristics of this system have been studied in detail 
in L. casei [98-102]. Mutants of the dlt system have been described in L. rhamnosus [89, 103], L. reuteri 
[97], and L. plantarum [104], revealing the impact of d-alanyl depletion on cell morphology, biofilm 
Figure 4. Lactobacillus teichoic acid backbones. (A) The structure of lipoteichoic acid (LTA) backbone 
in Lactobacillus, which consists of 1, 3-linked poly(glycerol-phosphate) and a glycolipid anchor which 
consists of Glc-β-1→6Gal-α-1→2Glc-α-1→3-diacylglycerol. Some LTAs contain an extra acyl chain 
(R3) attached to the C6 carbon of the glucose linked to di-acyl chains. (Modified from [88]). (B) Two 
types of wall teichoic acid (WTA), glycerol-type and ribitol-type. In Lactobacillus plantarum, glycerol-type 
WTA has glucose substitutions being parts of the repeating backbones. Ribitol-type WTA has also glucose 
substitutions added to the backbone, possibly on the –OH group of ribitol C2 to C4.  
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formation, colonization in the gastrointestinal tract, and host immune responses. By contrast to 
the mechanism of d-alanylation of LTA which is well understood, the genes and enzymes involved 
in LTA glycosylation are poorly characterized, which in part may be due to the high variation of the 
glycosyl components involved, as well as their substitution linkage type and  α-/β-configurations. 
The immunomodulatory effects of purified LTAs have been studied in various lactobacilli, 
including L. plantarum WCFS1 [104], L. plantarum KCTC10887BP [105], L. casei YIT9029 [106] 
and L. fermentum YIT0159 [106]. The LTA purified from WCFS1, YIT9029 and YIT0159 induces 
TNF-α production in a TLR2-dependent manner [104, 106], whereas LTA from L. plantarum 
KCTC10887BP, attenuates the TNF-α production induced by LTA from S. aureus [105]. Jang et 
al. suggested that the third acyl chain and the unsaturated fatty acids in the lipid anchor as well 
as the glucose and galactose substitutions of L. plantarum KCTC10887BP LTA may be responsible 
for this attenuating effect [82]. Yet, LTA of L. plantarum WCFS1 also consists of tri-acylated lipid 
anchors while other LTA structures (from L. casei YIT9029 and L. fermentum YIT0159) have not 
been determined. Hence, it is premature to draw a conclusion on the exact factors that determine 
the immunomodulatory effects of LTAs. 
Besides studies involving purified LTA, the impact of LTA modifications when it resides in 
the cell envelope of intact cells has also been studied in several lactobacilli. An LTA deficient 
mutant of L. acidophilus NCFM exhibits enhanced anti-inflammatory capacity in an in vitro assay 
employing DCs, but also in vivo in a mouse model for colitis, where this mutant was demonstrated 
to protect mice from dextran sulfate sodium (DSS)-established colitis [107, 108]. In addition, 
the same group further tested the ability of this LTA-deficient mutant to regulate inflammation 
in a mouse colonic polyposis model [109]. They employed this unique mouse model in which 
the adenomatous polyposis coli gene (apc), the gate-keeper of colonic epithelial proliferation, 
was truncated specifically in the colon and distal ileum which resulted in extensive polyposis 
throughout the colon and distal ileum. Oral treatment with the LTA deficient mutant was shown to 
result in a reduced frequency of interferon-γ-producing CD4+ T-cells and attenuation of colonic 
inflammation [109]. Studies that employed dlt mutants that produce LTA devoid of d-alanylation, 
indicate that TLR2-mediated LTA-signaling requires the presence of d-alanylation in LTA in the 
case of L. plantarum NCIMB8826 [104]. However, the influence of d-alanylation with respect to its 
signaling capacity appears to be less profound in L. rhamnosus GG [89]. Moreover, the dlt mutant of 
L. plantarum NCIMB8826, had significantly enhanced anti-inflammatory capacity compared to the 
wild-type strain, which was shown in both in vitro immune assays as well as in a mouse colitis model 
[104]. Notably, the dlt mutant of L. rhamnosus GG suppresses colitis symptoms in a mouse model 
as well, but the in vitro immunomodulation data obtained did not consistently show enhanced 
anti-inflammatory capacities for this strain in comparison with the wild-type strain [89, 110]. 
In general, loss of d-alanylation of LTA appears to generate more anti-inflammatory capacities 
for the producing Lactobacillus species, yet different in vitro and in vivo experimental set-ups (e.g. 
mouse-derived macrophages, DCs, or human peripheral blood mononuclear cells (PBMCs)) 
as well as various LTA sources (e.g. purified LTA, heat-killed bacteria or whole bacterial cells) 
could contribute to the results that are obtained. Hence, the direct link between subtle structural 
differences of LTA and differential host immune responses have not yet reached unambiguous 
conclusions. 
In contrast to LTA, WTA is not universally synthesized in the cell wall of lactobacilli, e.g. the 
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genomes of L. rhamnosus, L. casei, L. fermentum, and L. reuteri lack the genetic capacity to produce 
WTA [38, 111]. Lactobacilli that do produce WTA typically synthesize the Gro-P type backbone 
polymer [38, 111], with the notable exception of L. plantarum for which strains have been reported 
to produce either Gro-P or Rbo-P type WTA [112-115]. Moreover, the frequent decoration with 
a-glucosyl residues distinguishes the WTA at the strain level [116]. Unlike LTA synthesis, WTA 
is assembled on undecaprenylphosphate as lipid carrier during the biosynthesis process [77, 
79, 117, 118]. Prior to the main chain formation, the linkage unit between the main chain and 
peptidoglycan, which is commonly (Gro-P)2-3-4ManNAc-β-1→4GlcNAc, is generated on the 
lipid carrier by sequential reactions catalyzed by TagO, TagA, and TagB [77, 79]. Subsequently, the 
main chain biosynthesis is performed through different pathways for poly(Gro-P) and poly(Rbo-P) 
backbone polymer chains (via the tagDF and tarIJKL gene clusters, respectively [117, 119-121]), 
while for both backbone types the repeating units are derived from nucleotide-activated alditol 
phosphate as substrates for the polymerization reaction. In L. plantarum strains the presence or 
absence of the tag and tar clusters in the genome is directly related to the type of WTA synthesized 
by the strain (Figure 4B)[115]. The tar locus is commonly conserved among the strains regardless 
of the WTA backbone polymer variant synthesized, whereas the tag locus is present only in the 
strains that produce the Gro-P type WTA [115]. Hence, the strains with Gro-P type WTA harbor 
both loci in the genome, however the tar locus has been shown to be inactive at the transcriptional 
level [115]. Recent work in our laboratory included the mutation of the tag locus in the Gro-P 
type WTA producing L. plantarum WCFS1, which led to a marked up-regulation of the tar locus 
and resulted in switching of WTA type from the conventional Gro-P type to an alternative Rbo-P 
type. These results demonstrated that the strains with Gro-P type WTA possesses the capacity to 
produce Rbo-P type WTA, but this capacity appears to be repressed under the conditions tested so 
far. Moreover, a mutant devoid of any WTA was also constructed by deleting tagO [122], the gene 
encoding for the enzyme that catalyzes the initial reaction in WTA biosynthesis. The deficiency as 
well as the artificial backbone switching of WTA corresponded to differential immunomodulatory 
properties in comparison with the wild-type bacterium [123]. A study on the structural diversity 
of WTA revealed that within a collection of L. plantarum strains six variants of the WTA repeating 
units could be identified (3 Gro-P and 3 Rbo-P backbone polymers with glucosyl substitutions in 
variable positions), suggesting that variation in WTA structure is important for the lifestyle of this 
bacterium [124]. 
Despite the complete separation in terms of their biosynthetic pathways, WTA and LTA backbones 
share the same d-alanine incorporation machinery [79]. Moreover, several additional genes 
that are involved in WTA glycosylation have been identified;  tagE of B. subtilis is involved in 
α-Glc decoration of its Gro-P type WTA [125, 126], tarM of S. aureus is involved in α-GlcNAc 
decoration of the Rbo-P type WTA [127], and the gltA−gltB and gtcA−lmo2550 genes of Listeria 
monocytogenes are involved in the β-Glc and α-GlcNAc decoration of the serotype-specific WTAs 
of this species, respectively [128-130]. In the six different WTA structures identified in different 
strains of L. plantarum, α-glucosyl residues in various positions within the polymers contribute 
to the structural diversity [116]. Interestingly, many tagE and gtcA homologues (tagE1−tagE6 
and gtcA1−gtcA3, respectively) are conserved among the genomes of L. plantarum WCFS1 
[131, 132], JDM1 [133], and ST-III [134]. Based on comparative genome hybridization data using 
L. plantarum WCFS1 DNA microarrays, all 42 analyzed L. plantarum strains have multiple but 
variable tagE and gtcA homologues [135]. This observation suggests that variations in presence/
absence patterns and expression levels of the tagE and gtcA gene sets among the different strains 
29
Probiotic effector molecules
2
plays a role in the production of the varied WTA structures. Genetic engineering may resolve the 
role of these genes in the determination of the WTA structural properties and may enable the 
elucidation of the impact of WTA structure on the immunomodulatory capacities of individual 
strains in an isogenic background.  
In contrast to LTA, the immunomodulatory roles of WTA have been less extensively investigated 
and remain poorly understood. The role of WTA in TLR2-dependent immunomodulation remains 
debated [136], which may in part be due to the lack of lipid-anchoring of WTA, which was 
reported to be essential for TLR2 recognition of LTA [57]. However, the anionic property and 
d-alanylation of WTA may still contribute to immune signaling [57, 137]. It has recently been 
proposed that the WTAs of L. casei Shirota and L. plantarum subsp. plantarum ATCC14917 induce IL-
10 production synergistically with LTA [138]. Furthermore, recent results in our group revealed 
that a WTA-deficient mutant of L. plantarum WCFS1 displayed increased NF-κB activation in an 
assay using TLR2/6 expressing HEK cells but no signaling was detected using WTA purified from 
the parental strain, suggesting a shielding effect of WTA rather than a direct signaling activity 
[123]. Moreover, mutation of a transcriptional regulator in L. plantarum WCFS1 (Lp_2991) that is 
anticipated to be involved in regulation of an immediately downstream encoded glycosyltransferase 
(GtcA3) which might be involved in TA glycoyslation, elicited higher IL-10 and TNF-α secretion 
in human monocyte-derived DCs [139]. Intriguingly, the mutation of this regulator also affects the 
expression of tagO, the gene involved in the initial step of WTA biosynthesis. In conclusion, further 
expansion of our knowledge of the subtle structural diversity among LTA and WTA molecules and 
its consequences for immunomodulation is required to eventually fully elucidate and appreciate 
their role in species and / or strain specificity in terms of immunomodulation.
Cell surface polysaccharides
Polysaccharides are ubiquitously found in Lactobacillus cell walls. They can be covalently linked 
to MurNAc of peptidoglycan (wall polysaccharides, WPS), loosely attached to the cell envelope 
(capsular polysaccharides, CPS) or released into the environment (exopolysaccharides, EPS). 
Despite the different terminologies, the localization and abundance of polysaccharides depends 
strongly on the bacterial growth conditions, thereby making the differentiation of WPS, CPS and 
EPS quite arbitrary [29, 42]. Therefore, we will discuss this group of molecules as cell surface 
polysaccharides without distinguishing their specific (predicted) positioning or linkage to 
the other components of the cell envelope. The structures of cell surface polysaccharides vary 
considerably in terms of the sugar compositions, modes of sugar-linkages, polymer branching, 
as well as their modifications such as phosphorylations, acetylations, and pyruvylations. The 
majority of surface polysaccharides known in lactobacilli are heteropolysaccharides, in which the 
polymer is composed of regular repeating units that contain different sugars, commonly including 
d-glucose, d-galactose and l-rhamnose, and in a few cases also N-acetylglucosamine (GlcNAc), 
N-acetylgalactosamine (GalNAc) or glucuronic acid (GlcA) [140]. 
The polysaccharide biosynthesis genes are organized in monocistronically-transcribed operons 
[141]. The sugar repeat unit builds up intracellularly using nucleotide-sugars as precursors and 
undecaprenyl phosphate as a recycling lipid carrier. The biosynthesis is initiated by a priming 
glycosyl transferase (WchA) that couples the first monosaccharide phosphate to the membrane-
associated lipid carrier. Subsequently the additional glycosyltransferases encoded by the gene 
cluster sequentially add monosaccharides to this membrane-anchored intermediate to generate 
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the repeat unit. The lipid-linked repeat unit is transported across the cytoplasmic membrane by 
the Wzx flippase, followed by the polymerization (Wzy) of individual repeat units to form the 
mature surface polysaccharide, which can then be attached to the peptidoglycan by the Wzd-Wze 
complex [141]. 
The genes involved in cell surface polysaccharide biosynthesis in lactobacilli are organized in gene 
clusters that share substantial structural similarity with those found in streptococci, and in many 
other bacteria. For example, four gene clusters involved in cell-surface polysaccharide biosynthesis 
that are encoded in L. plantarum WCFS1 have recently been characterized [38, 122, 142]. 
Individual deletions of these clusters led to altered surface polysaccharide compositions in these 
L. plantarum WCFS1-derivatives, supporting their roles in production of cell surface associated 
polymeric glycan structures. Notably, the deletion of all four clusters (cps1A-I, 2A-K, 3A-I and 4A-
J) in the same background led not only to a substantial reduction of cell-surface polysaccharide 
production but also had dramatic impacts on cell morphology, and growth. Moreover, this surface 
polysaccharide biosynthesis-cluster deficient derivative displayed altered signaling capacities when 
applied to TLR2-reporter cell lines, suggesting either a direct role of these polysaccharides in host 
communication or an indirect role via their capacity to shield alternative signaling compounds that 
reside in the bacterial cell envelope [Remus D.M. PhD thesis Wageningen University, submitted]. 
L. rhamnosus GG, one of the best documented probiotic lactobacilli, produces two major types 
of cell-wall associated polysaccharides. The most abundant polymer is a long and galactose-rich 
polysaccharides, while the lower abundant polymer is significantly smaller-sized and glucose-
rich [143]. The biosynthesis cluster of the galactose-rich polysaccharide of L. rhamnosus GG was 
recently characterized and has a genetic organization that resembles the typical polysaccharide 
biosynthesis clusters as have also been described for S. pneumonia. By contrast, the gene cluster 
involved in production of the glucose-type surface polysaccharide of strain GG has not been 
functionally characterized [144]. The polysaccharide biosynthesis clusters display substantial 
diversity between individual strains of a species, as is exemplified by L. plantarum, where one of 
the polysaccharide biosynthesis clusters belongs to the least conserved regions of the WCFS1 
genome [135]. Hence, the polysaccharide producing capacity of lactobacilli can create an immense 
diversity of surface decorations in individual strains, which may be of great relevance for their 
molecular communication with the host mucosal system [145].  
The biological functions of the cell surface polysaccharides in lactobacilli have been reported to 
be related to phage absorption (L. plantarum [146] and L. casei [147]), the attachment of surface 
layer proteins (Lactobacillus buchneri [148]), and immunomodulation [145] (for recent reviews 
see [29, 42]). Although some examples have been reported, our overall knowledge about the 
immunomodulatory properties of surface polysaccharides remains very fragmented. For 
example, the polysaccharides in L. casei Shirota reduced the susceptibility of its peptidoglycan to 
N-acetylmuramidase digestion, which influences IL-12 production of macrophages [59], while 
the isolated polysaccharide of this strain suppressed pro-inflammatory responses in macrophages 
[145]. Moreover, L. casei NIZO B255 and L. reuteri ASM20016 stimulate human DC maturation and 
regulatory T cell differentiation through a C type lectin DC-specific ICAM3-gabbing non-integrin 
(DC-SIGN) [149]. The fact that DC-SIGN recognizes mannose or fucose-containing structures 
[150] suggests the presence of these sugar moieties on the surface of these bacteria. Although the 
exact nature of these carbohydrate containing molecules remains uncharacterized, a role for the 
cell surface associated polysaccharides can certainly not be excluded [149]. In addition, deprivation 
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of the long, galactose-rich type polysaccharide in L. rhamnosus GG appeared to promote adherence 
to intestinal epithelial cells [144], yet increases the sensitivity of this bacterium toward innate 
immune defensive factors, such as antimicrobial peptide LL-37 [151]. 
For many of the polysaccharides derived from lactobacilli, their role in host-cell interaction is 
likely dependent on the shielding effect they may provide for other surface molecules such as LTA 
or peptidoglycan. However, a direct role of some polysaccharide molecules of specific Lactobacillus 
strains has also been proposed for the polysaccharide derived from L. casei Shirota [145]. Taking 
into account the immense chemical diversity of the polysaccharides that can be produced by 
lactobacilli, in combination with their variations in terms of exact subcellular location, polymer 
size, and conformational properties, it is likely that eventual direct signaling effects depend on the 
exact characteristics of the molecule in the cellular context. Moreover, the lack of knowledge on 
the corresponding PRRs or alternative recognition pathways involved in eventual host interactions 
leaves the immunomodulatory effects of lactobacilli derived polysaccharide largely obscure. 
Nevertheless, some examples of other bacteria, e.g., the polysaccharide A produced by Bacteroides 
fragilis [152], exemplify the huge potential of these cell surface molecules when it comes to host 
response modulation, which implies that substantial investigation of these molecular structures in 
lactobacilli in the perspective of their role in probiotic functionality is fully justified.
Surface Proteins
Proteins of Gram-positive bacteria are transported to the cell surface via seven main protein 
secretion mechanisms, namely the main secretion machinery (Sec), twin-arginine translocation 
(tat), the flagella export apparatus (FEA), the fimbrilin-protein exporter (FPE), the holin 
mechanism (pore-forming), peptide-efflux ABC transporters, and the WXG100 secretion system 
(Wss) (for reviews, see [153-156]). Mining 13 complete genomes of lactobacilli revealed that this 
group of bacteria appeared to possess genes encoding the Sec, RPE, peptide-efflux ABC and holin 
systems (for a recent review see [38]). The secreted proteins can be divided into two major types, 
firstly the proteins that are released into the environment and secondly those that are covalently 
or non-covalently anchored to the cell surface. Among the latter group of proteins several modes 
of anchoring have been described, including anchoring in the cytoplasmic membrane by single 
or multiple membrane spanning protein-domains, or by N-terminal linkage to long-chain fatty 
acids (i.e. lipoproteins). Alternatively, C-terminal LPxTG motifs target proteins to the sortase 
dependent anchoring machinery that covalently attaches these proteins to the peptidoglycan. 
Finally, a variety of domains has been recognized that enable secreted proteins to non-covalently 
bind to different cell envelope structures like peptidoglycan or LTA (for a review see [38]). 
Overall, the cell envelope is richly decorated with proteinaceous compounds that are either firmly 
or loosely attached to the different structural components that collectively form the cell envelope. 
These proteins may play important roles in host cell communication and could be playing a central 
role in the beneficial effects of probiotic lactobacilli which are discussed below. 
Two secreted proteins of L. rhamnosus GG, originally designated p75 and p40 but recently 
renamed to Msp1 and Msp2 [110], inhibit cytokine-induced apoptosis of epithelial cells, reduce 
TNF-induced epithelial damage in the colon and as a result promote epithelial homeostasis [157]. 
Homologues proteins that can also elicit similar host responses have also been identified in L. 
casei strains ATCC 334, ATCC 393 [157], and BL 23 [158]. Less specific is the observation that 
the probiotic mixture VSL#3, which contains L. casei, L. plantarum, L. acidophilus and L. delbureckii 
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subsp. bulgaricus, was reported to promote epithelial barrier functions (e.g. tight junctions and 
mucin production) via an unidentified soluble proteinaceous factors [159]. Although bacteriocins 
may fulfill probiotic functions via their primary function as antimicrobial components that inhibit 
the growth of pathogens (see also above and [30]), they were recently reported to also play a direct 
role in immunomodulation [160]. These bacteriocin (plantaricin) encoding genes were identified 
as potential effector molecules by a gene trait matching approach using 42 L. plantarum strains, 
and subsequent mutation analysis established their importance in anti-inflammatory properties 
of this species in both PBMCs and DCs [135, 139, 160, 161]. The importance of plantaricin is 
further supported by the notion that a specific plantaricin gene (plnI) is induced in vivo during 
gastrointestinal passage of L. plantarum [162-164]. An analogous gene-trait matching approach also 
identified the mannose-specific adhesin (Msa) in L. plantarum WCFS1, which is a LPxTG-anchored 
protein involved in mannose specific recognition and binding to epithelial surface glycan-
structures in the host mucosa [165]. Subsequent work showed that this protein is important for 
the induction of specific innate immune responses in pig intestinal tissues in vivo [166]. Moreover, 
purified STp, a recently identified serine and threonine rich peptide (STp) harbored by protein 
D1 that is secreted by L. plantarum BMCM12, was shown to stimulate regulatory responses in 
human intestinal DCs in vitro [167]. Using polyclonal serum generated against purified STp, it 
could also be established that proteins containing regions homologous to STp can be found in the 
healthy human colonic microenvironment, whereas STp-containing proteins appeared absent in 
the intestinal microenvironment from inflammatory bowel disease patients, suggesting that STp 
can be employed as a biomarker for gut homeostasis [167]. 
Specific lactobacilli, such as L. acidophilus, L. helveticus and L. brevis, produce a paracrystalline 
protein-monolayer as the most exterior layer of their cell envelope, termed surface layer [29, 
168-171]. Notably, surface layer protein A (SlpA) of L. acidophilus NCFM is recognized by 
DC-SIGN and modulates human DCs and T cell functions, leading towards more regulatory 
differentiation through increased IL-10 and reduced IL-12p70 production [172]. On the other 
hand, many lactobacilli lack surface layer proteins but might still stimulate immune responses 
through DC-SIGN by glycoproteins other than surface layer proteins [29, 32]. These examples 
support a prominent role of (surface-associated) proteins in the interaction with the host cells in 
the mucosa, but for the majority of these proteins it remains relatively unclear how they achieve 
these effects, and how important their contribution to eventual probiotic effects is in vivo.
Despite the long-existing belief that protein glycosylation is restricted to eukaryotic organisms, 
more and more evidence emerges that this form of post-translational modification also occurs 
frequently in the bacterial world. The first bacterial O-glycosylation, i.e. glycan attachment to Ser 
or Thr residues, was reported for surface layer proteins of hyperthermophilic Clostridium species, 
while the first bacterial N-glycosylation machinery, i.e., attaching glycans to asparagine residues, 
was discovered in Campylobacter jejuni (for reviews see [38, 173]). Bacterial protein glycosylation 
has been studied mainly in pathogenic organisms, but is also found in certain human intestine 
commensals, including several Bacteroides species [173]. Interestingly, glycoproteins were recently 
discovered in L. plantarum WCFS1 [174] and L. rhamnosus GG [175] as well. In L. plantarum WCFS1 
the major autolysin, Acm2, was shown to be O-glycosylated with GlcNAc moieties in its N-terminal 
AST domain, which is an alanine, serine and threonine rich region. This O-glycosylation occurs 
intracellularly, prior to Acm2 export to the cell surface. Although the biological significance of 
glycosylation has not yet been elucidated, one may speculate that O-glycosylation has a regulatory 
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role in modulation of the Acm2 function in peptidoglycan turn-over, which is supported by the 
dynamic nature of its glycosylation [174]. Intriguingly, the N-terminal AST domain is also present 
in 10 other peptidoglycan hydrolases that are encoded within the L. plantarum WCFS1 genome, 
suggesting that many of these proteins could also be subject to glycosylation [174]. Another AST-
domain containing protein is encoded by lp_2145 and this protein displayed a smearing pattern 
on SDS-PAGE gels, which is in agreement with its postulated glycosylation and was speculated to 
depend on glycosylation of Lp_2145 by the genetically linked glycosyltransferase encoding gene 
ica2 (lp_2142). Moreover, heterologous expression of Lp_2145 in Lc. lactis MG1363, led to a 
discrete band of the expected molecular weight on SDS-PAGE gels, suggesting that the proposed 
glycan modification does not take place in this host background and supporting a role of an L. 
plantarum specific gene in this post-translational modification, e.g. ica2 [32]. 
Protein glycosylations were also found in the secreted protein Msp1 of L. rhamnosus GG that, 
similar to the Acm2 protein of L. plantarum, functions as a peptidoglycan hydrolase. The Msp1 
protein is O-glycosylated at serine residues 106 and 107 and its glycan moieties are recognized 
by the Concanavalin A (ConA) lectin, which is specific for α-mannose and α-glucose [175]. 
Interestingly, the Msp1 homologue of two other L. rhamnosus strains also contain these serine 
residues, whereas 3 L. casei strains analyzed lack these residues. Concomitantly, ConA recognition 
appeared specific for the L. rhamnosus strains, suggesting species-specific glycosylation of Msp1 
[175]. Glycosylation in L. rhamnosus GG did not play a role in peptidoglycan hydrolyase activity, 
nor in the activation of Akt signaling that is related to its effect on epithelial cell-apoptosis [157]. 
On the other hand, glycosylation was demonstrated to be of importance for the resistance to 
protease degradation and overall stability of Msp1 [175]. Moreover, the glycosylation of Msp1 
was found in supernatant but not in cytosolic or cell wall fractions [175], which suggests a link 
between the glycosylation of Msp1 and its subcellular localization [175]. Notably, this also hints 
towards a different glycosylation machinery in L. rhamnosus GG as compared to the glycosylation 
of Acm2 in L. plantarum which occurs intracellularly [174], reiterating the species-specificity of 
Lactobacillus protein glycosylation. Experimental evidence also suggests the presence of additional 
glycosylated proteins in L. rhamnosus GG, such as LGG-02225, another putative cell wall hydrolase. 
Taken together, the existing data support the glycosylation of specific proteins in lactobacilli, but 
it is anticipated that many other proteins (containing AST or other glycosylation domains) are 
subject to post-translational glycosylation in lactobacilli [175]. Importantly, SlpA of L. acidophilus 
NCFM has shown its regulatory effects on DC functions through DC-SIGN, which is a C-type 
lectin recognizing mannose- and fucose-containing glycans [172], strongly suggesting SlpA is 
glycosylated. The other surface protein (SlpB) of L. acidophilus NCFM failed to interact with DC-
SIGN and displayed dramatically different immunomodulatory properties than that of SlpA [172], 
implying the glycosylation of SlpA may be essential in the modulation of DCs and T cells functions. 
An in silico analysis performed with the L. rhamnosus GG genome led to a list of 50 genes encoding 
glycosyltransferases potentially involved in protein glycosylation. Unfortunately, initial analysis of 
a subset of corresponding mutants revealed identical ConA-reactive glycosylation of Msp1 as was 
observed for the wild-type strain, leaving the glycosylation machinery and the glycosyl transferase(s) 
involved to be identified [176]. Similarly, six putative glycosyltransferases that share sequence 
similarities with Gtf1, involved in O-GlcNAc glycosylation of the streptococcal Fap1 adhesin [177, 
178] were identified within the L. plantarum WCFS1 genome, identifying these genes as tempting 
candidates for further research [174]. Development of in silico tools allowing bioinformatics-based 
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predictions of substrate specificity of glycosyltransferases could significantly constrain the amount 
of candidate genes encoding protein glycosyltransferases, thereby accelerating the identification of 
Lactobacillus protein glycosylation machineries.  
The road ahead; molecular cross-talk makes the difference 
The line of research described in this review is bound to deliver a more detailed structure-function 
relationship for probiotic effector molecules, which when combined with advanced understanding 
of how these molecules may elicit their effects in specific host cells can provide the mechanistic 
understanding of the (species-specific) health benefits that these bacteria can confer. An enhanced 
characterization and understanding of probiotic effector molecules is not only relevant for the 
food industry but might also enable targeted pharmaceutical applications. Evidence is emerging 
that subtle structural differences in the effector molecules expressed by individual strains are 
responsible for the strain-specificity of probiotic functions. As this field is still in its infancy, 
identification of the true effector structures in the canonical MAMPs is essential, while it is also 
crucial to understand their molecular interaction with their corresponding PRRs expressed in host 
tissues. Detailed investigation of the biosynthesis pathways for the canonical cell wall associated 
effector molecules including peptidoglycan, TAs and polysaccharides, and their modifications will 
greatly improve our capacity to accurately predict probiotic function. 
The growing availability of genome sequences as well as the corresponding molecular tools allows 
us to pursue more knowledge driven approaches. The growing availability of Lactobacillus genome 
sequences and annotations provides information for the encoded gene functions, including their 
metabolic and biosynthetic pathways, stress responses, cell-wall associated proteins, and potential 
host interaction factors [38, 179]. Gene-trait matching (GTM) approaches may decipher strain-
specific functions that are involved in host interactions, as has been successfully illustrated in the 
identification of pili formation in L. rhamnosus GG and its role in mucus binding and intestinal 
persistence [180, 181], the mannose binding capacity of L. plantarum [165] and some of the L. 
plantarum genes involved in immunomodulation [139]. Transcriptome-trait matching (TTM) 
offers a further possibility to correlate genes to specific functionalities, and compensates for the 
blind spots of GTM with respect to genes that are conserved among the strains tested [182, 183]. 
Candidate genes selected on basis of GTM or TTM still require functional verification in relation 
to specific phenotypes, which can be achieved by studies using genetically engineered strains [139, 
161, 165, 166, 171, 180, 183]. Many genetic engineering tools have been developed for the 
construction of gene deletion derivatives, as well as (controlled) gene expression in lactobacilli, 
which have been reviewed elsewhere [29, 179]. Mutational analysis has the potential drawback 
that the changed genetic make-up has pleiotropic effects that exceed the primary effects of the 
gene targeted by mutation. Especially when targeting cell envelope associated functions, such 
pleiotropic or compensatory effects have been observed. For instance, a WTA-deficient mutant of 
L. plantarum WCFS1 also displays altered growth and morphology [122]. Moreover, a dltB mutant 
of L. plantarum WCFS1 synthesizes LTA that lacks d-ala substitutions, but was also reported to 
produce LTA of three-fold increased length which contained 25% glucose substitution, which is 
absent in LTA derived from the wild-type [96].  Notably, a recent study from our group showed 
that a dlt mutant devoid of the complete dlt operon constructed in the same strain did not show 
altered LTA chain length [123]. These changes have potential impact on host immune response, 
e.g. additional glucose substitutions of LTA might be recognized and interact with C-type lectins 
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and may affect the immune responses of the host. It is important to establish such pleiotropic 
consequences and take them into account, since they may lead to drastic changes in surface 
associated biochemical structures and the corresponding consequences in terms of host responses. 
The modulation of human mucosa transcriptomic profiles was shown to be affected by the growth 
stage from which Lactobacillus plantarum was harvested [184, 185], implying that the outcome of 
microbial interaction with the mucosa is potentially influenced by the way probiotics are produced. 
Therefore, genetically modified lactobacilli may be an important strategy to enhance or ensure 
their functionality in situ in humans after consumption. However, their application in consumer 
products is currently not considered due to legislation constraints and consumer concerns about 
genetically modified food ingredients, although food-grade genetic engineering strategies may 
be possible [186]. Finally, the consumption of live-microorganisms with a safe status like the 
probiotics that are currently marketed, is virtually without risk in a healthy population, but may 
not be desired for the application in certain (severely) health-compromised populations. These 
considerations support an approach that is built on the concept of ‘synthetic’ probiotic effectors 
that allows bypassing of these potential problems. Among the probiotic effector molecules, 
proteins but especially peptides are probably the most straightforward and cost-effective to 
chemically synthesize, and effectors such as the muropeptide produced by L. salivarius Ls33 [63] and 
a peptide, STp, secreted by L. plantarum BMCM12 [167] might have potential for applications that 
follow more pharmacological production and administration regimes. However, if glycosylation 
of proteinaceous molecules in some instances is required for their functionality in interactions 
with the host system, their in vitro synthesis may become more complicated. Nevertheless, these 
hurdles may be taken by identifying suitable biotechnological or synthetic biology approaches to 
produce such glycosylated protein or peptide compounds in an efficient and cost-effective way. 
Identification of the mechanisms involved in protein glycosylation is bound to stimulate this route.
On the other hand, it is important to better understand the basis of variations seen in individual 
humans. Notably, both the molecular and cellular characteristics of the human mucosal tissues 
[184, 185], as well as those of the luminal microbiota [187, 188] are considerably different 
between individual humans. The endogenous microbiota may play a crucial role in determining 
the differences in overall intestinal functionality in individual humans, which is supported 
by recent metagenomics studies that discovered three distinct microbiome types, termed 
enterotypes [187, 188]. Besides differential microbiomes, also the genotype, dietary habits, life-
style, or a combination of all these factors may determine the molecular status of the human 
mucosal tissues, which we previously proposed to designate as  “the human band-width of 
health” [5]. These components of human individuality may significantly influence the molecular 
responsiveness to probiotic interventions or probiotic-effector molecule treatment, as well as 
their relevance for the health status of the individual consumer [32, 189]. Despite this complexity, 
the increasing knowledge on the structural details of probiotic effectors and on their consequent 
immunoregulatory properties enlighten the molecular mechanisms of probiotic function. A 
better understanding of the precise mechanism of effector molecule interaction and the cognate 
responses elicited may help to improve the effector application in specific susceptible population 
subgroups that are predictably responsive to this treatment. As some probiotic effector molecules, 
for example Msp1 and Msp2 of L. rhamnosus GG, SlpA of L. acidophilus NCFM, and STp of L. 
plantarum BMCM12, have been identified as important immunomodulators, their application 
holds great promise especially providing we are able to recognize the susceptible / responsive 
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subgroups in the human population that can benefit from such treatment.  
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Abstract
Lipoteichoic acid (LTA) is one of the major surface components of Gram-positive bacteria and 
plays many important roles in bacterial physiology, including ion homeostasis, physicochemical 
surface properties, and cell division. Pro-inflammatory responses in mammalian immune cells 
can commonly be elicited by LTA from various bacterial species, such as Staphylococcus aureus 
and Bacillus subtilis. Conversely, LTA from specific lactobacilli can inhibit inflammation and act 
as an antagonist of LPS or pro-inflammatory LTA. However, different LTA purification protocols 
employed may lead to different levels of contamination with lipoproteins, which may confound 
these conclusion. Here, we focus on the LTA of the model probiotic Lactobacillus plantarum WCFS1, 
to study the role of LTA in bacterial physiology, TLR2 signaling capacity, and immunomodulatory 
properties upon co-incubation with human peripheral blood mononuclear cells (PBMCs). To this 
end, we established a purification procedure that minimizes the lipoprotein contamination of LTA 
preparations, while maintaining the structural integrity of the molecule. Purified LTA from L. 
plantarum WCFS1 and from B. subtilis 168 displayed opposite TLR2 signaling capacities and elicited 
different immunomodulation responses in PBMCs. In a gene deletion approach we targeted the 
two LTA synthase encoding genes lp_1283 (ltaS1) and lp_2580 (ltaS2), which both were shown 
to be required for LTA synthesis. Moreover, both mutants displayed defects in growth and cell 
division, and alterations in their physicochemical surface properties, supporting the important 
role of LTA in bacterial physiology. The deletion mutants elicited similar pro-inflammatory 
cytokine production but less anti-inflammatory IL10 production in PBMCs as compared to the 
wild type. However, the considerable pleiotropic effects observed in both mutants makes it unclear 
whether these observations can be exclusively assigned to LTA. Nevertheless, the differences in 
the structural properties of purified LTA from B. subtilis and L. plantarum are likely to play a key 
role in the differential immunomodulatory properties elicited by these molecules.   
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Introduction 
Probiotics are defined as “live microorganisms which when administered in adequate amounts 
confer a health benefit on the host” [1]. One of the most commonly proposed modes of action via 
which probiotics exert their beneficial effects is through immunomodulation [2]. Bacterial surface 
molecules are logic candidates to be the first components communicating with the immune system 
[3, 4] and as a consequence are considered to play a key role in the immunomodulatory capacity 
of probiotic and other bacteria. Lipoteichoic acid (LTA) is one of the major structural components 
of the cell envelope of most Gram-positive bacteria [5], including the most commercialized 
probiotic genus Lactobacillus [2]. This major surface component typically consists of a backbone of 
polyglycerol-phosphate [poly(Gro-P)], decorated with amino acid and/or glycosyl-substitutions 
and is anchored to the cell membrane through a basal glycolipid moiety [6]. Importantly, the 
structure of LTA varies between species and strains, including variations in the length of the 
backbone polymer, the chemical nature and degree of its substitutions, and the cell membrane 
anchoring glycolipid structure, including its acyl chains (di- or tri- acylation, and degree of 
saturation) [5, 7, 8]. LTA of lactobacilli has the canonical glycerol-phosphate backbone, with 
glucosyl- and d-alanyl substitutions and is commonly anchored to the cell membrane via a di- or 
tri-acyl glycolipid moiety [9-13].  
LTA plays many important roles in bacterial physiology. For example, the charged repeating unit 
of the LTA backbone contributes to surface charge and can act as a scavenger for cations, especially 
Mg2+ [14, 15]. Moreover, the d-alanine ester substitutions of LTA have been suggested to play a 
prominent role in the determination of surface hydrophobicity [16, 17] and contribute to bacterial 
adhesion to epithelial cells [18] and to colonization in the murine gastrointestinal tract [19]. In 
addition, LTA has also been reported to regulate autolysin activity, a process in which d-alanylation 
of LTA plays a pivotal role [20-22]. 
The biosynthesis of LTA has been studied in various bacteria, including Staphylococcus aureus [23, 
24], Bacillus subtilis [25] and Listeria monocytogenes [26]. As a first step, glycolipid anchors are 
synthesized in the cytoplasm, followed by their translocation from the inner to the outer face of 
the cytoplasmic membrane by a flippase, encoded by ltaA [23]. The subsequent polymerization 
of phosphatidylglycerol into the poly(Gro-P) chain is catalyzed by a LTA synthase (LtaS) [24, 
25, 27]. In Listeria monocytogenes 10403S, the polymerization step is performed by a two-enzyme 
system in which a LTA primase (LtaP) adds the initial Gro-P residue to the glycolipid, followed 
by polymerization of the poly-Gro-P backbone by LtaS [26]. The dltABCD genes are responsible 
for d-alanylation of LTA [6, 27]. By contrast to the well-characterized mechanism of d-alanylation 
of LTA, the genes and enzymes involved in the glycosyl-substitution remain unknown. LTA 
biosynthesis has also been studied in lactobacilli, and mining of their genomes identified at 
least one ltaS gene homologue and a high degree of conservation of the dlt operons among all 
lactobacilli, which underpins the important biological role of LTA in this species [5, 7]. Given the 
multiple roles that have been established for LTA, mutations in genes involved in LTA biosynthesis 
often severely impact on bacterial physiology [22, 25, 28].   
Since LTA is one of the major components in the bacterial cell envelope, many studies focused on 
the immunomodulatory properties of LTA. Typically, LTA is able to stimulate the production of 
pro-inflammatory cytokines by mouse and human immune cells, such as tumor necrosis factor-
alpha (TNFα) [29-31], interleukin (IL)-1β [32, 33], and IL-6 [33, 34]. The immunomodulation 
48
Chapter 3
3
of LTA is generally thought to be mediated by Toll-like receptor (TLR) 1/2 and 2/6 heterodimer 
complexes, because of the similarity of the acyl chains structures of LTA and lipoproteins, where 
TLR 1/2 and 2/6 complexes recognize di- and tri-acylated LTA molecules, respectively [33, 
35, 36]. However,  LTA from Lactococcus lactis G121 induces IL-6 secretion in human monocytes 
in a TLR2- and TLR4-independent manner [37]. Additionally, LTA purified from L. plantarum 
KCTC10887BP elicited much less immunostimulation as compared to the LTA purified from 
S. aureus ATCC 6538 or B. subtilis ATCC 6633, including reduced TLR2 stimulation and NO 
production in macrophages [38]. It was also shown that LTA from L. plantarum KCTC10887BP 
can inhibit TNFα production induced by S. aureus LTA [35] and LPS [39] in monocytes as well as 
down-regulate the inflammation induced by Shigella flexneri peptidoglycan [40]. Analogously, LTA 
from Lactobacillus johnsonii La1 and Lactobacillus acidophilus La10 were shown to act as antagonists 
of LPS- and Gram-negative bacteria-induced pro-inflammatory cytokine productions in human 
intestinal epithelial cells [41]. Recently, structural comparison of LTA from S. aureus and L. plantarum 
KCTC10887BP shed new light on the role of structural diversity of LTA molecules, which may 
explain the diverse results obtained in immune-cell interaction studies using different bacterial 
LTA sources [13]. Furthermore, Hashimoto et al. suggested that contamination of lipoproteins is 
the main cause of the observed immunmodulatory activity in purified LTA fractions [42].
Here we focus on the LTA from L. plantarum WCFS1, a model probiotic for which a well-annotated 
genome and sophisticated genetic tools for mutagenesis are available. We identified two ltaS 
homologues, lp_1283 and lp_2580 (named, ltaS1 and ltaS2, respectively), in the WCFS1 genome, 
and could show that both are required for LTA backbone synthesis by mutation analysis. We also 
report on the consequences of the deletion of the ltaS genes on bacterial physiology, surface 
characteristics, TLR-signaling capacity and immunomodulatory properties. Furthermore, purified 
LTA of L. plantarum WCFS1 was analyzed in TLR2-signaling capacity assays and immunomodulation 
in PBMCs. The results strongly contrast with those obtained with purified LTA from B. subtilis 
168 that was isolated using the same procedure. These results suggest that structural differences 
between LTA from B. subtilis and L. plantarum are key determinants in the immunomodulatory 
properties of these molecules.  
Material and Method
Bacterial strains and culture conditions. Bacterial strains used in this work are listed in 
Table 1. Lactobacillus plantarum WCFS1 and its derivatives were grown at 37°C in MRS broth 
(Difco, West Molesey, United Kingdom) without aeration. Bacillus subtilis 168 was grown at 37°C 
in LB-broth with aeration. Escherichia coli strain TOP10 (Invitrogen, Bleiswijk, The Netherlands) 
was used as an intermediate cloning host, and was grown at 37°C in TY broth [43] with aeration 
[44]. Solid media were prepared by adding 1.5% (w/v) agar to the broths. Antibiotics were 
added where appropriate and concentrations used for L. plantarum and E. coli were 10 μg/ml 
chloramphenicol (Cm), and 30 and 200 μg/ml erythromycin (Ery), respectively. 
DNA manipulations. Plasmids and primers used are listed in Table 2. Standard procedures were 
used for DNA manipulations in E. coli [44]. Plasmid DNA was isolated from E. coli using a JETSTAR 
kit (Genomed GmbH, Bad Oberhausen, Germany). L. plantarum DNA was isolated as described 
previously [45]. PCR amplifications were performed using hot-start KOD polymerase (Novagen, 
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Madison, USA) according to the protocol of the manufacturer. Amplicons were purified using the 
Wizard®SV Gel and PCR Clean-Up System (Promega, Leiden, The Netherlands). Restriction 
endonucleases (Fermentas GmbH, St. Leon-Rot, Germany), MSB® Spin PCRapace (Invitek 
GmbH, Berlin, Germany), PCR Master Mix (Promega) and T4 DNA ligase (Invitrogen) were 
used as specified by the manufacturers. 
Construction of ltaS deletion mutants. The ltaS1 and ltaS2 deletion mutants were constructed 
essentially as described previously [46], using a double crossing-over strategy to replace the target 
genes by a chloramphenicol resistance cassette (lox66-P32cat-lox71)[46]. In this study, a derivative 
of the mutagenesis vector pNZ5319 [46], designated pNZ5319TAG was used to introduce a 
unique 42-nucleotide tag into chromosome during gene deletion, which can be used for mutant 
tracking purposes in mixed populations (not relevant for the study presented here). The upstream 
and downstream flanking regions of ltaS1 (lp_1283) and ltaS2 (lp_2580) genes were amplified 
by PCR using corresponding primer sets (Table 2). Each amplicon generated was subsequently 
joined by a second PCR to lox66-P32cat-lox71-tag by a splicing by overlap extension strategy [47], 
using targets-Up-F/targets-Down-R primer pairs (Table 2). The resulting PCR products were 
digested with SwaI and Ecl136II, and cloned into similarly digested pNZ5319TAG. The obtained 
mutagenesis plasmids were transformed into L. plantarum WCFS1 as described previously [45]. The 
resulting transformants were assessed for a double cross over integration event by selecting for 
colonies with a Cm resistant and Ery sensitive phenotype, in which the anticipated chromosomal 
organization of the mutated ltaS1 or ltaS2 locus was confirmed by PCR using targets-out-F/R 
primers (Table 2). For each of the mutant constructions a single colony displaying the anticipated 
genotype was selected, yielding the mutants NZ3537Cm (ΔltaS1), and NZ3538Cm (ΔltaS2). 
For complementation of ΔltaS1 and ΔltaS2, the ltaS1 and ltaS2 genes of L. plantarum WCFS1 
were amplified, including their native promoters, using primers IS311/IS312 and IC004/IC005, 
respectively. A SacI site was introduced by primer IS312 and IC005 downstream of ltaS1 and 
Table 1. Bacterial strains and plasmids used in this study
Strains Characteristicsa Reference
L. plantarum
WCFS1 Single-colony isolate of L. plantarum NCIMB8826. Isolate from human saliva, 
UK. 
[66]
NZ3400Cm Cmr; WCFS1 derivative; chromosomal integration of cat cassette into H-locus [61]
NZ3537Cm Cmr; derivative of WCFS1 containing a lox66-P32-cat-lox71-tagF2 replacement of ltaS1 (lp_1283)   (ltaS1::lox66-P32-cat-lox71-tagF2)
this work
NZ3538Cm Cmr; derivative of WCFS1 containing a lox66-P32-cat-lox71-tagF4 replacement of ltaS2 (lp_2580) (ltaS2:: lox66-P32-cat-lox71-tagF4)
this work
NZ8200CmEry Cmr, Eryr; NZ3537Cm derivative; chromosomal integration of a single 
copy of ltaS1 gene mediated by pMEC10 vector
this work
NZ8201CmEry Cmr, Eryr; NZ3538Cm derivative; chromosomal integration of a single 
copy of ltaS2 gene mediated by pMEC10 vector
this work
B. subtilis 
168 [88]
E. coli
TOP 10 Cloning host; F- mcrA Δ(mrr-hsdRMS-mcrBC) φ80lacZΔM15 ΔlacX74 recA1 
araD139 Δ(ara-leu)7697 galU galK rpsL (StrR) endA1 nupG
Invitrogen
a Cmr , chloramphenicol resistant; Emr, erythromycin resistant
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ltaS2, respectively. pMEC10 was digested by SacI and SfoI, whereas PCR products of ltaS1 and 
ltaS2 were digested with SacI. Digested vector and inserts were ligated using T4 DNA ligase. 
Subsequently, the ligation mixtures were transformed into E. coli TOP10; positive clones were 
selected by colony PCR (52) using primers Ip_1283F/IS260 for ltaS1 and Ip_2580F/IS260 for 
ltaS2. Resulting plasmids were designated pNZ8200 and pNZ8201 for the complementation 
Table 2. Plasmids and primers used in this study
Plasmids Descriptiona Reference
pNZ5319 Cmr Emr; Mutagenesis vector for gene replacements in  L. plantarum [46]
pMEC10 Emr; integration plasmid [67]
pNZ3537 Cmr Emr; pNZ5319 derivative containing homologous regions up- and 
downstream of ltaS1 (lp_1283)
this work
pNZ3538 Cmr Emr; pNZ5319 derivative containing homologous regions up- and 
downstream of ltaS2 (lp_2580)
this work
pNZ8200 Emr; pMEC10 derivative containing a single copy of ltaS1 gene and its 
own promoter 
this work
pNZ8201 Emr; pMEC10 derivative containing a single copy of ltaS2 gene and its 
own promoter
this work
Primers Sequenceb Reference
is128 tag-lox66-F3 5’-AAATCTACCGTTCGTATAATGTATG-3’ [69]
is129 tag-lox71-R3 5’-CTCATGCCCGGGCTGTAACCG-3’ [69]
IS169 5’-TTATCATATCCCGAGGACCG-3’ [89]
87 5’-GCCGACTGTACTTTCGGATCC-3’ [46]
CreF 5’-CGATACCGTTTACGAAATTGG-3’ [46]
CreR 5’-CTTGCTCATAAGTAACGGTAC-3’ [46]
EryintF 5’-TCAAATACAGCTTTTAGAACTGG-3’ [46]
EryintR 5’-ATCACAAACAGAATGATGTACC-3’ [46]
ltaS1-Up-F 5’-GTGCTTCTTGAATGATGGGG-3’ this work
ltaS1-Up-R 5’-GCATACATTATACGAACGGTAGATTTTTTAGGCATGGTA-
ATTTCTTCC -3’
this work
ltaS1-Down-F 5’-CGGTTACAGCCCGGGCATGAGAGTAGTTCTGATTAATC-
GAACTCG-3’
this work
ltaS1-Down-R 5’-TTTCCCACGTGTTACTCACC-3’ this work
ltaS1-out-F 5’-AAATCGTTAACGCCTGTATCC-3’ this work
ltaS1-out-R 5’-CGGTCCAAGTTGTTATGCGG-3’ this work
ltaS2-Up-F 5’-AGCTCCATATGTACAATACTGC-3’ this work
ltaS2-Up-R 5‘-GCATACATTATACGAACGGTAGATTTCGGGTTCACGAGCAT-
CAGG -3‘
this work
ltaS2-Down-F 5’-CGGTTACAGCCCGGGCATGAGTCCAAATAGCAACAAGCAT-
TCC -3’
this work
ltaS2-Down-R 5‘-GAATTCCAAGGTAACCAGCC-3‘ this work
ltaS2-out-F 5’-CACCAGTTAGTGATTCACGC-3’ this work
ltaS2-out-R 5’-CCGTTTTCCATGGAAGCCG-3’ this work
IS311 5’-GCGATAGCTTCAGTCGCTCC-3’ this work
IS312 5’-AAATTGAGCTCACCATTCCAACTTTGCATTTACTTGG-3’ this work
IC004 5’-GAGAATACGCGTTTCACCGGTTATCG-3’ this work
IC005 5’-TCGGAGAGCTCTGAACGGCACTGAACTTAAGAGATGG-3’ this work
lp_1283F 5’-ACTGTCGAAACAGCATAACC-3’ this work
lp_2580F 5’-TTATGGCGGTGAAATTGACG-3’ this work
IS260 5’-GTTGAAAGAACCTGTACTCTCC-3’ [90]
TRNA 5’-GCGAACCGGCTAATACCGGC-3’ [91]
a Cmr , chloramphenicol resistant; Emr, erythromycin resistant
b Underlined nucleotides indicate parts of the primers that are complementary to the is128-lox66-F3 and is129-
lox71-R3 primers.
51
3
Lipoteichoic acid of L. plantarum WCFS1
plasmid of ltaS1 and ltaS2, respectively. Integrity of nucleotide sequences for each construct was 
confirmed by sequence analysis. Subsequently, the complementation plasmids were introduced into 
the corresponding deletion strains by electroporation as described previously (49). Transformants 
were screened for chloramphenicol and erythromycin resistance, followed by PCR amplifications 
to confirm the chromosomal integration of introduced plasmid using primers lp_1283F/TRNA 
and lp_2580/TRNA for ltaS1 (NZ8200CmEry) and ltaS2 complementation (NZ8201CmEry) 
strains, respectively.
SDS-PAGE and western blot analyses. SDS-PAGE and wet blotting were performed using 
the NuPAGE® electrophoresis system (Invitrogen) and XCell II™ Blot Module (Invitrogen), 
respectively, as described in the user manuals. Whole cell extracts were mixed with NuPAGE 
sample buffer and were separated under denaturing condition on NuPAGE®Novex® 4-12% Bis-
Tris gels with MOPS SDS running buffer (Invitrogen). 
For western blots, the gels were transferred to nitrocellulose membranes (Thermo Scientific, 
Bremen, Germany) using the wet blotting method described in the NuPAGE manual (Invitrogen). 
The membranes were blocked with 3% bovine serum albumin (BSA) in PBS containing 0.05% 
Tween20 (PBST) for 1 hour at room temperature. The membranes were then incubated with a 
final concentration of 0.2 μg/ml (1:1000 dilution) of monoclonal mouse IgG3 against LTA Clone 
55 (HyCult Biotechnology, Uden, The Netherlands) in blocking solution, followed by incubation 
with 1:5000 dilution Horse anti-mouse IgG, horseradish peroxidase conjugated (Cell Signaling 
Technology, Beverly, USA ). In between the incubations the membranes were washed three times 
with PBST for 15min. Precision Plus Protein™ Dual Color Standard (Bio-Rad, Richmond, USA) 
was used as a reference of molecular size. After the membranes were washed, they were developed 
by using Super Signal West Pico Chemiluminescent Substrate (Thermo Scientific) and Kodak 
BioMax Light film (Kodak, Rochester, USA).  
Microscopy. For phase-contrast microscopy, mid-logarithmic cultures (OD600 = 1.0) of L. 
plantarum strains were negatively stained with nigrosin [48] and spotted onto glass slides. After 
drying, the cultures were examined at 1250× magnification using a Dialux 20 microscope (Leitz, 
Wetzlar, Germany). Fluorescence microscopy was performed as described previously [49] with 
some modifications. Mid-logarithmic cultures of L. plantarum strains were incubated with 20 μg/
ml FM4-64 and 0.5 μg/ml Syto9 (Both from Molecular Probes, Eugene, USA) for 30 min and 
imaged by oil immersion fluorescence microscopy (BX51TRF Fluorescence Microscope, Olympus 
Corporation, Tokyo, Japan) at a 500x magnification.    
Scanning electron microscopy (SEM) analysis was performed as described previously [49]. Briefly, 
8-mm circular coverslips were coated with 0.01% (w/v) Poly-L-lysine (in water) and incubated 
for 30 min in L. plantarum mid-logarithmic cultures (OD600 = 1). The bacteria-adhered coverslips 
were then fixed with 4% (v/v) glutaraldehyde for 30 minutes, rinsed with water, followed by 
dehydration in serial acetone solutions. The samples were subsequently critical point dried with 
carbon dioxide (CPD 030, BalTec, Liechtenstein). The cover slips were then sputter coated with 
5 nm platinum in a dedicated preparation chamber (CT 1500 HF, Oxford Instruments, Oxford 
UK). The bacteria were analyzed with a field emission scanning electron microscope (FEI Magellan 
400 FESEM, Hillsboro, USA) at room temperature at a working distance between 4 and 5 mm, 
with SE detection at 2.0 kV. Images were digitally recorded (Orion 6 PCI, E.L.I. sprl. Belgium).  
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Zeta potential and hydrophobicity measurements. Overnight cultures were washed 
twice with 10 ml PBS and bacteria were resuspended in PBS at an optical density at 600 nm 
(OD600) of 1. Zeta potential was measured according to the manufacturer’s manual at 20°C using 
ZetaSizer cuvettes DST1070 (Malvern Instruments, Malvern, UK) in a Zetasizer nano series 
(Malvern Instruments). 
Surface hydrophobicity was determined using microbial adhesion to solvents (MATS) method 
[50]. Briefly, overnight cultures of L. plantarum strains were harvested by centrifugation at 5,000 
x g for 10 min, washed twice and resuspended to OD600 of 1.0 (A0) in PBS. 5 ml of bacterial 
suspension was mixed with 2 ml petroleum ether (the solvent) by 2 min vortexing in a 10 ml 
glass tube. The tubes were incubated statically for 15 min at room temperature to allow phase 
separation of the mixture. The aqueous phase was collected and its OD600 was measured (A1). The 
cell surface hydrophobicity (CSH) was presented as the percentage of microbial retained in the 
solvent, and calculated as (1 − A1/ A0) × 100.
RNA isolation and DNA microarray analysis. RNA isolation, labeling and hybridization 
were performed according to previously described methods [51, 52]. Briefly, L. plantarum WCFS1 
and its ltaS1 deletion derivative (NZ3537Cm) were grown in MRS with chloramphenicol and 
cells were harvested by centrifugation, following quenching and cell disruption by bead beating. 
RNA was purified using the High Pure Isolation Kit (Roche Diagnostics, Mannheim, Germany) 
including 1 h treatment with DNaseI (Roche Diagnostics). Five microgram of total RNA was 
used for cDNA synthesis. Cyanine-3 (Cy3) and cyanine-5 (Cy5) cDNA labeling was performed 
as described previously [51], using the CyScribe Post-Labeling and Purification kits according to 
the manufacturer’s instructions (Amsersham Biosciences, Buckinghamshire, UK). Cy-dye-labeled 
cDNAs (0.5 μg each) were hybridized to L. plantarum WCFS1 printed-oligonucleotide DNA 
microarrays (Agilent Technologies, Amstelveen, the Netherlands). Hybridization and scanning 
procedures were performed as previously described [51]. The data were normalized using the 
Lowess normalization as available in MicroPrep [53]. CyberT [54] was used to compare the 
transcriptomes of WCFS1 and ltaS1 mutant, resulting in a gene expression ratio and Benjamini 
and Hochberg’s False Discovery Rate (FDR) [55] for each gene. The expression of a gene was 
considered significantly altered when the FDR-adjusted p value was < 0.05. The transcript data of 
the ltaS2 mutant were analyzed by employing the CyberT package and were compared with those 
of WCFS1 and the ltaS1 mutant by Pearson correlation analysis and visualized using maximum 
likelihood trees (Phyml) for all genes or for genes within specific functional classes.
LTA purification and structure analysis by NMR spectroscopy. LTAs of L. plantarum 
and B. subtilis were extracted by the 1-butanol method as described in previous studies [56] with 
some modifications. Using a Techfors-S fermentor (Infors, Bottmingen, Switzerland), L. plantarum 
cells were cultured in 10 L of MRS-broth at 37°C at a constant pH of 6.8 and harvested after 
20 hr incubation, while B. subtilis was aerobically grown in 10 L of LB-broth [57] at 37°C and 
harvested after 8 hr incubation when the rising medium pH reached 7.2. The earlier harvesting 
time for B. subtilis was chosen to avoid degradation of d-Ala residues under alkaline conditions. 
Harvested cells (ca. 100 g and 30 g wet weight biomass were obtained for L. plantarum and B. 
subtilis, respectively) were washed with PBS and resuspended in the same buffer containing 
DNase and RNase (1 mg each, Roche diagnostics, Basel, Switzerland), followed by 5 cycles of 
cell disruption by passage through a French press cell (SLM Instruments Inc., Urbana, USA) at 
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10000 psi. The suspensions were centrifuged at 12000 rpm for 30 min at 4°C, and 100 ml of the 
supernatants were collected. The supernatants were mixed with an equal volume of 1-butanol and 
then stirred at room temperature for 30 min, followed by centrifugation for phase separation. 
The lower aqueous phase was collected and lyophilized. Subsequently, LTAs in the lyophilized 
butanol extracts were purified by hydrophobic interaction chromatography and anion-exchange 
chromatography. Briefly, the extracts were dissolved in 20 ml of 15% (v/v) 1-propanol in 100 
mm sodium acetate (NaOAc) buffer (pH 4.7) and subjected to a column packed with Octyl-
Sepharose 4 FastFlow (GE Healthcare, Chalfont St. Giles, England; i.d. 50 mm × 10 cm). The 
column was eluted with 1–2 column volume (CV) of 15%, 20%, 25%, 35%, and 45% (v/v) 
1-propanol in NaOAc buffer. The LTA-containing eluate was identified by their organic phosphate 
contents, which are determined by the method described previously by Tomita et al. [58]. The 
LTA-containing eluate (35% 1-propanol fraction in most cases) was dialyzed and lyophilized, 
and the isolate was dissolved with NaOAc buffer and was further subjected to fractionation 
on a column packed with DEAE-Sepharose 4 FastFlow (GE Healthcare; i.d. 26 mm × 11 cm). 
The column was washed with 2 CV of NaOAc buffer and eluted with a linear gradient elution 
of sodium chloride (0–1.0 m, 5 CV) using an AKTA fast performance liquid chromatography 
system (GE Healthcare). The fractions were measured for the presence of hexose [59] and organic 
phosphate [58] to identify LTA-containing fractions, which were pooled, dialyzed, and lyophilized 
to obtain the purified LTA. For structural comparison, proton nuclear magnetic resonance (1H 
NMR) spectrum of purified LTAs was recorded on an Avance III 500 MHz NMR spectrometer 
(Bruker BioSpin, Karlsruhe, Germany) under the condition described previously [60].
Toll-like receptor (TLR) assay. The assay was performed as described previously [61]. 
Briefly, human embryonic kidney (HEK)-293 TLR reporter cell lines expressing human TLR1/2, 
TLR2/6, or TLR4, and pNIFTY, a NF-κB luciferase reporter construct (InvivoGen, Toulouse, 
France) [62], were used. The HEK-293 reporter cell lines were seeded at 6 × 104 cells/well in 96-
well plates and incubated overnight under standard culture conditions. Cells were then stimulated 
with purified LTA or bacterial cells isolated from the stationary phase of growth of the L. plantarum 
wild type WCFS1 and its LtaS1- and LtaS2-deficient derivatives (NZ3537Cm and NZ3538Cm, 
respectively) at a MOI of 1:10, HEK cell to bacteria. The TLR1/2 agonist Pam3CSK4 (5 μg/
mL, InvivoGen) and TLR2/6 agonist Pam2CSK4 (5 μg/mL, InvivoGen) were used as positive 
controls, whereas PBS served as the negative control. 
For signal-attenuation assays, the LTA from L. plantarum WCFS1 (0.1, 1.0, and 10 µg/ml), control 
IgA2 antibody and neutralizing monoclonal IgA antibody to human TLR2 (both from InvivoGen, 
San Diego, USA; 5 µg/ml), were added to the TLR expressing reporter cell lines 15 min prior 
to the addition of the stimulant, 1 µg/ml of purified LTA from B. subtilis. Following a 6 hr 
incubation period, the medium was replaced with Bright-Glo™ (Promega Benelux BV, Leiden, 
The Netherlands), the plate was vortexed for 5 min, and the luminescence was measured using a 
Spectramax M5 (Molecular Devices, Sunnyvale, USA).   
Peripheral blood mononuclear cells (PBMCs) assay. The assay was performed as 
described previously [63] and was approved by Wageningen University Ethical Committee and 
was performed according to the principles of the Declaration of Helsinki. Peripheral blood of 
healthy donors was obtained from the Sanquin Blood Bank, Nijmegen, The Netherlands. PBMCs 
were separated from the blood using Ficoll-Paque Plus gradient centrifugation according to the 
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manufacturer’s description (Amersham biosciences, Uppsala, Sweden). The mononuclear cells 
were collected, washed in Iscove’s Modified Dulbecco’s Medium (IMDM) + glutamax (Invitrogen, 
Breda, The Netherlands) and adjusted to 1 × 106 cells/ml in IMDM + glutamax supplemented 
with penicillin (100 U/ml) (Invitrogen), streptomycin (100 μg/ml) (Invitrogen), and 1% human 
AB serum (Lonza, Basel, Switzerland). PBMCs (1 × 106 cells/well) were seeded and cultured 
overnight prior to the experiment in 48-well tissue culture plates, incubated at 37°C in 5% CO2. 
Bacteria or purified LTA were added to PBMCs at a MOI of 1:10, PBMCs to bacteria or at 1 µg/
ml, respectively. PBMCs from 3 different donors were used in the assay. Following 24 hr incubation 
at 37°C in 5% CO2, culture supernatants were collected and stored at -20°C until cytokine 
analysis. Cytokines were measured using a FACS CantoII flow cytometer (BD Biosciences, New 
Jersey, USA) and BD Cytometric Bead Array Flexsets (BD Biosciences) for interleukin (IL)10 and 
IL12p70, TNFα, IL6, IL1β, and IL8 according to the manufacturer’s procedures. Concentrations 
of cytokines were calculated based on the standard curves in the BD Biosciences FCAP software. 
Statistical analysis. The hydrophobicity, TLR and PBMCs assays analyses were performed in 
triplicate, while zeta potential was measured in quarduplicate. The One-way ANOVA followed 
by Tukey’s multiple comparison test was used to compare the means of surface properties and 
TLR2 activations between strains. The paired t test was used to determine the Log10 values of 
PBMCs cytokine productions after stimulated with wild-type verse mutant strains with respects 
of individual donors. GraphPad Prism 5 software (GraphPad Software, San Diego, CA) was used 
for all determinations, and a P value <0.05 was considered significant. 
Results
Identification of LtaSs involved in LTA synthesis in L. plantarum WCFS1
LtaS is responsible for the synthesis of polyglycerolphosphate [poly(Gro-P)] backbone of LTA 
[24]. A BlastP analysis [64] using the sequences of known LtaS enzymes from S. aureus [24], B. 
subtilis [25] and  L. acidophilus NCFM [65], revealed two homologous genes, lp_1283 and lp_2580 
(named ltaS1 and ltaS2, respectively) in L. plantarum WCFS1. Both Lp_1283 and Lp_2580 are 
annotated as a membrane-bound sulfatase of the alkaline phosphatase superfamily [66] and share 
high protein sequence similarity with known LtaS (45% identity with LtaS from S. aureus, 48% for 
LtaS1 and 46% for LtaS2 with LtaS from B. subtilis, and 53% with LBA0447 from L. acidophilus in 
protein sequences). Gene deletion mutants for both genes were constructed using double cross-
over gene replacement of either ltaS1 or ltaS2 by the chloramphenicol acetyltransferase gene (cat), 
resulting in L. plantarum WCFS1 ΔltaS1 (NZ3537Cm) and ΔltaS2 (NZ3538Cm), respectively. To 
complement the mutants, single copies of the respective genes were inserted in the chromosome 
downstream of the serine tRNA encoding gene under control of their own promoter, using the 
pMEC10 vector for targeted integration [67]. Notably, the growth and accessibility for genetic 
manipulations of the mutants were much compromised, prohibiting the construction of a double 
deletion mutant that lacks both ltaS1 and ltaS2. 
To confirm that LtaS1 and LtaS2 are involved in LTA poly(Gro-P) synthesis, whole cell extracts 
of the deletion and complementation strains were subjected to western blotting using a primary 
antibody against poly(Gro-P). Both the ltaS1 and ltaS2 deletion strains did no longer contain the 
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component recognized by the poly(Gro-P) antibody, which is assumed to represent LTA, and was 
detected in the wild type and the complemented strains (Figure 1). Taken together we identified 
LtaS1 (Lp_1283) and LtaS2 (Lp_2580), in L. plantarum WCFS1 and demonstrated that the LTA 
backbone synthesis in this strain requires both enzymes. 
The role of LTA in bacterial physiology and surface properties
While the deletion of ltaS (LBA0447) in L. acidophilus resulted in unaffected growth characteristics 
of the mutant strain relative to its parental strain [65], in other organisms, including S. aureus [24], 
B. subtilis [25] and Listeria monocytogenes [26] deficiency of this function had a substantial impact 
on growth and cell division. To investigate what the consequences of mutation are in L. plantarum, 
we investigated growth rate and cell morphology of the ltaS1 and ltaS2 deletion mutants. The 
maximum growth rate of the wild type is 0.39 ± 0.006 h-1, whereas the growth rate of ΔltaS1 and 
ΔltaS2 were strongly reduced, and were approximately half of that of wild type (0.18 ± 0.027 and 
0.29 ± 0.162 h-1, respectively). Moreover, while the ltaS1 mutant reached a final optical density 
(OD600; 8.39 ± 0.042) similar to the parental strain L. plantarum WCFS1 (8.50 ± 0.651) at 37°C 
in MRS, the ltaS2 mutant displayed a much lower final density under the same culture condition 
(6.33 ± 1.032). Subsequently, we investigated possible defects in cell division and morphology by 
microscopy. Light microscopy of ΔltaS1 and ΔltaS2 indicated that both mutants had lost the normal 
rod shape observed in the parental strain, and displayed distinct morphologies. The ltaS1 mutant 
displayed long and curly shaped cells, whereas the ltaS2 mutant appeared to form filamentous cells 
(Figure 2) that had a tendency to clump together (data not shown). The filamentous and clumpy 
phenotype of ΔltaS2 may be the cause of the high standard deviations observed in growth rate and 
OD600 measurements, since the culture is not homogeneous. Scanning electron microscope (SEM) 
analysis clearly showed that ΔltaS1 displayed abnormal positioning of cell separation, resulting in 
curly cell shapes, whereas ΔltaS2 grew in very long cells due to an apparently strongly impaired 
cell division (Figure 2). By visualization of cell membranes using the lipophilic dye FM4-64, it 
Figure 1. Whole cell extracts of wild type, ΔltaS1, ΔltaS2, and complemented mutants were analyzed by 
the western blot using a polyglycerolphosphate-specific monoclonal antibody to detect the poly-GroP LTA 
backbone. On the left side of the blot the protein sizes (kDa) are indicated based on the Precision Plus 
Protein™ Dual Color Standards (Bio-Rad) molecular marker. 0.1 μg/ml of purified LTA from wild type 
was loaded.
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forms much more elongated cells as compared to ΔltaS1 (Figure S1). We also observed normal 
rod-shaped cells in both mutants, indicating that the cell division is delayed or less efficient but 
not completely lost. The complementation strains seem only partially restored in terms of their 
morphology. For instance, the ltaS2 complemented strain does not show filamentous morphology 
but forms a chain of rod-shaped cells (Figure S2). It is likely that the expression levels of LtaS2 is 
slightly different in the complemented strain as compared to the wild-type situation which could 
lead to these altered phenotypes, albeit less distinct as in the ΔltaS2 mutant. These observation 
indicate that both growth and cell division are substantially, but distinctly modulated by deletion 
of either of the LtaS encoding genes in L. plantarum WCFS1. 
The surface properties of bacterial cells are considered to play an important role in the capacity 
of bacteria to physically interact with specific surfaces, including their capacity to interact with 
host cells in the intestinal tract. Important bacterial surface characteristics include its net-charge 
and hydrophobicity. Since LTA is one of the major cell envelope components and the fact that 
the poly(Gro-P) backbone contains a high amount of negative charges, as well as substitutions of 
d-alanine and glucose on the backbone [33, 68], it is likely that removal of mature LTA impacts 
on surface properties. To this end, surface charge and hydrophobicity of L. plantarum WCFS1 was 
compared to that of the ltaS1/2-deficient mutants. Notably, despite obvious changes in growth and 
cell division, ΔltaS1 does not alter surface charges nor hydrophobicity (Figure 3). Conversely, ltaS2 
mutation led to a strong increase in negative surface charge as well as the surface hydrophobicity 
(Figure 3). Importantly, although deletion of both ltaS1 and ltaS2 led to loss of normal LTA 
production (Figure 1), the impact of these mutations on the bacterial surface properties is quite 
distinct, strongly suggesting distinct functions for these two enzymes. 
Mutation of ltaS elicits pleiotropic transcriptional changes
To further assess the impact on overall physiology, genome-wide transcriptional profiles of 
Figure 2. Images of L. plantarum WCFS1 wild type and ltaS deletion derivatives under phase-contrast 
microscopy (upper panel) and scanning electron microscopy (lower panel). The phase-contrast microscopy 
shows 1250x magnified views of nigrosin-stained cells. The scanning electron microscopy shows images 
under different magnifications (160000x, 50000x, and 40000x for wild type, ΔltaS1, and ΔltaS2, 
respectively) to capture the morphology.
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Figure 3. (A) Zeta potential and (B) cell surface hydrophobicity (CSH) of L. plantarum WCFS1 (NZ3400Cm) 
and its deletion mutant derivatives. All individual data points are shown (n = 4 for zeta potential and n 
= 3 for hydrophobicity measurements) as well as the median (bar). Statistical significance of observed 
differences was determined by applying Kruskal-Wallis test; P ≤ 0.05 (overall ANOVA); ***, P ≤ 0.001; 
**, P ≤ 0.01; *, P ≤ 0.05. 
the ltaS1 deletion strain were generated and compared with those of the wild-type strain. The 
transcriptome analysis confirmed the abolishment of ltaS1 expression in the mutant strain and 
showed the expression of a large number of genes were significantly altered by the deletion. 
The ltaS1 deletion affected the expression of a total of 1258 genes; 709 genes were significantly 
down-regulated and 576 genes were up-regulated compared to the wild-type strain, reflecting 
a substantial role of LTA in bacterial physiology. Among these altered genes, genes involved in 
energy metabolism (58 up-regulated and 21 down-regulated) and stress/environment adaptation 
(16 up-regulated and 2 down-regulated) appeared mainly up-regulated, whereas genes involved in 
biosynthesis of proteins (14 up-regulated and 51 down-regulated), nucleotides (17 up-regulated 
and 31 down-regulated), cofactors (7 up-regulated and 14 down-regulated), and fatty acids (2 up-
regulated and 16 down-regulated)were mostly down-regulated. The ltaS1 deletion also affected 
a large group of genes (134 genes) involved in the biosynthesis of other cell surface components, 
including peptidoglycan, surface polysaccharides and proteins. Notably, while the genes involved 
in peptidoglycan and surface polysaccharide synthesis were both down- and up-regulated without a 
clear consistent pattern, the genes encoding surface proteins were almost exclusively up-regulated. 
The genes involved in d-alanylation of LTA and wall teichoic acids, WTA, (dltA, dltB, dltC1, dltD, 
and dltX) were up-regulated in the ltaS mutant, suggesting a potential influence of LTA on WTA 
structures. Interestingly, two genes, tagF2 (lp_0269), tagD2 (lp_1248), involved in glycerol-type 
wall teichoic acid (WTA) biosynthesis were down-regulated while tagL (lp_1819) that is involved 
in ribitol-type WTA synthesis, was up-regulated. It has been shown that L. plantarum WCFS1 has 
the ability to synthesis both types WTA but under tested conditions only produce glycerol-type 
WTA [69]. Comparative analysis showed that the transcriptomes of both the ΔltaS1 and ΔltaS2 
strains were substantially different from the wild-type and also quite distinct from each other 
(Figure S3A). However, the evaluation specifically focusing on changes in cell envelope-associated 
genes in the ltaS2 mutant revealed a significant degree of coherence with ltaS1, in comparison to 
the wild-type strain (Figure S3B), suggesting a similar impact on surface molecules by both LTA 
deficiency causing mutations. These data indicate the pleiotropic and distinct impact of the ltaS 
deletions on overall bacterial physiology and underpin the stress induced by ltaS1 deletion that 
drives the reduction of biosynthetic pathways and the increase of energy generating metabolism, 
while both ltaS mutations broadly affect a variety of surface molecules. 
58
Chapter 3
3
LTA and TLR2 signaling
Several studies have shown that LTA signals through TLR2 [29, 33, 70]. Therefore the effect 
of LTA-deficiency in L. plantarum WCFS1 on host cell signaling was investigated by employing 
a TLR2 activation reporter cell assay. The dosage of bacterial cells to which the reporter cells 
were exposed was normalized on basis of total bacterial biomass rather than on bacterial colony 
forming units (CFU), with the intention to avoid confounding of the data due to the altered 
morphology and tendency towards cell-clumping observed in the LTA deficient strains. Notably, 
the LTA-deficient mutants stimulated significantly higher TLR1/2 and TLR2/6 signaling (Figure 
4A and 4B, respectively) as compared to the wild-type strain (WCFS1). Deletion of ltaS1 led 
to an approximately 5-fold increased TLR1/2, and approximately 1.5-fold increased TLR2/6 
signaling in the respective reporter cell lines. The ltaS2 deletion resulted in an even stronger 
increase in TLR1/2 (ca. 10-fold) and TLR2/6 (ca. 5-fold) signaling, respectively, relative to the 
activation by WCFS1 (Figure 4). These results apparently exclude a direct role of L. plantarum LTA 
in TLR1/2 or TLR2/6 signaling pathway activation, although this conclusion should be taken with 
caution and the differences are possibly not only assigned to a lack of LTA but may involve other 
compensatory changes in these mutants that display quite pleiotropic differences in cell-envelope 
pathways compared to the parental strain (see above). 
To further investigate the TLR2 signaling role of L. plantarum LTA, we purified LTA from L. 
plantarum (LTA-Lp) and tested this component in the TLR2 signaling reporter cell assay. As a 
positive control, LTA from Bacillus subtilis 168 was purified (LTA-Bs) using the same purification 
procedure. This preparation was considered as a suitable positive control, since LTA-Bs is 
commercially available as a TLR2 ligand (InvivoGen), although the purification procedure for this 
material is not clearly described. Purified LTA-Lp stimulates only very low TLR1/2 activation 
and fails to activate TLR2/6 signaling. By contrast, LTA-Bs activates strong TLR1/2 and TLR2/6 
signaling, already at low concentrations (0.1 µg/ml), which is comparable to the stimulants 
Figure 4. TLR1_2 (A) and TLR2_6 (B) signaling stimulated by L. plantarum wild type and ltaS deletion 
derivatives (ΔltaS1 and ΔltaS2), using TLR-expressing HEK cell lines, containing a NF-kB responsive 
luciferase reporter system. Measurements were performed in two independent experiments each with 
three technical replicates (n = 6) and are presented as Log values, and individually displayed and the bar 
indicates the median. PBS serves as negative control, and Pam3CysSK4 (Pam3) and Pam2CysSK4 (Pam2) 
are the positive stimulants of TLR1_2 and TLR2_6 activation, respectively. Data comparison of the ltaS 
deletion strains and the wild-type strains were tested for significant differences using one-way ANOVA 
followed by Tukey’s multiple comparison correction and significant differences are indicated; ***, P ≤ 
0.001.
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Pam3CSK4 and Pam2CSK4 that are the synthetic tri-acylated and di-acylated lipopeptide agonists 
of TLR1/2, and TLR2/6, respectively (Figure 5). These results indicate that contrary to LTA of 
B. subtilis, which is an effective TLR2 signaling ligand, the LTA molecule produced by L. plantarum 
WCFS1 is a poor TLR2 stimulator and elicits more than 40- and 8-fold reduced TLR1/2- and 
TLR2/6-mediated NF-κB activation in the HEK-reporter cell line, respectively (Figure 5). 
The low TLR2-stimulating capacity of the purified L. plantarum LTA in combination with the 
enhanced TLR2 signaling elicited by L. plantarum cells in which the LTA synthesis is eliminated 
by ltaS1/2 mutation, possibly implies that the LTA molecules of L. plantarum WCFS1 plays an 
attenuating role in molecular signaling through the TLR2-dependent pathway. Such attenuation 
effect would most likely involve binding of the L. plantarum LTA to the TLR-receptor without 
eliciting the signal transduction activated by LTA molecules of other species (e.g., B. subtilis). To 
examine the postulated attenuation effect, the TLR1/2 and TLR2/6 reporter cell lines were pre-
incubated with LTA-Lp in different concentrations and subsequently stimulated with LTA-Bs. As 
a positive control for TLR2 activation, a neutralizing IgA monoclonal antibody directed against 
human TLR2 was used [71], whereas human IgA isotype was included as a negative control. Of 
these controls, only the TLR2-specific IgA controls effectively attenuated the LTA-Bs activation 
of TLR2 signaling in both the TLR1/2 and TLR2/6 expressing reporter cell lines, illustrating 
the validity of the approach chosen. However, the pre-incubation of the TLR1/2 and TLR2/6 
reporter cells with LTA-Lp prior to stimulation with LTA-Bs failed to affect the LTA-Bs signaling 
capacity, indicating that LTA-Lp does not display attenuation capacity in this assay or at least not at 
the concentrations employed (Figure S4A and S4B, respectively). 
The impact of LTA on immunomodulatory properties of L. plantarum
To evaluate whether LTA can modulate immune responses via other PRRs, the general 
immunomodulatory properties of LTA-deficient mutants and of purified LTA were investigated 
using PBMCs assay and the production of inflammation-related cytokines, namely interleukin (IL) 
12p70, tumor necrosis factor (TNF) α, IL1β, IL8, IL6, and IL10, were measured. The deletion 
Figure 5. TLR1_2 (A) and TLR2_6 (B) signaling stimulated by purified LTA from L. plantarum WCFS1 
(LTA-Lp) or B. subtilis 168 (LTA-Bs). Measurements were performed in triplicate and are presented as 
Log luminescence units, and individually displayed (n = 3) and the bar indicates the median. PBS serves as 
negative control, and Pam3CysSK4 and Pam2CysSK4 are the positive stimulants of TLR1_2 and TLR2_6 
activation, respectively. LTA-Lp was tested in 0.1, 1, and 10 μg/ml while LTA-Bs was tested in 0.1 μg/
ml. Data were tested for significant differences using one-way ANOVA followed by Tukey’s multiple 
comparison correction and samples showed significant differences are marked with different letters. 
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mutants, ΔltaS1 and ΔltaS2, both induced similar amounts of pro-inflammatory cytokines as the 
wild type strain (Figure 6A and S5), except in one donor where ΔltaS1 induces about 4.5-fold 
higher amount of IL12 than WCFS1 (Figure 6A). On the other hand, the productions of anti-
inflammatory cytokine IL10 induced by LTA-deficient mutants were significantly lower than by 
wild type strain while complemented strains stimulated similar level of IL10 as wild type (Figure 
6B). The IL10/IL12 ratio, which has been reported as an indicator for in vivo performance in a 
mouse colitis model, displayed no significant differences between the mutants and the wild type 
(Figure S6). Overall, despite the enhanced TLR2 activations by LTA-deficient L. plantarum strains, 
they do not trigger more pro-inflammatory cytokine productions in PBMCs. Notably, it seems 
LTA plays a role in stimulating the production of anti-inflammatory cytokine IL10 in PBMCs since 
reduced IL10 productions observed with LTA-deficient strains. However, given the pleiotropic 
impacts of ltaS deletions on L. plantarum cells, we measured cytokine productions of PBMCs using 
purified LTA to evaluate the direct involvement of LTA in stimulating IL10 production.  
The purified LTA from L. plantarum WCFS1 (LTA-Lp) and from Bacillus subtilis 168 (LTA-Bs) were 
tested for their immunomodulation responses in PBMCs assay and the responses were compared 
with those stimulated by L. plantarum WCFS1 cells. Despite the large difference in TLR2 signaling, 
LTA-Lp and LTA-Bs stimulate similar levels of all cytokines measured (Figure 7 and S7), suggesting 
TLR1/2 and TLR2/6 alone are not the major contributors to LTA recognition in inflammatory 
responses of PBMCs. Notably, the production of IL12p70 was below the detection limit.  
Although individual cytokine production does not significantly differ between LTA-Lp and LTA-
Bs, LTA-Lp stimulates generally less cytokines, both pro- and anti-inflammatory, as compared to 
LTA-Bs (Figure S7), which demonstrates an overall difference in immunomodulatory properties 
between LTA isolated from L. plantarum and B. subtilis. When comparing the responses of PBMCs 
stimulated by the cells and purified LTA of L. plantarum WCFS1, the purified LTA stimulates lower 
Figure 6. Immunomodulatory effect of L. plantarum WCFS1 and, ltaS deletion derivatives, and 
complementated strains in PBMC stimulation assays (n=3 donors), measuring inflammation-related 
cytokine secretions. The productions of pro-inflammatory cytokine IL12p70 (A) and anti-inflammatory 
cytokine IL10 (B) are presented in Log values. One measurement, labeled as ‘x’, of IL12p70 in ΔltaS2 
was under the detection limit and was set at the detection limit. The cytokine levels for individual donors 
stimulated with wild-type and deletion mutants bacteria were connected by a line to focus the read-outs 
on changes elicited by the mutations. Significant differences between cytokine levels induced by wild-
type strains and mutants (paired t-test) are indicated; *, P ≤ 0.05. No significant differences were found 
between samples in IL12 measurements. The measurements of TNFα, IL1β, IL6 and IL8 from the same 
assays are presented in supplemental figure S3.
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production of the pro-inflammatory cytokines, IL12 (below the detection limit), TNFα (Figure 
7A) and IL1β (Figure S7A), relative to whole bacterial cells. The purified LTA does not stimulate 
elevated IL10 production in PBMCs as compared to the bacterial cells of L. plantarum WCFS1 
(Figure 7B), suggesting that LTA is not directly involved in IL10 production in PBMCs and the 
reduced IL10 level stimulated by LTA-deficient mutants may be caused by other factors, which 
are likely other surface-exposed components that are affected by ltaS deletion. Taken together, our 
results implies that LTA-Lp is not signaling actively in purified form and also does not contribute 
significantly to immune signaling in the context of the whole cell interaction with PBMCs.  
Discussion
LtaS plays an essential role in LTA biosynthesis in various bacteria, such as S. aureus [24], B. subtilis 
[25], Listeria monocytogenes [26], and L. acidophilus [65]. While only a single copy of ltaS is found 
in the genome of S. aureus, Streptococcus pyogenes, and Streptococcus agalactiae [24], there are 4 
homologues (ltaS, yfnI, yqgS, and yvgJ) found in B. subtilis [25]. Our analysis concludes that most 
lactobacilli, including L. plantarum WCFS1, L. acidophilus NCFM and Lactobacillus rhamnosus GG, 
possess 2 homologues of ltaS encoding gene in their genome (Table S1), showing that multiple 
copies of ltaS genes are commonly found in Lactobacillus species. While one of the four LtaS-like 
proteins of B. subtilis (designated LtaS) plays the major role in LTA biosynthesis [25], our study 
shows that both LtaS1 and LtaS2 in L. plantarum WCFS1 are required for LTA backbone synthesis, 
and deletion of either of their encoding genes eliminates LTA production. Notably, a two-enzyme 
system for LTA backbone synthesis has been proposed for Listeria monocytogenes, involving a LTA 
primase (LtaP) that produces the priming molecule  Gro-P-glycolipid and a LTA synthase (LtaS) 
that catalyzes the formation of the poly(Gro-P) backbone [26]. To evaluate whether it is likely 
that LtaS1 and LtaS2 of L. plantarum WCFS1 also function in a similar concerted manner, the 
protein sequences of LtaS1 and LtaS2 were aligned with the LtaS and LtaP of Listeria monocytogenes, 
revealing that both L. plantarum proteins are significantly more homologous to LtaS of Listeria 
monocytogenes, disallowing their segregation in the possible LtaP- and LtaS-like functions. Moreover, 
Figure 7. Immunomodulatory effect of L. plantarum WCFS1 cells, purified LTA from L. plantarum WCFS1 
(LTA-Lp) or B. subtilis 168 (LTA-Bs) in PBMC stimulation assays (n=3 donors), measuring inflammation-
related cytokine secretions. The productions of pro-inflammatory cytokine TNFalpha (A) and anti-
inflammatory cytokine IL10 (B) are presented in Log values. Measurements of PBS were all under the 
detection limit and thus were set at the detection limit and labeled as ‘x’. The cytokine levels for individual 
donors stimulated with WCFS1 strain or purified LTA were connected by a line to focus the read-outs on 
changes elicited by the origin of LTA. Significant differences between cytokine levels induced by wild-type 
strains and mutants (paired t-test) are indicated; *, P ≤ 0.05. 
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no Gro-P-glycolipid intermediate could be detected in either the ltaS1 or the ltaS2 mutant strain 
(Figure S8) underpinning the suggestion that neither of the genes encodes a typical LtaP function. 
Nevertheless, ΔltaS1 and ΔltaS2, are not phenotypically identical, and displayed clearly distinct 
cell-morphology characteristics and transcriptomes, indicating phenotypic differences between 
these strains, despite their consistent loss of LTA backbone synthesis. Taken together, both LtaS1 
and LtaS2 functions of L. plantarum are required for LTA backbone synthesis but have a differential 
role in bacterial cell division and surface properties.
Previous studies employing ltaS deletion mutants have shown the link between LTA and cell division 
in Staphylococcus aureus [24, 28], B. subtilis [25], and Listeria monocytogenes [26], in which ltaS mutants 
display a filamentous phenotype. One exceptional appears the ltaS (LBA0447) deletion derivative 
of L. acidophilus NCFM that displays normal growth and morphology [65]. We observed elongated 
and curly cells in the ltaS1 mutant and filamentous cells in the ltaS2 mutant, indicating that cell 
division is affected by LTA in L. plantarum WCFS1. Besides cell division, ltaS deletion also has been 
shown to link with lipid metabolism in S. aureus [72] and B. subtilis [73]. It has been described in 
S. aureus that the membrane lipid pool of phosphatidylglycerol (PG) sustains a high turnover rate 
to support LTA synthesis, based on the LtaS-catalized hydrolysis of PG to extend LTA by a single 
Gro-P unit and generating a diacylglycerol (DAG) molecule [72], which is subsequently recycled 
to PG or is used for glycolipid synthesis [74]. Diacylglycerol kinase (DgkB) is responsible for the 
first step of DAG recycling [74] and deletion of dgkB is lethal in B. subtilis, due to accumulation 
of DAG [73]. The lethality of dgkB deletion could be avoided by deletion of either of the two 
ltaS homologues in B. subtilis (ltaS and yfnI), showing the impact of LtaS in lipid turnover [73]. 
We also observed that many of the genes involved in lipid metabolism were down-regulated in 
ltaS1 deletion mutant, including the gene annotated as diacylglycerol kinase (lp_1968), suggesting 
an intimate link between LTA biosynthesis and lipid metabolism in L. plantarum. Notably, LTA-
deficiency in L. plantarum WCFS1 enhanced the expression of the dlt operon, which is responsible 
for d-alanylation of both LTA and WTA. A previous study showed d-alanylation of LTA becomes 
essential when WTA is lacking in S. aureus, suggesting d-alanylation of LTA and WTA could have a 
redundant role in bacterial physiology [75]. On the other hand, WTA isolated from LTA-deficient 
S. aureus strain has lower d-alanine decoration isolated than that from wild type. The authors 
suggested that the presence of LTA affects the efficiency of d-alanylation in WTA [76]. Thus, 
the enhanced dlt operon expression in ltaS1 strain of L. plantarum WCFS1 could suggest a higher 
degree of WTA d-alanylation as a compensatory mechanism for absence of LTA, or alternatively a 
compensation for the reduced efficiency of d-alanylation in WTA. 
It has been reported that Lactobacillus mutants with modified LTA stimulate anti-inflammatory 
responses. A reduction of d-alanyl substitutions in LTA of L. plantarum NCIMB8826 [33] and a 
complete removal of d-alanyl substitutions in LTA of L. rhamnosus GG [77] resulted in enhanced 
anti-inflammatory capacity and improved effects in treating murine colitis models. Moreover, a 
complete removal of LTA in L. acidophilus NCFM resulted in a strain that exhibits enhanced anti-
inflammatory capacities, which was illustrated by suppressed production of IL12 and TNFα and 
enhanced production of IL10 in dendritic cells. Moreover, the LTA deficient L. acidophilus strain 
was shown to ameliorate colonic inflammation in mouse colitis [65] as well as reduced local DC 
cell densities and pro-inflammatory cytokines and reduced the formation of colonic polyposis in 
a mouse model [78]. These findings suggest LTA acts as a pro-inflammatory molecule in the cell 
envelope of lactobacilli. However, this role of LTA was not observed for L. plantarum WCFS1, 
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where LTA-deficient derivatives do not suppressed pro-inflammatory cytokine productions 
nor stimulate more anti-inflammatory cytokine production in PBMCs as compared to the wild 
type strain. Importantly, the alteration of LTA leads to pleiotropic changes on bacterial surface 
components, including polysaccharides, proteins, and teichoic acids, based on the transcriptome 
analysis. In addition, purified LTA from L. plantarum WCFS1 does not elicit clear pro- nor anti-
inflammatory responses in PBMCs. Taken together, it is likely that the changes in immune 
properties of the LTA-deficient mutants are driven by complex and multifactorial changes in a 
variety of surface molecules, rather than by LTA removal alone. Also, the enhanced TLR2-signaling 
in LTA-deficient derivatives of L. plantarum WCFS1 may come from other TLR2 ligands, such as 
lipoproteins/lipopeptides. The indirect impact of LTA modification on surface components also 
has been reported in L. rhamnosus GG, in which abolishing the d-alanine substitution of LTA by 
deleting dltD was shown to elevate the level of secreted Msp2 (formerly p40)  [77]. Msp2 is 
a soluble protein that was shown to prevent cytokine-induced apoptosis in intestinal epithelial 
and DSS-induced acute colitis in a mouse model via epidermal growth factor receptor (EGFR)-
dependent mechanism [79]. However, the link between increased Msp2 secretion and the enhanced 
anti-inflammatory properties by dltD mutant of L. rhamnosus GG remains to be verified. Overall, 
purified LTA of L. plantarum WCFS1 is not a potent immune stimulator in PBMCs. 
The purified LTA from L. plantarum WCFS1 stimulates a very low TLR1/2 signaling and no 
TLR2/6 signaling. These findings could imply a remaining trace of lipoproteins in LTA purified 
fraction, since lipoproteins of L. plantarum WCFS1 are mainly signaling via TLR1/2 but not 
TLR2/6 (chapter 4). Previously, Grangette et al. have reported that purified LTA from L. plantarum 
NCIMB8826 (L. plantarum WCFS1 is a single colony isolate of strain NCIMB8826) induced 
TNFα production in mouse bone marrow cells in a TLR2-dependent manner [33]. The apparent 
difference in these observations could be the result of different LTA purification procedures; 
Grangette et al. employed a method that lacks the anion-exchange chromatography and thereby 
may lead to a higher residual lipoprotein level [33]. Alternatively, the TLR-2 signaling capacity 
of L. plantarum NCIMB8826 LTA was determined using mouse bone marrow cells [33], whereas 
we employed a TLR-2 reporter cell line derived from human embryonic kidney (HEK) 293cells, 
which lacks potentially essential co-receptors for the TLR-2 signaling by LTA such as CD14 and 
CD36 [80]. Notably, the latter explanation appears in agreement with the observation that the LTA 
we purified from WCFS1 was capable of inducing cytokine production in PBMCs, implying that 
LTA can be sensed by these cells through other receptors. Furthermore, dltD deletion derivatives 
of L. plantarum NCIMB8826 that have lost the d-alanylation capacity, were shown to be more anti-
inflammatory as compared to their cognate wild-types [33]. The LTA of this dltD strain has also 
been reported to have increased glucose substitution and an extended Gro-P backbone compared 
to the LTA of the parental strain [33]. However, in a mutant of L. plantarum WCFS1 that lacks the 
entire dlt operon (ΔdltD-X), no extended LTA molecules were detected and no enhanced anti-
inflammatory properties were observed in vivo in healthy mice [81]. Moreover, the dlt mutant of 
Lactobacillus rhamnosus GG did not display enhanced anti-inflammatory properties in vitro [22], but 
still suppressed disease symptoms in a mouse colitis model [77]. Based on these results, differences 
in bacterial species, construction of mutations, and the choice in animal and in vitro models could 
all contribute to differences in the immunological readouts obtained. 
Following the same purification procedure, remarkable differences were observed between 
LTA-Lp and LTA-Bs in TLR2 signaling, suggesting that structural differences between these LTA 
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molecules may underlie the differential immunomodulatory properties. Structural analysis of LTA 
reveals extensive non-uniformity of this molecule with at present 5 reported LTA structure-types 
[for reviews, see [82, 83]]. Both LTA-Lp and LTA-Bs belong to type-I LTA, the best characterized 
LTA type with an unbranched 1–3 linked GroP backbone, which can be found in a wide range 
of Gram-positive bacteria, including S. aureus and Listeria monocytogenes [82]. We compared the 
LTA structure of L. plantarum WCFS1 and B. subtilis 168 using proton-NMR spectroscopy. Using 
published structures of LTA from L. plantarum [13] and B. subtilis [84, 85] in a comparative mode, 
our analyses revealed that both LTAs contain d-alanine substitutions (Figure 8), which is in 
agreement with previous studies [13, 84, 85]. However, the glycoside-substitution of the LTA 
backbone appeared to differ substantially, where L. plantarum LTA is glucosylated and B. subtilis LTA 
is substitutes with N-acetyl-α-d-glucosamine residues (GlcNAc) (Figure 8). In addition, the LTA-
Bs has a shorter poly(Gro-P) backbone as compared to LTA-Lp, which is approximately 20-22 
Gro-P residues in length [21]. These structural differences are relevant targets for further study, 
particularly in the context of their role in TLR2 signaling and immunomodulation, which is clearly 
different between the two LTA molecules. Importantly, since the glycol-substitutions of LTA seem 
to be an important structure distinction between strong and weak immune-stimulatory LTAs, 
the identification of the pattern recognition receptor (PRR) involved in glycoside-substitutions 
recognition is important for a better understanding of the immunomodulatory capacity of LTA. 
Candidate PRRs for such role may be discovered among the C-type lectin receptors, a PRR family 
that currently has been proposed to have at least 17 groups, and is proposed to be involved in 
glycoside recognition through their lectin-like domains [86]. 
In conclusion, we have shown that LTA plays important roles in bacterial growth, cell division, and 
surface properties in L. plantarum WCFS1, analogous to what has been observed in other Gram-
positive bacteria. Interestingly, we found that the deletion mutants exhibit more pro-inflammatory 
properties relative to their parental strain, which is in apparent contradiction with the suggested 
pro-inflammatory characteristics of the LTA from other Gram-positive bacteria. Our work 
pointed out that the pleiotropic impact of LTA deficiency, complicates the interpretation of the 
immunomodulation capacities of LTA in studies that employ LTA deficient mutants as we have 
constructed here and as were also reported for Staphylococcus aureus [24, 28], B. subtilis [25], and 
Figure 8. 1H NMR spectrum of purified LTA from B. subtilis (LTA-Bs, top) and L. plantarum WCFS1 
(LTA-Lp, bottom). Intensity of the spectra was approximately adjusted by the signal intensities of fatty 
acid CH2 and CH3. Chemical shift was calibrated to trimethylsilyl propanoic acid (TMSP) signal (0.00 
ppm). Abbreviations stand for: Ala, d-alanine; FA, fatty acids; Glc, α-d-glucose; GlcNAc, N-acetyl-α-d-
glucosamine; Gro, glycerol. 
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Listeria monocytogenes [26]. For strict immunomodulatory analysis of LTA itself, purified molecules 
are required. We developed a purification procedure that minimizes lipoprotein contamination 
while maintaining the structural integrity of LTA, and appears applicable in different Gram-
positive bacteria. Notably, purified LTA from L. plantarum WCFS1 and from B. subtilis 168 are 
ineffective and effective TLR2 ligands, respectively. The differences in TLR2-signaling capacity 
are likely explained by structural differences of the LTA molecules, particularly their differential 
glycoside substitution, and could possibly also involve their acyl chain anchors. Importantly, 
the differences between purified LTA-Lp and LTA-Bs are much smaller in terms of stimulating 
cytokine responses of PBMCs as compared to their TLR2 signaling capacities. This observation 
strongly suggests the participation of other PRRs besides TLR2 in inflammation responses in 
immune cells and recognition of LTA. Our study strongly underpins that the commonly accepted 
perspective that Gram-positive LTA molecules act as pro-inflammatory compounds through TLR-
mediated signaling is invalid and quite naive. This perspective ignores the substantial diversity 
that exists in the chemical structures that are present in LTA from different bacteria, which is a 
subject that deserves much more research in order to explain the role of different bacterial LTA 
molecules in host-microbe communication. Remarkably, a similar conclusion is reached when 
the canonical TLR4 signaling capacity of Gram-negative lipo-polysaccharides (LPS) is evaluated, 
revealing that LPS structural diversity (e.g., penta- or hexa-acylation forms) critically affects 
the LPS-TLR-4 interaction [87]. Taken together, these findings illustrate that generalization of 
PRR-ligand interactions is unreliable and requires much more insight in ligand structure-function 
requirements in the context of PRR signaling. Overall, this study supports the critical role of 
bacterial cell envelope components in the species- and strain-specific interactions with the 
extensive PRR repertoire of the host cells. 
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Supplemental Material
Figure S1. Images of L. plantarum WCFS1 and ltaS deletion derivatives under fluorescence microscope at a 500x 
magnification. Visualization of DNA by Syto9 and membrane by FM4-64 are shown in upper and middle panels, 
respectively. The lower panel shows the merge image of the Syto9 and FM4-64 images. 
Figure S2. Images of L. plantarum ltaS2 complementation strain under phase-contrast microscopy. The phase-
contrast microscopy shows 1250x magnified views of nigrosin-stained cells. 
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Figure S5. Immunomodulatory effect of L. plantarum WCFS1 and strains and ltaS deletion derivatives in PBMC 
stimulation assays (n=3 donors), measuring inflammation-related cytokine secretions. The productions of pro-
inflammatory cytokine TNFα (A), IL1β (B), IL6 (C) and IL8 (D) are presented in Log values. The cytokine levels 
for individual donors stimulated with wild-type and deletion mutants bacteria were connected by a line to focus 
the read-outs on changes elicited by the ltaS deletion. No significant differences between cytokine levels induced 
by wild-type strains and mutants (paired t-test) are found. 
Figure S3. Dendrograms visualizing Pearson correlation analyses of the transcriptomes of L. plantarum WCFS1 
(WT), ltaS1 and ltaS2 mutants based on the transcript levels of all genes (A) or of cell envelope-associated genes 
(B). 
Figure S4. Attenuation assay of purified LTA from L. plantarum WCFS1 (LTA-Lp) in TLR1/2 (A) and TLR2/6 (B) 
signaling. The tested attenuating substances, LTA-Lp (0.1, 1, or 10 μg/ml), were added to TLR1/2 and TLR2/6 
cell lines prior to the stimulant, purified LTA from B. subtilis (1 µg/ml). Measurements were performed in 
triplicate and are presented as Log values, and individually displayed (n = 3) and the bar indicates the median. The 
PBS and control IgA (InvivoGen) serve as negative controls while a monoclonal antibody blocking human TLR2 
(mAb-hTLR2, InvivoGen) serves a positive control.   
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Figure S6. IL10/IL12 was also compared of between L. plantarum wild type (NZ3400Cm) and the deletion 
mutants (ΔltaS1 and ΔltaS2). The cytokine levels for individual donors stimulated with L. plantarum strains were 
connected by a line to focus the read-outs on changes elicited by the mutations. The differences between wild-type 
and corresponding mutant were statistically analyzed by using paired t test. No significant difference was found 
between the IL10/IL12 ratios stimulated by the strains.     
Figure S7. Immunomodulatory effect of cells and purified LTA from L. plantarum WCFS1 (LTA-Lp), and purified 
LTA from B. subtilis (LTA-Bs) in PBMC stimulation assays (n=3 donors), measuring inflammation-related cytokine 
secretions. The productions of pro-inflammatory cytokine IL1β (A), IL6 (B) and IL8 (C) are presented as Log 
values. The cytokine levels for individual donors stimulated with purified LTA were connected by a line to focus 
the read-outs on changes elicited by the origins of LTA. Significant differences between cytokine levels induced by 
the cells and purified LTAs (paired t-test) are indicated; *, P ≤ 0.05.
Figure S8. Total membrane lipids (1 mg each) isolated 
from L. plantarum WCFS1, NZ3400Cm, and ltaS 
mutants (ΔltaS1 and ΔltaS2) were separated by thin 
layer chromatography (TCL) according to the method 
described previously [1]. Digalactosyl-diacylglycerol 
(30 µg) was used as a reference. Possible identity of the 
bands were indicated by the arrows on the right based on 
published LTA structure of L. plantarum [2].  
73
3
Lipoteichoic acid of L. plantarum WCFS1
Table S1. ltaS homologues found in lactobacilli strains and their similarity to LtaS of Staphylococcus aureus and L. 
plantarum WCFS1.
Bacterial strains
ltaS 
homologues
Identity to S. 
aureus LtaS (%)
Identity to 
ltaS1 (%)
Identity to 
ltaS2 (%)
L. plantarum WCFS1 ltaS1 (lp_1283) 46 100 54
ltaS2 (lp_2580) 45 53 100
L. acidophilus NCFM LBA0447 44 60 47
LBA0750 40 45 52
L. amylovorus GRL 1112 LA2_02370 45 60 48
LA2_03975 40 46 53
L. brevis ATCC 367 LVIS_1546 44 72 50
LVIS_1812 43 50 65
L. casei ATCC 334 LSEI_0868 46 64 50
LSEI_1123 42 47 55
L. casei BL23 YfnI (LCABL_09330) 46 64 50
LCABL_12830 42 47 55
L. crispatus ST1 LCRIS_00447 45 60 48
LCRIS_00753 41 46 54
L. delbrueckii subsp. bulgaricus 
ATCC 11842
Ldb0690 40 47 54
Ldb1835 45 57 47
L. delbrueckii subsp. bulgaricus 
ATCC BAA-365
LBUL_0623 40 47 53
LBUL_1707 45 57 50
L. delbrueckii subsp. bulgaricus 
ND02
LDBND_0620 40 47 53
LDBND_1710 45 57 47
L. fermentum CECT 5716 LC40_1044 44 63 48
LC40_1079 49 55 71
L. fermentum IFO 3956 LAF_1649 44 63 48
LAF_1697 45 51 67
L. gasseri ATCC 33323 LGAS_1259 40 47 52
LGAS_1586 46 61 48
L. helveticus DPC 4571 lhv_0470 44 60 48
L. helveticus CNRZ32 lhe_0753 40 44 53
lhe_1606 44 60 48
L. jensenii 1153 LBJG_00011 44 60 48
LBJG_00646 41 48 53
L. johnsonii ATCC 33200 FC22_GL000409 45 61 48
FC22_GL001103 40 47 52
L. johnsonii FI9785 FI9785_1288 40 47 52
FI9785_1550 46 61 48
L. johnsonii NCC 533 LJ_1768 46 61 48
LJ_0920 40 47 49
LJ_0921 42 53 65
LJ_0922 39 47 46
L. paracasei subsp. paracasei 
8700:2
LBPG_02966 46 64 50
LBPG_03057 42 47 55
L. paracasei subsp. paracasei 
ATCC 25302
HMPREF0530_2689 43 47 55
HMPREF0530_3015 46 64 50
L. reuteri 100-23 Lreu23DRAFT_4562 46 64 49
Lreu23DRAFT_4733 45 50 65
L. reuteri JCM 1112 LAR_1513 46 64 49
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LAR_1723 45 50 65
L. rhamnosus GG LGG_00830 46 64 50
LGG_01082 42 47 56
L. rhamnosus HN001 LRH_03392 46 64 50
LRH_04568 42 46 56
L. rhamnosus Lc 705 LC705_00824 46 64 50
LC705_01159 42 47 56
L. rhamnosus LMS2-1 HMPREF0539_0057 46 64 50
HMPREF0539_1187 42 47 56
L. sakei subsp. sakei 23K LCA_0465 44 65 50
LCA_1207 43 52 59
L. salivarius CECT 5713 HN6_00326 45 68 49
HN6_00432 44 49 59
L. salivarius  UCC118 LSL_0394 45 68 49
 LSL_0465 44 49 60
References
1. Webb, A.J., Karatsa-Dodgson, M., and Grundling, A., Two-enzyme systems for glycolipid and 
polyglycerolphosphate lipoteichoic acid synthesis in Listeria monocytogenes. Mol Microbiol, 2009. 74(2): p. 
299-314.
2. Jang, K.S., et al., Multi-spectrometric analyses of lipoteichoic acids isolated from Lactobacillus plantarum. 
Biochem Biophys Res Commun, 2011. 407(4): p. 823-30.
Chapter 4
Lipoproteins contribute to the 
anti-inflammatory capacity of 
Lactobacillus plantarum WCFS1
I-Chiao Lee, Iris I. van Swam, Sjef Boeren, Jacques 
Vervoort, Marjolein Meijerink, Nico Taverne, 
Marjo Starrenburg, Peter A. Bron, and Michiel 
Kleerebezem
76
Chapter 4
4
Abstract
Bacterial lipoproteins are well-recognized microorganism-associated molecular patterns, which 
interact with Toll-like receptor (TLR) 2, an important pattern recognition receptor of the host 
innate immune system. Lipoproteins are conjugated with two- and/or three-acyl chains (di- or 
tri-acyl), which is essential for appropriate anchoring in the cell membrane as well as for the 
interaction with TLR2. Lipoproteins have mostly been studied in pathogens and have established 
roles in various biological processes, such as nutrient import, cell wall cross-linking and remodeling, 
and host-cell interaction. By contrast, information on the role of lipoproteins in the physiology 
and host interaction of probiotic bacteria is scarce. By deletion of lgt, encoding prolipoprotein 
diacylglyceryltransferase, responsible for lipidation of lipoprotein precursors, we studied the roles 
of the collective group of lipoproteins in the physiology of the probiotic model strain Lactobacillus 
plantarum WCFS1 by transcriptome and proteome analysis. To investigate the consequences of the 
lgt mutation in host-cell interaction, the capacity of mutant and wild-type bacteria to stimulate 
TLR2 signaling and inflammatory responses was compared using (reporter-) cell based models. 
These experiments exemplified the critical contribution of the acyl chains of lipoproteins in 
immunomodulation. To the best of our knowledge, this is the first study that investigated collective 
lipoprotein functions in a model strain for probiotic lactobacilli, and we show that the presence 
of lipoproteins in L. plantarum WCFS1 are critical drivers of anti-inflammatory host responses 
towards this strain.
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Introduction
Bacterial lipoproteins are proteins that are post-translationally modified by acyl-conjugation, 
which anchors the protein on the extracellular face of the cytoplasmic membrane. These 
lipoproteins contain a typical N-terminal signal sequence that ends with the conserved [L/V/I]-
[A/S/T]-[G/A]-C motif that is designated “lipobox” [1]. After export across the cell membrane, 
these lipoprotein precursors undergo their lipid modification, which is catalyzed by three 
conserved enzymes, following a mechanism that was first established in Escherichia coli [2]. 
Initially, the prolipoprotein diacylglyceryltransferase (Lgt) transfers a di-acylglyceryl moiety onto 
the indispensable cysteine residue in the lipobox [2], which is targeted by the lipoprotein signal 
peptidase (Lsp) that cleaves of the signal sequence directly N-terminally of the lipid-modified 
cysteine residue. In the third step, lipoprotein N-acyl transferase (Lnt) adds a third acyl chain to 
the free amino group of the lipidated cysteine (Figure 1). In Gram-negative bacteria, the third step 
is essential for the release and transport of lipoproteins from the cytoplasmic membrane to the 
outer membrane, but the E. coli-type Lnt enzyme appears to be absent in low-GC-content Gram-
positive bacteria of the Firmicutes phylum [3, 4]. However, tri-acylated lipoproteins have recently 
reported in Staphylococcus aureus, suggesting the presence of an unidentified N-acyltransferase in 
some Firmicutes, and which has low sequence similarity with Lnt of Gram-negative bacteria, 
prohibiting its recognition as its functional equivalent [5, 6].  
Figure 1. Schematic representation of bacterial lipoprotein biogenesis. After export across the cell 
membrane, pre-prolipoproteins undergo lipid modification by prolipoprotein diacylglyceryl-transferase 
(Lgt) which transfers a di-acylglyceryl moiety onto the cysteine residue in the lipobox, and results in 
prolipoproteins. Subsequently, lipoprotein signal peptidase (Lsp) cleaves of signal peptide at the direct 
N-terminal of the lipid-modified cysteine residue and results in diacyl lipoproteins. In some bacteria, 
lipoprotein N-acyl transferase (Lnt) adds a third acyl chain to the free amino group of the lipidated 
cysteine. The di- and tri-acyl lipoproteins produced by bacteria are differentially recognized by distinct 
TLR-2 heterodimers TLR2/6 and TLR1/2, respectively. 
Lipoproteins are involved in various biological functions. Many lipoproteins function as substrate 
binding proteins (SBPs) of ATP-binding cassette (ABC) transporters involved in import of a 
variety of substrates, such as sugars, metal ions, amino acids, oligopeptides, and nucleotides [4]. 
SBPs provide high affinity substrate binding and delivery to the membrane permease components 
[7], which is important for nutrient uptake and may also play a role in environmental sensing [8-
10]. Besides SBPs, lipoproteins in various Gram-positive bacteria also are predicted to function 
as enzymes, which are involved in modulation of two-component signal transduction systems, 
cell envelope stability, adhesion, protein secretion and folding, and electron transfer processes 
at the cell membrane [4, 11]. Several studies also evaluated the relation between lipoproteins 
and virulence, mainly by deleting essential genes in lipoprotein biogenesis like lgt or lsp, which 
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typically led to reduced adhesion and internalization and/or to attenuation of virulence in animal 
infection models [12]. 
By contrast, the role that lipoproteins play in the physiology and host interaction of probiotic 
bacteria has not been reported in much detail. Probiotics are defined as live microorganisms which, 
when administered in adequate amounts, confer a health benefit on the host [13]. Interaction 
between probiotics and the host is proposed to play a key role in this beneficial relationship [14-
16]. Bacterial lipoproteins are well-recognized microorganism-associated molecular patterns 
(MAMPs), which interact with Toll-like receptor (TLR) 2, an important pattern recognition 
receptor (PRR) of the host innate immune system [17, 18]. Moreover, the di- and tri-acyl 
lipoproteins produced by bacteria are differentially recognized by distinct TLR2 heterodimers 
TLR2/6 and TLR1/2, respectively [19]. Initially, it was thought that TLR2 heterodimers with 
TLR1 or TLR6 do not contribute to divergent immune responses but merely expand the repertoire 
of bacterial ligand recognition [20]. However, recent evidence illustrated that both the strength 
of signaling activation [21], and the downstream interaction with intracellular adaptors [22] are 
different for TLR1/2 and TLR2/6, suggesting their distinct role in innate signaling. 
Deletion of lgt provides a means to study the general role of all lipoproteins in bacterial physiology 
and immunomodulation. Here we describe the impact of lgt mutation in the probiotic model 
strain Lactobacillus plantarum WCFS1 [23]. We explored the impacts of Lgt deficiency on the 
genome-wide gene expression pattern and on the secreted proteome. Furthermore, the capacity 
of the L. plantarum lgt mutant to stimulate TLR2 signaling and inflammatory responses was 
compared to those of the wild-type, illustrating the contribution of the lipoprotein acyl chains to 
immunomodulation.  Although it has previously been established that lipoproteins are among the 
main TLR2 signaling ligands, to the best of our knowledge, this is the first study that explored the 
role of lipoproteins in immunomodulation by a model species of the probiotic lactobacilli.   
Materials and methods
Bacterial strains and culture conditions. Bacterial strains used in this work are listed in Table 
1. Lactobacillus plantarum WCFS1 and its derivatives were grown at 37°C in MRS broth (Difco, 
West Molesey, United Kingdom) without aeration. Escherichia coli strain TOP10 (Invitrogen, 
Bleiswijk, The Netherlands) was used as an intermediate cloning host, and was grown at 37°C in 
TY broth [24] with aeration [25]. Solid media were prepared by addition of 1.5% (w/v) agar to 
the broths. Antibiotics were added where appropriate and concentrations used for L. plantarum and 
E. coli strains were 10 μg/ml chloramphenicol (Cm), and 30 and 200 μg/ml erythromycin (Ery), 
respectively. 
DNA manipulations. Plasmids and primers used are listed in Table 1. Standard procedures 
were used for DNA manipulations in E. coli [25]. Plasmid DNA was isolated from E. coli using a 
JETSTAR kit (Genomed GmbH, Bad Oberhausen, Germany). L. plantarum DNA was isolated as 
described previously [26]. PCR amplifications were performed using hot-start KOD polymerase 
(Novagen, Madison, USA). Amplicons were purified using Wizard®SV Gel and PCR Clean-Up 
System (Promega, Leiden, The Netherlands). Restriction endonucleases (Fermentas GmbH, St. 
Leon-Rot, Germany), MSB® Spin PCRapace (Invitek GmbH, Berlin, Germany), PCR Master 
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Mix (Promega) and T4 DNA ligase (Invitrogen) were used as specified by the manufacturers. 
Construction of lgt deletion strain. The lgt deletion mutant was constructed as described 
previously [27], using a double crossing-over strategy to replace the lgt gene by a chloramphenicol 
resistance cassette (lox66-P32cat-lox71)[27]. In this study, a derivative of the mutagenesis vector 
pNZ5319 [27], designated pNZ5319TAG was used to introduce a unique 42-nucleotide tag into 
chromosome during gene deletion, which can be used for mutant tracking purposes in mixed 
populations (not relevant for the study presented here). The upstream and downstream flanking 
regions of lgt (lp_0755) gene were amplified by PCR using the primer pairs lgt-up-F/R and lgt-
down-F/R primers, respectively (Table 1). The amplicons generated were joined by a second 
PCR to lox66-P32cat-lox71-tag by a splicing by overlap extension strategy [28], using lgt-up-F/lgt-
down-R primers. The resulting PCR products were digested with SwaI and Ecl136II, and cloned 
into similarly digested pNZ5319TAG. The obtained mutagenesis plasmids were transformed into 
L. plantarum WCFS1 as described previously [26]. The resulting transformants were assessed for a 
double cross over integration event by selecting for Cm resistance and Ery sensitivity. The selected 
colonies were further confirmed by PCR using targets-out-F/R primers (Table 1). A single colony 
Table 1. Bacterial strains, plasmids, and primers used in this study
Strains Characteristicsa Reference
L. plantarum
WCFS1 Single-colony isolate of L. plantarum NCIMB8826. Isolate from human 
saliva, UK.
(23)
NZ3400Cm Cmr; WCFS1 derivative; chromosomal integration of cat cassette into 
H-locus
(37)
NZ3565Cm     
(Δlgt)
Cmr; derivative of WCFS1 containing a lox66-P32-cat-lox71-tag6.6 replacement of lgt (lp_0755)   (lgt::lox66-P32-cat-lox71-tag6.6)
This work
E. coli
TOP 10 Cloning host; F- mcrA Δ(mrr-hsdRMS-mcrBC) φ80lacZΔM15 ΔlacX74 
recA1 araD139 Δ(ara-leu)7697 galU galK rpsL (StrR) endA1 nupG
Invitrogen
Plasmids Descriptionsa Reference
pNZ5319 Cmr Eryr; Mutagenesis vector for gene replacements in  L. plantarum (27)
pNZ3565 Cmr Eryr; pNZ5319 derivative containing homologous regions up- and 
downstream of lgt (lp_0755)
This work
Primers Sequenceb Reference
is128 tag-lox66-F3 5’-AAATCTACCGTTCGTATAATGTATG-3’ (51)
is129 tag-lox71-R3 5’-CTCATGCCCGGGCTGTAACCG-3’ (51)
IS169 5’-TTATCATATCCCGAGGACCG-3’ (52)
87 5’-GCCGACTGTACTTTCGGATCC-3’ (52)
CreF 5’-CGATACCGTTTACGAAATTGG-3 (52)
CreR 5’-CTTGCTCATAAGTAACGGTAC-3’ (52)
EryintF 5’-TCAAATACAGCTTTTAGAACTGG-3 (52)
EryintR 5’-ATCACAAACAGAATGATGTACC-3’ (52)
lgt-up-F 5’-TTTGGCAGGAAGTGTAACCG-3’ This work
lgt-up-R 5’-GCATACATTATACGAACGGTAGATTTATTCACGCTACTGC-
CATCTCC-3’
This work
lgt-down-F 5’-CGGTTACAGCCCGGGCATGAGGCAGAAAATAAGTAGATTA-
GAGG-3’
This work
lgt-down-R 5’-AATCTCAGGTTTCCCCTCGC-3’ This work
lgt-out-F 5’-AAGTGTGGCCGCTTGAAAGGG-3’ This work
lgt-out-R 5’-AACATTTCTTTAGGCATCGCC-3’ This work
a Cmr , chloramphenicol resistant; Eryr, erythromycin resistant
b Underlined nucleotides indicate parts of the primers that are complementary to the is128-lox66-F3 and is129-
lox71-R3 primers
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displaying the anticipated antibiotic resistance phenotype and genotype was selected, yielding 
NZ3565Cm (L. plantarum WCFS1 Δlgt). 
Isolation of released proteins and SDS-PAGE. For the isolation of proteins released into 
the culture supernatants, L. plantarum WCFS1 and its Δlgt derivative were grown overnight to an 
OD600 of approximately 5 in 100 mL of 2 x CDM. The culture supernatants were filtered through 
a hydrophilic polyvinylidene fluoride (PVDF) filter (0.22 µm pore size, 25 diameter; Millex 
Millipore, USA) to remove any remaining bacterial cells, and proteins were precipitated by adding 
trichloroacetic acid (TCA) to a final concentration of 16%, followed by an overnight incubation 
at 4°C. The precipitated proteins were pelleted by centrifugation at 16000×g for 15 min. The 
protein pellets were washed with 200 µl acetone and then air-dried at 50°C. Dried protein pellets 
were solubilized in NuPAGE loading buffer and dithiothreitol (DTT) reducing agent (both from 
Invitrogen). The samples of released proteins were visualized by SDS-PAGE using the NuPAGE® 
electrophoresis system with NuPAGE®Novex® 4-12% Bis-Tris gels with MOPS SDS running 
buffer (Invitrogen), followed by Coomassie brilliant blue staining using standard procedures [25] 
and overnight destaining in Milli-Q water.
Sample preparation for mass spectrometry. For in-gel trypsin digestion, the protein-
containing SDS-PAGE gel was reduced with 10 mM dithiotreitol (DTT) in 50 mM ammonium 
bicarbonate (ABC) for 1 h at 60°C, followed by alkylation with 20 mM iodoacetamide in 100 
mM Tris buffer (pH 8.0) in the dark for 1 h at room temperature. After thorough washing in 
Milli-Q water, the gel lane of each sample was divided into 5 slices that were individually cut into 
small pieces (ca. 1 mm3). The gel pieces were transferred to protein LoBind tubes (Eppendorf, 
Hamburg, Germany) for all following procedures to minimize protein loss. Sample were freeze-
thawed to increase enzyme accessibility of the gel pieces, and incubated in ABC buffer containing 
5 ng/µL Bovine Sequencing Grade Trypsin (Roche) for 2 h at 45°C. The solution was sonicated 
briefly (1 sec) and was adjusted to an approximate pH of 2 with 10% trifluoroacetic acid (TFA). 
The trypsin-digested samples were further cleaned up to remove any gel residues using C18 
microcolumns as described previously [29]. In short, C18 microcolumns were prepared in 200-
μL Eppendorf tips by placing a small piece (ca. 1 mm in diameter) of a C18 Empore disk and then 
applying 4 μL of 50% slurry of Lichroprep C18 column material in methanol. The microcolumns 
were washed twice with 200 µl methanol and subsequently equilibrated with 100 µl of 1ml/l 
formic acid (HCOOH). The samples were applied to the microcolumns and washed with 1ml/l 
HCOOH. Samples were eluted using 50 µl of 50% acetonitrile/30% 1 ml/l HCOOH into 
clean LoBind tubes. The sample volume was then reduced in a vacuum concentrator (Eppendorf 
Vacufuge) at 45°C for 20 to 30 minutes until a volume below 20 μl was reached. 
The liquid-chromatography tandem mass spectrometry (LC-MS/MS) analysis was performed 
on a Proxeon EASY-nLC system (Thermo Scientific) coupled with a LTQ-Orbitrap XL mass 
spectrometer (Thermo Scientific). The chromatographic separation was performed on a 
combination of a Prontosil 300-5-C18H pre-concentration column with a Prontosil 300-3-C18H 
analytical column (Bischoff Chromatography, Leonberg, Germany)[30]. For peptide identification, 
the protein reference database of Lactobacillus plantarum (strain ATCC BAA-793 / NCIMB 8826 / 
WCFS1) for peptides and proteins identification downloaded from Uniprot (http://www.uniprot.
org/ accessed July 2014) was used. A set of 31 protein sequences of common contaminants was 
added including Trypsin (P00760, bovine), Trypsin (P00761, porcine), Keratin K22E (P35908, 
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human), Keratin K1C9 (P35527, human), Keratin K2C1 (P04264, human), and Keratin K1C1 
(P35527, human). Label-free quantitation (LFQ) of detected proteins was calculated by MaxQuant 
algorithm to compare quantity cross samples. Relative abundances were calculated by the ratio of 
LFQ of detected peptides in wild type and lgt mutant and presented in Log10 value.
RNA isolation and microarray analysis. RNA isolation, labeling and hybridization were 
performed according to previously described methods [31, 32]. Briefly, L. plantarum NZ3400Cm 
and its lgt deletion derivative, NZ3565Cm, were grown in MRS with chloramphenicol and cells 
were harvested by centrifugation, following quenching and cell disruption by bead beating. 
RNA was purified using the High Pure Isolation Kit (Roche Diagnostics, Mannheim, Germany) 
including 1 h treatment with DNaseI (Roche Diagnostics). Five microgram of total RNA was 
used for cDNA synthesis. Cyanine-3 (Cy3) and cyanine-5 (Cy5) cDNA labeling was performed 
as described previously [31], using the CyScribe Post-Labeling and Purification kits according 
to the manufacturer’s instructions (Amsersham Biosciences, Buckinghamshire, UK). Cy-dye-
labeled cDNAs (0.5 μg each) were hybridized to L. plantarum WCFS1 printed-oligonucleotide 
DNA microarrays (Agilent Technologies, Amstelveen, the Netherlands). Hybridization and 
scanning procedures were performed as previously described [31]. The data were normalized 
using the Lowess normalization as available in MicroPrep [33]. CyberT [34] was used to compare 
the transcriptomes of NZ3400Cm and NZ3565Cm, resulting in a gene expression ratio and 
Benjamini and Hochberg’s False Discovery Rate (FDR) [35] for each gene. The expression of a 
gene was considered significantly altered when the FDR-adjusted p value was < 0.05. The level 
of gene expression was also estimated on the basis of probe signals for a correlation analysis of 
transcriptional results and proteome detection.
Toll-like receptor (TLR) assay. Human embryonic kidney (HEK)-293 TLR reporter cell lines 
expressing human TLR1/2, TLR2/6, or TLR4, harboring pNIFTY, a NF-κB luciferase reporter 
construct (Invivogen, Toulouse, France) [36], were used. The HEK-293 reporter cell lines were 
seeded at 6 × 104 cells/well in 96-well plates and incubated overnight under standard culture 
conditions. Cells were then stimulated with late-stationary bacterial cultures of the L. plantarum 
NZ3400Cm, a L. plantarum WCFS1 derivative with a chromosomal integration of the cat cassette 
in a neutral chromosomal locus [37], and lgt deletion strain (NZ3565Cm) at a multiplicity of 
infection (MOI) of 1:10, HEK cell to bacteria. The TLR1/2 agonist Pam3CSK4 (5 μg/mL, 
Invivogen) and TLR2/6 agonist Pam2CSK4 (5 μg/mL, Invivogen) were used as positive controls 
and PBS served as the negative control. 
Peripheral blood mononuclear cells (PBMC) assay. The assay was performed as described 
previously [38] and was approved by Wageningen University Ethical Committee and was performed 
according to the principles of the Declaration of Helsinki. Peripheral blood of healthy donors 
was from the Sanquin Blood Bank, Nijmegen, The Netherlands. PBMCs were separated from the 
blood using Ficoll-Paque Plus gradient centrifugation according to the manufacturer’s description 
(Amersham biosciences, Uppsala, Sweden). The mononuclear cells were collected, washed in 
Iscove’s Modified Dulbecco’s Medium (IMDM) + glutamax (Invitrogen, Breda, The Netherlands) 
and adjusted to 1 × 106 cells/ml in IMDM + glutamax supplemented with penicillin (100 U/ml) 
(Invitrogen), streptomycin (100 μg/ml) (Invitrogen), and 1% human AB serum (Lonza, Basel, 
Switzerland). PBMCs (1 × 106 cells/well) were seeded a night prior to the experiment in 48-well 
tissue culture plates and incubate at 37°C in 5% CO2. Bacteria from late-stationary phase were 
added to PBMCs at a MOI of 1:10 (PBMC to bacteria) PBMCs from 3 different donors were used 
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in the assay. Following 24 hr incubation at 37°C in 5% CO2, culture supernatants were collected 
and stored at -20°C prior to cytokine analysis. Cytokines were measured using a FACS CantoII 
flow cytometer (BD Biosciences, New Jersey, USA) and BD Cytometric Bead Array Flexsets 
(BD Biosciences) for interleukin (IL)10 and IL12p70, TNFα, IL6, IL1β, and IL8 according to the 
manufacturer’s procedures. Concentrations of cytokines were calculated based on the standard 
curves in the BD Biosciences FCAP software. 
Statistical analysis. The TLR and PBMC assays were performed in triplicate. One-way ANOVA 
followed by Tukey’s multiple comparison correction was used to compare TLR2 activations 
between strains. The paired t-test was used to determine the Log values of PBMCs cytokine 
production after stimulated with wild-type verse mutant strains for individual donors. GraphPad 
Prism 5 software (GraphPad Software, San Diego, CA) was used for all determinations, and a P 
value <0.05 was considered significant. 
Results
Impacts of lgt deletion on L. plantarum transcriptome
Prolipoprotein diacylglyceryl transferase (Lgt) is the key enzyme for lipidation in lipoprotein 
biosynthesis, where it catalyzes the transfer of a diacylglyceryl moiety onto a conserved cysteine 
in the lipobox of prolipoproteins [4]. The gene annotated to encode this function (lgt; lp_0755) 
in the L. plantarum WCFS1 genome [23] was mutated by double cross-over gene replacement 
of the lgt coding region by a chloramphenicol acetyltransferase (cat) cassette [27], resulting in 
an lgt deficient derivative of strain WCFS1, designated NZ3565Cm (Δlgt). This lgt-mutant strain 
enables the study of the generic impact of lipoproteins on physiological and immunomodulatory 
properties of this model probiotic-bacterium. 
Under laboratory conditions, the growth and cell-morphology of the lgt deletion mutant were 
undistinguishable from those of the wild-type strain (data not shown). This is in agreement with 
earlier observations that suggested that although Lgt is essential in Gram-negative bacteria, it 
appears to be dispensable in Gram-positive bacteria grown under laboratory conditions [4]. To 
further evaluate the impact on L. plantarum physiology, global transcriptional profiles of the lgt 
deletion strain were generated and compared to those of the wild-type strain. The transcriptome 
analysis confirmed the abolishment of lgt expression in the mutant strain (Table S1). Besides this 
clear effect, the lgt deletion only affected the expression of a small group of genes; 6 genes were 
down-regulated and 43 genes were up-regulated compared to the wild-type strain. These genes 
included a variety of functional categories, which were dominated by diverse metabolic pathways, 
but also included genes involved in cell envelope architecture, some ribosomal proteins, and 
several membrane-transport functions (Table S1). Furthermore, the gene encoding sucrose-6-
phosphate hydrolase (lp_0187, scrB) was up-regulated almost 40-fold in lgt mutant (Table S1). This 
gene is involved in galactose metabolism, suggestive of possible impacts of lgt deletion in sugar 
metabolism. However, other genes in the same pathway do not appear to be concurrently up-
regulated. Another gene, lp_2001, encoding a small membrane protein (70 a.a.) with unknown 
function, is down-regulated about 1000-fold. Notably, the expression of all lipoprotein encoding 
genes appeared to be unaltered in the lgt deletion strain relative to the wild-type.
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Lgt is important for membrane anchoring of lipoproteins 
We investigated the impact of lgt deletion on the membrane-anchoring of lipoproteins, by comparing 
the supernatants of wild type and the mutant using SDS-PAGE. The protein-pattern observed 
revealed a clear difference between the supernatant of the wild type strain and lgt mutant, which 
released much more proteins into its culture medium as compared to its parental strain (Figure 
2). The SDS-PAGE gel containing supernatant proteins were subjected to in-gel trypsin digestion 
and were subsequently analyzed by tandem mass spectrometry (MS/MS) to identify the released 
proteins. There are 7 and 9 proteins that are exclusively detected in the supernatant of wild type 
and lgt mutant cultures, respectively (Table S2). The protein abundances of these proteins were 
set to detection limit to enable the calculation of the relative protein abundance of the proteins 
detected in both the wild type and lgt mutant culture supernatants. The overall protein-abundance 
in the culture supernatant of the wild type and its lgt derivative appeared to be similar, but the 
relative abundance of predicted lipoproteins was significantly more abundant in the supernatant 
of the lgt deficient strain compared to other classes of secretome proteins (Figure 3 and S1). 
Many of the lipoproteins found in higher abundance in the supernatant of lgt mutant belong to 
the predicted substrate binding proteins of ATP-binding cassette (ABC) transporters associated 
with various substrates, including iron, phosphate, amino acids, maltose and maltodextrin (Table 
S2). The proteome analysis detected 38 out of the 47 predicted lipoproteins encoded by the 
WCFS1 genome [39], thereby broadly representing this group of proteins. We compared the gene 
expression level of the lipoprotein encoding genes with the lipoproteins that were detected in 
Figure 2. Secreted proteins extracted 
from L. plantarum WCFS1 (WT) and its 
lgt deletion derivative (Δlgt). Proteins 
were separated by SDS-PAGE and 
visualized by Coomassie blue staining. 
On the right side, the protein size 
marker (kDa), Precision Plus Protein™ 
Dual Color Standards (Bio-Rad). 
Figure 3. Relative abundance of secreted proteins in L. plantarum 
WCFS1 wild type (WT) and the lgt deletion strain (Δlgt). The 
relative abundance is defined as the ratios in the label free 
quantitation (LFQ, Log10 value) of detected proteins in wild 
type and the deletion strain in tandem mass spectrometry (MS/
MS) analysis. The abundance was compared with all proteins 
detected in both samples, or within specific protein groups. 
The ratios from specific proteins groups were compared 
against all proteins to test for significant differences using 
one-way ANOVA followed by Tukey’s multiple comparison 
correction and significant differences are indicated; ***, P ≤ 
0.001. 
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the culture supernatant of lgt strain. Most of the higher expressed lipoprotein encoding genes 
were detected in the proteomic analysis. However, the highest expressed lipoprotein encoding 
gene (lp_1452) was not detected in the proteome analysis, and also two lipoprotein encoding 
genes that were among the lowest in terms of transcript detection (lp_0200 and lp_0201) were 
among the detected lipoproteins in the proteome analysis (Table S3). These findings illustrate 
that there is a relatively poor relationship between the transcript level of a specific gene and the 
detection of the protein it encodes in the supernatant fraction of these cells. The overall result 
of these analyses confirms the importance of Lgt in appropriate anchoring of lipoproteins in the 
cytoplasmic membrane. 
Acyl chains of lipoproteins are important for TLR1/2 signaling capacity of L. 
plantarum WCFS1 
The human innate immune system has been reported to recognize bacterial lipoproteins by 
TLR1/2 and TLR2/6 heterodimers that recognize tri- and di-acylated lipoproteins, respectively 
[1]. The impact of lgt deletion in L. plantarum on TLR2 heterodimer signaling was investigated using 
established HEK-293 reporter cell lines that express human TLR1/2 or TLR2/6 heterodimers 
and contain a NF-κB promoter controlled luciferase gene [37]. The synthetic agonists Pam3CSK4 
and Pam2CSK4 were used as positive controls for TLR1/2 and TLR2/6 activation, respectively. 
The wild-type strain L. plantarum NZ3400Cm [37] stimulated both TLR1/2 and TLR2/6 signaling 
at a moderate level (Figure 4A and B, respectively). The lgt deletion strain, Δlgt (NZ3565Cm), 
stimulated significantly lower TLR1/2 signaling as compared to the wild-type strain (Figure 4A), 
whereas its capacity to stimulate TLR2/6 signaling appeared to be unaffected as compared to the 
wild-type strain (Figure 4B). The observation that the lgt mutant of L. plantarum WCFS1 affected 
Figure 4. TLR1_2 and TLR2_6 signaling capacities of NZ3400Cm, a L. plantarum WCFS1 derivative with 
a chromosomal integration of the cat cassette in a neutral chromosomal locus [37] and the lgt deletion 
mutant, NZ3565Cm (Δlgt). TLR1_2 (A) and TLR2_6 (B) activation were determined using TLR-
expressing HEK cell lines, containing a NF-κB responsive luciferase reporter system. Measurements were 
performed in triplicate and are presented as Log luminescence units, and individually displayed (n=3), 
while the bar indicates the median. PBS serves as a negative control, while Pam3CysSK4 (Pam3) and 
Pam2CysSK4 (Pam2) are the positive stimulus of TLR1_2 (A) and TLR2_6 (B) activation, respectively. 
Data comparison of the wild-type and the deletion derivative was tested for significant differences using 
one-way ANOVA followed by Tukey’s multiple comparison correction and samples with significant 
different NF-κB activation are indicated with different letters. 
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TLR1/2 signaling and not TLR2/6 signaling, suggests that tri-acylated lipoproteins are dominant 
in this strain. However, there is no homologue genes of E. coli-type lnt, which encodes N-acyl 
transferase responsible for the addition of the third acyl chain [2], found in the WCFS1 genome. 
This could suggest a presence of an unidentified N-acyltransferase in L. plantarum.
Lipid moiety of lipoproteins is important for anti-inflammatory properties of L. 
plantarum WCFS1 
Although many studies have shown that Gram-positive pathogens that lack Lgt activity display 
attenuated immune activation or virulence, little is known about the effect of this phenotype in 
probiotic bacteria. We explored the impact of lgt deletion on general immune responses using 
cytokine production by human peripheral blood mononuclear cells (PBMCs). The lgt deletion 
mutant stimulated a more pro-inflammatory responses in PBMCs as compared to the wild type 
strain (NZ3400Cm), including a higher production of the pro-inflammatory cytokines, IL12, 
TNFα, IL1β, and IL8 (Figure 5ABDE, respectively). Moreover, the lgt mutant strain induces 
significantly lower levels of production of the anti-inflammatory cytokine IL10 relative to the 
wild-type (Figure 5C). As a consequence, the IL10/IL12 ratio, which has been reported as an 
indicator for in vivo performance in a mouse colitis model, is significantly lower in lgt mutant 
than the wild type (Figure S2), implying a more pro-inflammatory properties in the mutant. 
These results illustrate the importance of Lgt and lipoproteins in the overall immunomodulatory 
properties associated with L. plantarum WCFS1, and in particular exemplify the contribution of 
lipoproteins in the anti-inflammatory properties in L. plantarum WCFS1.   
Figure 5. Immunomodulatory effect of NZ3400Cm, a L. plantarum WCFS1 derivative with a chromosomal 
integration of the cat cassette in a neutral chromosomal locus [37], and the lgt deletion strain NZ3565Cm 
(Δlgt). Cytokine production was determined in human PBMCs (n=3 donors) after 24 h co-incubation with 
the bacterial cells. The IL12 (A), TNFα (B), IL10 (C), IL1β (D), IL8 (E), and IL6 (F) cytokine production 
levels are presented as Log10 values. The cytokine levels for individual donors stimulated with the strains 
were connected by a line to focus the read-outs on changes elicited by the deletion. Significant differences 
between cytokine levels induced by wild-type strains and their corresponding mutants (paired t-test) are 
indicated; *, P ≤ 0.05; **, P ≤ 0.01; the P value of the difference of IL10 production by the NZ3400Cm 
and Δlgt strains is indicated in the corresponding panel C. 
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Discussion
Lgt is an essential enzymes in Gram-negative bacteria [4]. Since many lipoproteins in Gram-
negative bacteria are localized at the outer membrane, defects in lipoprotein biosynthesis will cause 
mislocalization and/or accumulation of the precursors in the periplasmic space, which has been 
reported to be lethal to the cells [3, 40]. In contrast, these enzymes appear dispensable in all tested 
Gram-positive bacteria to date [4]. The lgt deletion derivative of L. plantarum not only displayed 
normal morphology and growth, it also affected the expression of only a relatively small amount of 
genes (Table S1). The smaller impact of lgt deletion in Gram-positive bacteria may be explained by 
the different impact of the loss of Lgt function on the subcellular location of lipoproteins, where 
in Gram-negative bacteria these proteins accumulate and possibly clog-up the periplasm, whereas 
in Gram-positive bacteria they tend to remain functionally localized in the appropriate location 
or are released into the medium. The former explanation (retained functional localization) is 
supported by the observation that an lgt mutation is not lethal in Bacillus subtilis, although at least 
the lipoprotein PrsA fulfills an essential role in this bacterial species [41]. The lgt deletion led to 
mislocalization and release of a range of lipoproteins into the culture supernatant in L. plantarum 
WCFS1, affecting the subcellular location of many substrate binding proteins (SBPs) associated 
with ABC transporters annotated to be involved in the import of amino acids, oligopeptides, 
maltose and maltodextrin. Such mislocalization of these SBPs could reduce the efficiency of 
transport of the corresponding substrates, which may be reflected in changes in the corresponding 
metabolic processes, and thereby explain some of the transcriptome adjustments observed in the 
lgt mutant strain. However, we did not observe differences in growth characteristics between the 
wild type strain and its lgt derivative when cultured in minimal medium with maltose as a sole 
carbon source (Figure S3). This lack of consequence in growth characteristics of the lgt mutation, 
may be explained by a certain proportion of SBPs that remains associated with the corresponding 
transporters or by the elevated expression of the transport functions, which may compensate for 
the erroneous localization of the corresponding SBP function. The latter explanation appears to 
be supported by the up-regulation of expression of some transporter encoding genes in the lgt 
mutant (Table S1). Nevertheless, the lgt encoded function is dispensable for the laboratory-growth 
of L. plantarum WCFS1 and deletion of the lgt gene has a minimal impact on bacterial physiology 
under the conditions tested.         
Our data showed that no clear correlation between transcriptional expression level and proteomic 
detection of lipoproteins in the supernatants. This result could imply that the anchoring of 
lipoproteins is affected by more than Lgt alone. It is not clear whether Lsp is able to efficiently 
cleave all the non-lipid modified precursor lipoproteins in lgt mutant. Studies have shown that 
differently processed lipoprotein precursors (with uncleaved signal peptides or cleaved by Lsp or 
other peptidases) can be detected in an Lgt deficient background [4]. Failure to cleave off the signal 
peptide may retain lipoprotein precursors anchored in the cell membrane. Alternatively, non-
lipidated lipoprotein precursors could also get trapped in the cell envelope which prevents their 
release into the cell’s environment. In addition, gene transcript levels may not predict protein level 
accurately, since protein abundance is controlled by multiple mechanisms, including transcript 
and protein stability, the translation efficiency of the transcript and the regulation thereof [42]. 
Irrespective of the relatively poor relationship between transcript and protein detection levels, 
our data indicate that the lgt deletion affected the biogenesis and cell membrane anchoring of at 
least the majority of lipoproteins.    
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TLR2/6 and TLR1/2 heterodimers recognize di- or tri-acylated lipoproteins, respectively. Crystal 
structure analyses revealed that TLR1 has a hydrophobic pocket that enables the binding of the third 
acyl chain, which is lacking in TLR6 that can only accommodate di-acylated lipoproteins [43, 44]. 
The third acyl chain has been shown to be essential for biosynthesis and biogenesis of lipoproteins 
in Gram-negative bacteria that are ending up on the outer membrane of these bacteria [3], and 
appropriate subcellular localization (i.e., outer membrane biogenesis) of lipoproteins is essential 
in these bacteria. Moreover, since no orthologue genes of lnt, the gene responsible for transferring 
a third acyl chain on the N-terminal cysteine of lipoproteins, has been recognized in the genomes 
of low-GC-content Gram-positive bacteria, such as species belonging to the genera of Bacillus, 
Lactobacillus, Listeria, Staphylococcus, and Streptococcus, it has been assumed that these Gram-positive 
bacteria have di-acyl lipoproteins [45]. However, recent studies revealed that staphylococcal 
lipoproteins are tri-acylated, suggesting the presence of an unidentified N-acyltransferase in 
some Gram-positive bacteria, and which has insufficient similarity with E. coli-type Lnt to be 
recognized as its functional equivalent [5, 6]. Similarly, although the L. plantarum genome lacks an 
Lnt homologue, the removal of acylation of its lipoproteins by lgt deletion significantly reduced 
the TLR1/2 signaling capacity but did not affect TLR2/6 signaling, implying that lipoproteins in 
this bacterial strain are mainly tri-acylated. Future biochemical analysis is still required to verify 
the lipoprotein structures in this strain. The genome of WCFS1 contains three genes that are 
annotated to encode acyltransferases, lp_0856, lp_0925, and lp_1181, while also the membrane 
protein encoded by lp_1916 also contains a conserved domain of the acyltransferase family. One 
of these genes is likely to encode the enzyme responsible for tri-acylation of lipoproteins in L. 
plantarum WCFS1, but such function remains to be established. Overall, the potentially important 
role of lipoproteins in probiotic function and in particular in immunomodulation is supported by 
the work presented here, and this role deserves further refined elucidation in terms of structure 
function correlation in the context of host-cell signaling by lipoproteins.
Given that lipoproteins are a ligand of TLR2, an important PRR of the innate immune system, 
many studies have addressed the effect of lgt or lsp deletions on immune responses to, and 
virulence of Gram-positive pathogens [4]. Although the majority of these studies reported that 
lgt or lsp deletion leads to attenuation in immune activation and/or reduced virulence of Gram-
positive pathogens in vitro and in vivo, some conflicting results have also been reported. For 
example, lgt and lsp deletion derivatives of Streptococcus equi [46] and Streptococcus suis [47], did not 
display attenuation in their natural hosts (pony and pig, respectively). Moreover, although a Listeria 
monocytogenes lgt mutant fails to activate TLR2 signaling it is significantly less virulent in a mouse 
infection model [48], whereas lgt mutants of Streptococcus agalactiae [49] and Staphylococcus aureus 
[50] are hypervirulent in mouse infection models, and this phenotype is thought to be related to 
the loss of TLR2 activation by these mutant strains. These results imply that a subtle and strain-
specific balance between escaping protective immune defense related to loss of TLR2 activation 
and attenuated virulence by the loss of lipoprotein acylation in lgt mutants. Although they are 
recognized as important signaling molecules, the role of lipoproteins in the immunomodulatory 
effect of probiotics has rarely been studied. Our results show that the L. plantarum lgt deletion 
derivative elicited more pro-inflammatory responses in PBMCs compared to its parental strain, 
suggesting that lipoproteins are important mediators of immune system recognition for probiotics 
and may drive a more anti-inflammatory response to such probiotic bacteria, a hallmark of tolerance. 
However, the exact mechanism (and diversity) behind lipoprotein mediated immune responses 
toward probiotics remains to be elucidated. Further studies focusing on purified lipoproteins could 
88
Chapter 4
4
enable the controlled attenuation of pro-inflammatory immune responses in PBMCs, and may 
also be used to decipher their mechanistic interplay with pro-inflammatory pathways elicited by 
lipoprotein deficient strains. Moreover, structure-function studies of lipoproteins from pathogens 
and probiotics may unravel some key determinants involved in immune system recognition and 
activation, which may enable the host cells to distinguish harmful and beneficial bacteria.  
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Supplemental Material
Figure S1. Relative abundance of secreted proteins in L. plantarum WCFS1 wild type (WT) and the lgt deletion 
strain (Δlgt). The relative abundance was the ratio taken from the label free quantitation (LFQ, Log10 value) of 
detected proteins in wild type and the deletion strain in tandem mass spectrometry (MS/MS) analysis. The Av 
iBAQ intensity represents average Intensity-based absolute quantification of the protein detected in WT and Δlgt. 
The red dots represent lipoproteins, whereas blue dots represent all other type of proteins. 
Figure S2. IL10/IL12 cytokine ratio elicited by L. 
plantarum NZ3400Cm and the lgt deletion strain 
NZ3565Cm (Δlgt) following co-incubation with 
PBMC. The cytokine levels for individual donors 
stimulated with the strains were connected by 
a line to focus the read-outs on intrapersonal 
changes elicited by the deletion. The differences 
of IL10/IL12 ratio between NZ3400Cm and 
NZ3565Cm were statistically analyzed using 
paired t test; *, P ≤ 0.05.      
Figure S3. Comparison of the growth curves of L. plantarum NZ3400Cm and the lgt deletion strain (Δlgt). 
Bacteria were cultured in chemical defined medium with 0.4% (A) or 0.8% (B) maltose as a sole carbon source at 
37° C. The growth was monitored for 26 hour by measuring the absorbance at 600 nm (OD600). 
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Chapter 5
GtfA and GtfB are both required 
for protein O-glycosylation in 
Lactobacillus plantarum
I-Chiao Lee, Iris I. van Swam, Satoru Tomita, 
Pierre Morsomme, Thomas Rolain, Pascal Hols, 
Michiel Kleerebezem and Peter A. Bron
This chapter was published as Lee, I-C., van Swam, I.I., Tomita, S., 
Morsomme, P., Rolain, T., Hols, P., Kleerebezem, M., and Bron, P. 
A. GtfA and GtfB are both required for protein O-glycosylation in 
Lactobacillus plantarum. J Bacteriol, 2014. 196(9): p. 1671-82.
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Abstract
Acm2, the major autolysin of Lactobacillus plantarum WCFS1, was recently found to be 
O-glycosylated with N-acetylhexosamine, likely N-acetylglucosamine (GlcNAc). Here, we set 
out to identify the glycosylation machinery by employing a comparative genomics approach 
to identify Gtf1 homologues, which are involved in fimbriae-associated protein 1 (Fap1) 
glycosylation in Streptococcus parasanguinis. This in silico approach resulted in the identification of 6 
candidate L. plantarum WCFS1 genes with significant homology to Gtf1, namely tagE1 to tagE6. 
These candidate genes were targeted by systematic gene deletion, followed by assessment of the 
consequences on glycosylation of Acm2. We observed a changed mobility of Acm2 on SDS-PAGE 
in the tagE5E6 deletion strain, while deletion of other tagEs resulted in Acm2 mobility comparable 
to the wild type. Subsequent mass spectrometry analysis of excised and in-gel digested Acm2 
confirmed the loss of glycosylation on Acm2 in the tagE5E6 deletion mutant, whereas a lectin blot 
using GlcNAc-specific succinylated wheat germ agglutinin (sWGA) revealed that besides Acm2, 
tagE5E6 deletion also abolished all-but-one other sWGA-reactive, protease-sensitive signals. Only 
complementation of both tagE5 and tagE6 restored those sWGA-lectin signals, establishing that 
TagE5 and TagE6 are both required for the glycosylation of Acm2 as well as the vast majority 
of other sWGA-reactive proteins. Finally, sWGA-lectin blotting experiments using a panel of 8 
other L. plantarum strains revealed that protein glycosylation is a common feature in L. plantarum 
strains. With the establishment of these enzymes as protein glycosyltransferases, we propose to 
rename TagE5 and TagE6 to GtfA and GtfB, respectively. 
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Protein glycosylation in L. plantarum
Introduction
Probiotics, of which the majority belong to the genera Lactobacillus and Bifidobacterium [1-3], have 
been defined as “live microorganisms which when administered in adequate amounts confer a 
health benefit on the host” [4]. One mechanism by which these health benefits are mediated is 
through molecular interactions between probiotic bacteria and host cells, in which bacterial surface 
molecules appear to play a pivotal role [1-3]. These surface effector molecules include canonical 
polymers such as wall- and lipo-teichoic acid, peptidoglycan, and capsular polysaccharides, but 
also proteinaceous molecules [2, 5-7]. 
Many proteinaceous molecules have established functions associated with adhesion to intestinal 
mucus, such as the mucin-binding proteins (Mub) of Lactobacillus acidophilus NCFM [8] and 
Lactobacillus reuteri 1063 [9], a mucus adhesion promoting protein (MapA) of L. reuteri 104R [10], 
and the mannose-specific adhesin (Msa) of Lactobacillus plantarum WCFS1 [11]. Examples of 
proteins involved in adhesion to epithelial cells include the surface layer proteins of Lactobacillus 
brevis ATCC 8287 [12], Lactobacillus crispatus JCM 5810 [13] and Lactobacillus helveticus R0052 [14]. 
In addition to their role in the adhesive capacity to mucus and epithelial cells, some Lactobacillus 
surface proteins are able to bind with extracellular matrix (ECM), which is a complex structure 
surrounding epithelial cells and is composed of various proteins including laminin, collagen and 
fibronectin. Reported examples include the collagen-binding protein of L. reuteri NCIB11951 [15] 
and fibronectin-binding protein A of L. acidophilus NCFM [8]. 
Other surface proteins impact on probiotic-host interactions via their immunomodulating 
capacity, for example Msp1 and Msp2, two peptidoglycan hydrolases of Lactobacillus rhamnosus 
GG, which promote epithelial homeostasis [16, 17]. Recombinant Msp2 was also shown to 
prevent and ameliorate experimental colitis in mice by an epidermal growth factor receptor-
dependent mechanism [18]. Furthermore, surface layer protein A (SlpA) of L. acidophilus NCFM 
was documented to be recognized by the dendritic cell-specific ICAM-3-grabbing nonintegrin 
(DC-SIGN) receptor and as a consequence modulates human DCs and T cell functions, leading to 
regulatory T cell differentiation through increased IL-10 and reduced IL-12p70 production [19]. 
A serine and threonine rich peptide (STp) harbored by protein D1 that is secreted by Lactobacillus 
plantarum BMCM12 represents another example of a proteinaceous effector molecule, as it was 
recently demonstrated to stimulate regulatory responses in human intestinal DCs [20]. 
The most common modification found in proteinaceous molecules is glycosylation, in which 
glycans can be attached to the amide nitrogen of asparagine, i.e. N-glycosylation, or to the 
hydroxyl oxygen of serine or threonine, i.e. O-glycosylation [21]. Although protein glycosylation 
was initially studied exclusively in eukaryotes, bacterial protein glycosylation has recently 
received increasing attention and it is now clear that bacteria can also modify proteins with 
diverse N-linked and O-linked glycan moieties [22-26]. So far, most studies on bacterial protein 
glycosylation focused on pathogenic organisms [23, 27-29], resulting in the identification of 
general glycosylation pathways [26], including an N-glycosylation pathway in Campylobacter jejuni 
[30, 31] and O-linked glycosylation systems in Neisseria gonorrhoeae [32, 33]. Specific machineries 
responsible for O-glycosylation of abundant surface proteins such as flagellin and pilin have also 
been described in various pathogenic bacteria [34-36]. Moreover, fimbriae-associated protein 1 
(Fap1), a serine-rich adhesin of Streptococcus parasanguinis, has been demonstrated to be heavily 
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glycosylated with N-acetylglucosamine (GlcNAc) and glucose [37, 38]. This glycosylation requires 
the concerted activity of two putative glycosyltransferases; Gtf1 and Gtf2 [37]. More recent 
studies pinpointed that protein glycosylation also occurs in certain human intestine commensals, 
including several Bacteroides species [39, 40], and probiotic species such as L. plantarum WCFS1 
[41, 42] and L. rhamnosus GG [43]. More specifically, Msp1 of L. rhamnosus GG is O-glycosylated 
at serine residues 106 and 107 and its glycan moieties are recognized by the Concanavalin A 
(ConA) lectin, which is specific for mannose and/or glucose moieties [43]. Similarly, the major 
autolysin of L. plantarum WCFS1, Acm2, was shown to be O-glycosylated in its N-terminal alanine, 
serine and threonine rich region (AST domain), which could be selectively detected by using 
the GlcNAc-specific biotinylated succinylated wheat germ agglutinin (sWGA) lectin [41, 42]. 
Intriguingly, AST domains are present in several other protein encoded in the L. plantarum WCFS1 
genome, including several other peptidoglycan hydrolases [41] and lp_2145 [44], suggesting that 
these proteins could also be subjected to glycosylation [41]. Indeed, a recent study found 10 
novel glycoproteins in L. plantarum WCFS1, including 2 AST domain-containing peptidoglycan 
hydrolases (Lp_2162 and Lp_3421), 4 cytoplasmic proteins (DnaK, ELp_2152, FtsY and FtsK1), 
and the secreted proteins Lp_2260 and Lp_1643 [45]. 
To date, no protein glycosylation machinery has been described for Lactobacillus species [41, 
43]. Here, we employed a comparative genomics approach to identify Gtf1 homologues in the 
genome of L. plantarum WCFS1, resulting in the identification of 6 candidate genes (previously 
annotated as poly(glycerol-phosphate) α-glucosyltransferases, i.e. tagE1 to tagE6) that might 
encode protein glycosyltransferases [46]. These candidate genes were targeted by a gene deletion 
and complementation approach, after which we assessed the consequences of these genetic 
modifications for the presence of glycan moieties in proteins by employing the GlcNAc-specific 
lectin sWGA in blotting experiments. Moreover, we specifically assessed the impact of tagE5E6 
deletion on the previously established glycosylation of Acm2 [41, 42] by mass-spectrometry analysis 
(MS). These experiments revealed that TagE5 and TagE6 are both required for the glycosylation 
of proteins, including Acm2, in L. plantarum WCFS1. Moreover, expansion of our lectin-blotting 
experiments to a panel of other L. plantarum strains revealed protein glycosylation is widespread 
in this species. To the best of our knowledge, these results represent the first example of a protein 
glycosylation machinery in a Lactobacillus species.
Materials and Methods
Bacterial strains, plasmids and growth conditions. Bacterial strains and plasmids used 
in this study are listed in Table 1. Lactobacillus plantarum strains were grown at 37°C in MRS 
broth (Difco, West Molesey, United Kingdom) without aeration. Escherichia coli strain TOP10 
(Invitrogen, Bleiswijk, The Netherlands) was grown at 37°C in TY broth [47] with aeration 
[48]. Solid media were prepared by adding 1.5% (w/v) agar to the broths. Where appropriate, 
antibiotics were added for L. plantarum and E. coli at 10 μg/ml chloramphenicol, and 30 and 200 
μg/ml erythromycin, respectively. 
DNA manipulations. Primers used are listed in Table 2 and were synthesized by Sigma-Aldrich 
(Zwijndrecht, The Netherlands). Standard procedures were used for DNA manipulations in E. 
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coli [48]. Plasmid DNA was isolated from E. coli using a JETSTAR kit (Genomed GmbH, Bad 
Oberhausen, Germany). L. plantarum DNA was isolated and transformed as described previously 
[49]. PCR amplifications were performed using hot-start KOD polymerase (Novagen, Madison, 
USA). Amplicons were purified using Wizard®SV Gel and PCR Clean-Up System (Promega, 
Leiden, The Netherlands). Restriction endonucleases (Fermentas GmbH, St. Leon-Rot, 
Germany), MSB® Spin PCRapace (Invitek GmbH, Berlin, Germany), PCR Master Mix (Promega) 
and T4 DNA ligase (Invitrogen) were used as specified by the manufacturers. 
Table 1. Bacterial strains and plasmids used in this study
Strains Characteristicsa Referenceb
L. plantarum
WCFS1 Single-colony isolate of L. plantarum NCIMB8826 [46]
ATCC 14917 Isolate from pickled cabbage ATCC
ATCC 8014 Isolate from maize ensilage ATCC
CIP104440 Isolate from human stool CIP
CIP104450 Isolate from human stool CIP
NC8 Isolate from grass silage [76]
NCIMB 12120 Origin from Ogi, Nigeria NCIMB
LP80 Isolate from silage [77]
LP85-2 Origin from silage, France [57]
Δacm2 NZ3557Cm; Cmr; derivative of WCFS1 containing a lox66-P32-cat-lox71-tagH9 replacement of acm2 (acm2::lox66-P32-cat-lox71-tagH9)
[41]
ΔtagE1 NZ3540Cm; Cmr; derivative of WCFS1 containing a lox66-P32-cat-lox71-tag8.5 replacement of tagE1 (tagE1:: lox66-P32-cat-lox71-tag8.5）
this work
ΔtagE2E3 NZ3541Cm; Cmr; derivative of WCFS1 containing a lox66-P32-cat-lox71-tagF10 replacement of tagE2E3 (tagE2E3::lox66-P32-cat-lox71-tagF10)
this work
ΔtagE4 NZ3542Cm; Cmr; derivative of WCFS1 containing a lox66-P32-cat-lox71-tagG1 replacement of tagE4 (tagE4:: lox66-P32-cat-lox71-tagG1）
this work
ΔtagE5E6 NZ3543Cm; Cmr; derivative of WCFS1 containing a lox66-P32-cat-lox71-tagG7 replacement of tagE5E6 (tagE5E6::lox66-P32-cat-lox71-tagG7)
this work
tagE5E6 
complementation 
NZ8204CmEm; CmrEmr; derivative of NZ3543Cm containing 
chromosomally integrated pNZ8204 at tRNASer site
this work
tagE6 
complementation 
NZ8205CmEm; CmrEmr; derivative of NZ3543Cm containing 
chromosomally integrated pNZ8205 at tRNASer site
this work
tagE5 
complementation 
NZ8206CmEm; CmrEmr; derivative of NZ3543Cm containing 
chromosomally integrated pNZ8206 at tRNASer site
this work
E. coli
TOP 10 Cloning host; F- mcrA Δ(mrr-hsdRMS-mcrBC) φ80lacZΔM15 ΔlacX74 
recA1 araD139 Δ(ara-leu)7697 galU galK rpsL (StrR) endA1 nupG
Invitrogen
Plasmids
pNZ5319 Cmr Emr; Mutagenesis vector for gene replacements in L. plantarum [50]
pNZ3540 Cmr Emr; pNZ5319 derivative containing homologous regions up- and 
downstream of tagE1
this work
pNZ3541 Cmr Emr; pNZ5319 derivative containing homologous regions up- and 
downstream of tagE2-E3
this work
pNZ3542 Cmr Emr; pNZ5319 derivative containing homologous regions up- and 
downstream of tagE4
this work
pNZ3543 Cmr Emr; pNZ5319 derivative containing homologous regions up- and 
downstream of tagE5E6
this work
pMEC10 Emr; Integration plasmid [78]
pNZ8204 Emr; pMEC10 derivative harboring tagE5E6 this work
pNZ8205 Emr; pMEC10 derivative harboring tagE6 this work
pNZ8206 Emr; pMEC10 derivative harboring tagE5 this work
a Cmr , chloramphenicol resistant; Emr, erythromycin resistant.
b ATCC, American Type Culture Collection, Manassas, Va.; CIP, Collection de l’Institut Pasteur, Paris, France.; 
NCIMB, National Collections of Industrial, Food and marine Bacteria, Aberdeen, Scotland. 
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Table 2. Primers used in this study
Primers Sequencea Reference
is128 tag-lox66-F3 5’-AAATCTACCGTTCGTATAATGTATG-3’ [79]
is129 tag-lox71-R3 5’-CTCATGCCCGGGCTGTAACCG-3’ [79]
87 5’-GCCGACTGTACTTTCGGATCC-3’ [50]
CreF 5’-CGATACCGTTTACGAAATTGG-3’ [50]
CreR 5’-CTTGCTCATAAGTAACGGTAC-3’ [50]
EryintF 5’-TCAAATACAGCTTTTAGAACTGG-3’ [50]
EryintR 5’-ATCACAAACAGAATGATGTACC-3’ [50]
tagE1-Up-F 5’-GCCGCAACAACCATACTGGG-3’ this work
tagE1-Up-R 5’-GCATACATTATACGAACGGTAGATTTAAAATAATACAT-
CACCTAGCCG-3’
this work
tagE1-Down-F 5’-CGGTTACAGCCCGGGCATGAGATAGCAGCACTTTA-
AGAACTGG-3’
this work
tagE1-Down-R 5’-GCGATTACATCGCCTTGGCG-3’ this work
tagE1-out-F 5’-GCTAGTCATGTCACGGATGC-3’ this work
tagE1-out-R 5’-TCACTCACAATAAATTCCCCC-3’ this work
tagE2E3-Up-F 5’-GCAATTACAATGTTGTGCGGC-3’ this work
tagE2E3-Up-R 5‘-GCATACATTATACGAACGGTAGATTTGAAGTAAAACATA-
CAGTCACCC-3‘
this work
tagE2E3-Down-F 5’-CGGTTACAGCCCGGGCATGAGACGGCTTAAGTAGATTT-
GACGG-3’
this work
tagE2E3-Down-R 5‘-AAGTGCGCGTTTTAGTACGC-3‘ this work
tagE2E3-out-F 5’-TACGGTTATTTTCCGGCTCG-3’ this work
tagE2E3-out-R 5’-ATCGGTGGCCTTTTACTTGG-3’ this work
tagE4-Up-F 5’-CGTATCGATTGTTGACAGCG-3’ this work
tagE4-Up-R 5‘-GCATACATTATACGAACGGTAGATTTATCGGCTAAACAAC-
CACATGC-3‘
this work
tagE4-Down-F 5’-CGGTTACAGCCCGGGCATGAGGAAATACATTTGCTACGC-
CCC-3’
this work
tagE4-Down-R 5’-CGAAGTGACGACTGCAAACG-3’ this work
tagE4-out-F 5’-CTTTCGTAGCCAAAATCGACG-3’ this work
tagE4-out-R 5’-CAAGAACAAGTCACAGCCGC-3’ this work
tagE5E6-Up-F 5’-ATTGGAAACGTTCTGTGCGG-3’ this work
tagE5E6-Up-R 5‘-GCATACATTATACGAACGGTAGATTTGTTGTTCAGTGAATAT-
CAAAAATGG-3‘
this work
tagE5E6-Down-F 5’-CGGTTACAGCCCGGGCATGAGATAATACATTATTACTC-
GCTCCC-3’
this work
tagE5E6-Down-R 5’-AGTTGTTGATGAACTGCTGC-3’ this work
tagE5E6-out-F 5’-AAATAATAGTTAGGGGTGAACAC-3’ this work
tagE5E6-out-R 5’-CTTCAGCACTACTTGATGTGC-3’ this work
tRNA 5’-GCGAACCGGCTAATACCGGC-3’ [80]
IC013 5’-AGCTAACAGACCGGTAGCTGCCAATGAAG-3’ this work
IC014 5’-AACCAGAGCTCCTGGCTGCTACGTGAACCTAATTCC-3’ this work
IC015 5’-TTTCCGAGCTCGCGTTACTAGTTTAGCCGGTGCCTG-3’ this work
IC016 5’-TATTGGTTCACAAAAAAATTCATTATTACTCGCTCCCTTA-
CACGA-3’
this work
IC017 5’-CGTGTAAGGGAGCGAGTAATAATGAATTTTTTTGTGAAC-
CAATATT-3’
this work
IC021 5’-ACGCCACATGCAGTCGATCC-3’ this work
IS169 5’-TTATCATATCCCGAGGACCG-3’ [81]
IS247 5’-AGATTGTACTGAGAGTGCACC-3’ this work
IS260 5’-GTTGAAAGAACCTGTACTCTCC-3’ this work
a Underlined nucleotides indicate parts of the primers that are complementary to the is128-lox66-F3 and is129-
lox71-R3 primers.
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Construction of tagE deletion mutants. The tagE deletion mutants were constructed as 
described previously [50], using a double crossing-over strategy to replace the target tagE genes 
by a chloramphenicol resistance cassette (lox66-P32cat-lox71) [50]. In this study, a derivative of 
the mutagenesis vector pNZ5319 [50], designated pNZ5319TAG (Bron et al., unpublished data) 
was used to introduce a unique DNA-tag into the chromosome during gene deletion, which can 
be used for mutant tracking purposes in mixed populations (not relevant for the study presented 
here). The upstream and downstream flanking regions of each tagE gene set (tagE1, tagE2E3, 
tagE4 and tagE5E6) were amplified by PCR using tagEs-Up-F/R and tagEs-Down-F/R primers, 
respectively (Table 2). Each amplicon generated was subsequently joined by a second PCR to 
tag-lox66-P32cat-lox71 by a splicing by overlap extension strategy [51], using tagEs-Up-F/tagEs-
Down-R primer pairs (Table 2). The resulting PCR products were digested with SwaI and Ecl136II, 
and cloned into similarly digested pNZ5319TAG. The obtained mutagenesis plasmids were 
transformed into L. plantarum WCFS1 as described previously [49]. The resulting integrants were 
assessed for a double cross over integration event by using tagEs-out-F/R primers (Table 2). For 
each of the mutant constructions a single colony displaying the anticipated genotype was selected, 
yielding the mutants NZ3540Cm (ΔtagE1), NZ3541Cm (ΔtagE2E3), NZ3542Cm (ΔtagE4), and 
NZ3543Cm (ΔtagE5E6). 
Complementation of ΔtagE5E6. The Genomic organization of tagE5 and tagE6 (lp_2843-
2844) is shown in figure 1A. The tagE5E6 genes and the individual tagE6 gene of L. plantarum 
WCFS1 were amplified including their native promoter (PtagE6, upstream of tagE6) using primers 
IC013/IC014 and IC013/IC015, respectively. Since tagE5 is also transcribed from the tagE6 
promoter, the PtagE6 promoter and tagE5 were joint by a splicing by overlap extension strategy 
[51]. The promoter was amplified by using primers IC013/IC016, while primer IC016 containing 
the initial 23 bp nucleotides of tagE5. The tagE5 gene was amplified using primer IC017 which 
contains the terminal 21 nucleotides of the promoter region, and primer IC014. These two PCR 
Figure 1. Genetic organization views of (A) tagE1-E6 and their neighboring genes, (B) acm2 generating by 
Microbial Genomic context Viewer (MGcV) [82]. The annotated Pfam domains of each gene was shown 
in grey shades.
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products were mixed in a molar ratio of 1:1 and amplified using primers IC013/IC014 to join 
the promoter and tagE5. A SacI site was introduced by primer IC014 and IC015 downstream 
of tagE6 or tagE5, respectively. pMEC10 was digested by SacI and SfoI whereas PCR products 
of tagE5E6, tagE6 and tagE5 were digested with SacI. Digested fragments were ligated using T4 
DNA ligase. Subsequently, the ligation mixtures were transformed into E. coli TOP10; positive 
clones were selected by colony PCR [52] using primers IC013/IC015 for tagE6, IC014/IC017 for 
tagE5 and IS260/IS247 for tagE5E6. Resulting plasmids were designated pNZ8204, pNZ8205 and 
pNZ8206 for the complementation plasmid of tagE5E6, tagE6 and tagE5, respectively. Integrity 
of nucleotide sequences for each construct was confirmed by sequence analysis. Subsequently, 
the complementation plasmids were introduced into the ΔtagE5E6 strain by electroporation as 
described previously [49]. Transformants were screened for chloramphenicol- and erythromycin-
resistance, followed by PCR amplifications to confirm the chromosomal integration of introduced 
plasmid using primers tRNA/IC021 for NZ8204 and NZ8205, and tRNA/IC020 for NZ8206. 
Preparation of surface proteins, whole cell extracts and proteinase K treatment. 
Overnight cultures of L. plantarum strains were diluted in fresh MRS broth to an optical density 
at 600 nm (OD600) of 0.1. After 5 hours of incubation at 37°C (OD600 of approximately 1.0), the 
exact OD600 of the cultures were determined and cells were harvested by centrifugation at 3000 
× g for 10 min at 4°C. For surface protein isolation, a procedure adapted from Fredriksen et al. 
[41] was used. Briefly, harvested cells were washed once with PBS to remove residual medium and 
resuspended in 1 ml cold PBS. Surface proteins were extracted by a gentle agitation at 600 rpm 
for 30 min using an eppendorf thermomixer (Eppendorf, Hamburg, Germany). The supernatants 
were collected after centrifugation at 5,000 × g for 10 min. The surface proteins were precipitated 
from supernatants by adding trichloroacetic acid (TCA) to a final concentration of 16% and an 
overnight incubation at 4°C, followed by centrifugation at 16,000 × g for 15 min. The precipitated 
proteins were washed with 200 µl acetone and then air-dried with open lids at 50°C. Dried protein 
pellets were solubilized in NuPAGE loading buffer and reducing agent (both from Invitrogen). The 
NuPAGE buffer volumes were normalized by OD600 measurement of original cultures to ensure 
the samples represent the surface proteins from similar amounts of cells and these samples were 
subsequently used for sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) 
analysis and Coomassie brilliant blue staining [48]. 
For whole cell extract samples, harvested cells were washed once 50 mM Sodium-phosphate 
buffer, pH 7 to remove residual medium and subsequently resuspended in 50 mM Sodium-
phosphate buffer, pH 7 to a final OD600 equivalent of 2.5. Cell suspensions of 1 ml were added to 
a screw-cap 2 ml tube containing 1 g zirconium beads. Cells were disrupted by three rounds of 
bead-beating (30 s at speed 4.0) using a Fastprep cell disrupter (QBiogene Inc., Cedex, France), 
interspaced with cooling intervals on ice. The tubes were left for 5 min to allow zirconium bead 
sedimentation. The resulting supernatants were collected as whole cell extracts and used in sWGA 
lectin blot experiments. 
For proteinase K treatment, the whole cell extract samples were treated with proteinase K 
(QIAGEN GmbH, Hilden, Germany; final concentration of 50 μg/ml) for 10, 30, or 60 min at 
37°C.
SDS-PAGE and lectin blot analyses. SDS-PAGE and wet blotting were performed using 
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the NuPAGE® electrophoresis system (Invitrogen) and XCell II™ Blot Module (Invitrogen), 
respectively, as described in the user manuals. Whole cell extracts were mixed with NuPAGE 
sample buffer and were separated under denaturing condition on NuPAGE®Novex® 4-12% Bis-
Tris gels with MOPS SDS running buffer (Invitrogen). 
For visualization of surface proteins by Coomassie brilliant blue, the standard procedure was used 
[48]. For lectin blotting, the gels were transferred to nitrocellulose membranes (Thermo Scientific, 
Bremen, Germany) using wet blotting method described in the NuPAGE manual (Invitrogen). 
The membranes were blocked with 3% bovine serum albumin (BSA) in PBS containing 0.05% 
Tween20 (PBST) for 1 hour at room temperature. The membranes were then incubated with 
a biotinylated succinylated wheat germ agglutinin (sWGA; Vector Labs, Burlingame, USA, 
final concentration of 14.3 μg/ml), Dolichos biflorus lectin (Sigma-Aldrich, Zwijndrecht, The 
Netherlands, final concentration of 14.3 μg/ml) or Lens culinaris lectin (EY Labs Inc., San Mateo, 
USA, final concentration of 5 μg/ml) in the blocking solution, followed by incubation with 0.1 
nl/ml (1:10000 dilution) of streptavidin poly-horse radish peroxidase (poly-HRP; ImmunoTools 
GmbH, Friesoythe, Germany). In between the incubations, the membranes were washed three 
times with PBST for 15 min. Precision Plus Protein™ Dual Color Standards (Bio-Rad, Richmond, 
USA) was used as a reference of molecular size. RNase B (New England BioLabs, Ipswich, USA) 
was used as a positive control for sWGA blotting. After the membranes were washed, they were 
developed by using Super Signal West Pico Chemiluminescent Substrate (Thermo Scientific) and 
Kodak BioMax Light film (Kodak, Rochester, USA). 
Mass spectrometry. The protein bands apparent around 100kDa were excised from a 
Commassie blue stained gel (see above), followed by characterization of the glycosylation pattern 
using the same method as described by Rolain et al. [42]. Briefly, the protein was in-gel digested 
with trypsin (Promega) for 16 h at 37°C. Digested peptides were recovered and vacuum dried 
(Speedvac SC200, Savant). Peptides were then dissolved in 0.025% (v/v) trifluoroacetic acid 
(TFA) and 5% (v/v) acetonitrile (ACN) and desalted using a C18 Pep Map 100 pre-column 
(10 mm, 5 μm i.d., 100 Å), and subsequently subjected to reverse phase chromatography using 
Ultimate 3000 chromatography chain (LC Packings) with a C18 Pep Map 100 analytical column 
(150 mm, 3 μm i.d., 100 Å). Peptides were back-flushed onto the analytical column with a flow 
rate of 300 nl/min using a 180 min linear gradient from 8 to 76% (v/v) ACN in water containing 
0.1% (v/v) TFA in 4% ACN-0.1% TFA and 0.085% (v/v) TFA in 80% ACN-0.1% TFA. The 
eluted peptides were mixed with a-cyano-4-hydrocinnamic acid (4 mg/ml in 70% ACN-0.1% 
TFA) and spotted directly onto a MALDI target using a Probot system (LC Packings). The spotted 
plates was analyzed in reflector mode on an Applied Biosystems 4800 MALDI TOF/TOF Analyzer 
using a 200 Hz solid state laser operating at 355 nm. MS spectra were obtained using a laser 
intensity of 3600 and 2000 laser shots per spot in the m/z range of 800 to 4000, while MS/MS 
spectra were obtained by automatic selection of the 20 most intense precursor ions per spot using 
a laser intensity of 4000 and 2000 laser shots per precursor. Collision induced dissociation was 
performed with an energy of 1 kV with air gas at a pressure of 1 x 106 Torr. Data were collected 
using the Applied Biosystems 4000 Series ExplorerTM Software. LC-MS/MS data were processed 
using the Applied Biosystems GPS ExplorerTM 3.6 Software. 
For peptide identification, a local database containing Acm2 sequence was used with the tolerance 
was set to 200 ppm on the precursors and 0.3 Da on the fragments. One trypsin miscleavage was 
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authorized. For modifications, methionine oxidation and HexNAc glycosylation (203.08 Da) on 
Ser, Thr and Asn were selected. HexNAc-modified peptides were checked by manual de novo 
sequencing on the MS/MS fragmentation spectra. The data presented for WT were combined 
of 2 independent analyses, while for tagE5E6 deletion mutant were combined of 3 independent 
analyses. 
Results 
Comparative genomics and mutagenesis of candidate protein glycosyl tranferases 
Acm2 of Lactobacillus plantarum WCFS1 was previously established to be O-glycosylated with 
N-acetylhexosamines (HexNAc), most likely GlcNAc, at multiple positions in its AST domain [41, 
42]. Glycosylation with GlcNAc was also found in flagellin of Listeria monocytogenes [35] and Fap1 of 
S. parasanguinis [37, 38]. The glycosylation with GlcNAc moieties in the latter species requires two 
genetically coupled functions, Gtf1 and Gtf2 [37]. Bu et al. suggested that Gtf1 catalyzes GlcNAc 
glycosylation via its C-terminal glycosyltransferase domain, while Gtf2 might act as a chaperon to 
maintain correct folding of Gtf1 and to promote efficient glycosylation [37, 53]. Based on these 
previous findings, we performed a BlastP analysis [54, 55] using the Gtf1 sequence to identify 
candidate protein-glycosyltransferases in the L. plantarum WCFS1 genome. Six genes (tagE1 to 
tagE6), which are annotated as poly(glycerol-phosphate) α-glucosyltransferases, and consequently 
are thought to be involved in teichoic acid glycosylation [46], appeared the closest homologues of 
the Gtf1 protein and all share more than 20% sequence identity with Gtf1. Two pairs of tagE genes 
are genetically coupled in the L. plantarum chromosome (tagE2-tagE3 and tagE5-tagE6) (Figure 
1). Therefore, all 6 tagE genes identified were targeted by gene deletion, with the notion that the 
genetically coupled tagE pairs were deleted jointly. This genetic engineering approach yielded four 
L. plantarum WCFS1 derivatives, NZ3540Cm (ΔtagE1), NZ3541Cm (ΔtagE2E3), NZ3542Cm 
(ΔtagE4), and NZ3543Cm (ΔtagE5E6). 
Deletion of tagE5 and tagE6 abolishes protein glycosylation in L. plantarum WCFS1
Surface proteins derived from the tagE deletion mutants, as well as the wild type and acm2 deletion 
mutant [41] were analyzed by SDS-PAGE. One protein band detected in the wild type extract 
appeared to be absent in the sample derived from the acm2 deletion derivative, suggesting this 
protein band represents Acm2 (Figure 2A). To substantiate this suggestion, the band representing 
Acm2 was excised, in-gel digested with trypsin, and the resulting peptides were extracted and 
subjected to liquid chromatography coupled to mass spectrometry analysis (LC-MS/MS), which 
generated MS-spectra that represented 75% and 69% coverage of the mature Acm2 protein 
sequence and its N-terminal glycosylated AST domain, respectively (Figure S1A). Importantly, 
the MS spectra detected 5 different glycopeptides (designated glyco I, II, IV, V and VI, according 
to nomenclature introduced by Rolain et al. [42]; Table 3) that appeared all located in the AST 
domain and to be one-, two-, or three-fold substituted with a molecule of an approximate mass 
of 203 Da, which corresponds to the previously suggested glycosylation with GlcNAc [41, 42, 
45] (Table 3 and Table S1). This observation is in agreement with the apparent molecular weight of 
wild type Acm2 that was estimated to be approximately 100 kDa (Figure 2), which is higher than 
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the predicted molecular weight of 78.9 kDa on basis of the mature protein sequence. Moreover, 
we were able to identified some of the glycosylated residues (Table 3 and Table S1), but not all. 
These glycosylated residues are all also found in the study of Rolain et al. [42]. Interestingly, 
different glycosylated forms were found in peptide Glyco II (one or two HexNAc) and Glyco 
VI (one, two or three HexNAc), which might imply a dynamic level of glycosylation in Acm2. 
In the ΔtagE1, ΔtagE2E3, and ΔtagE4 mutants, the mobility of the Acm2 protein appeared to 
be unaffected as compared to the wild-type strain. By contrast, the Acm2 protein present in 
the wild type was absent in the ΔtagE5E6 deletion strain but a protein band of higher mobility 
(lower apparent molecular weight) appeared in the gel (Figure 2A). These observations provide 
a first clue that TagE5 and/or TagE6 are involved in the glycosylation of Acm2. Indeed, the loss 
of glycosylation of Acm2 in the ΔtagE5E6 deletion strain could also be confirmed by LC-MS/
MS, as the Acm2 protein band extracted from gel was used to generate MS-spectra that enabled 
52% and 59% coverage of the mature Acm2 protein sequence and its AST domain, respectively 
(Figure S1B). Notably, 6 distinct peptides of the AST domain that contained proposed HexNAc 
glycosylations [42] (designated glyco II to VII; Table 3) that were detected in the wild type Acm2 
protein spectra (glyco II, IV, V and VI in this work and glyco VII in the work of Rolain et al. [42]) 
were also detected in the Acm2 protein spectra derived from the tagE5E6 deletion strain, albeit, 
in the latter strain these peptides consistently lacked the substitutions seen in the wild type (Table 
Figure 2. (A) Coomassie brilliant blue stained SDS-PAGE of surface proteins extracted from the tagE 
deletion mutants as well as from wild type and acm2 deletion mutant to detect Acm2 (indicated by the 
arrow). (B) Succinylated wheat germ agglutinin (sWGA), Dolichos biflorus lectin, and Lens culinaris lectin 
blots of whole cell extracts derived from the tagE deletion mutants, Lactobacillus plantarum WCFS1 (wild 
type) and the acm2 deletion mutant to assess glycan moieties. On the left side of the blot the protein size 
(kDa) are indicated based on the Precision Plus Protein™ Dual Color Standards (Bio-Rad) molecular 
marker (data not shown). The arrow indicates Acm2.
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3 and Table S1). In addition, three peptides (glyco III, IV, and V) were exclusively detected in 
their non-glycosylated form in Acm2 isolated from the ΔtagE5E6 mutant (Table 3). These data 
reveal that the HexNAc-glycosylated peptides derived from Acm2 are only detected in their non-
glycosylated form in the ΔtagE5E6 mutant (Table 3), supporting the role of TagE5E6 in the Acm2 
glycosylation that is observed in the wild type strain.
To further investigate this, we employed a lectin-based detection of glycan moieties using 
biotinylated sWGA, specific for GlcNAc, in a Western-blot like set up. This approach showed that 
an sWGA-recognized protein of approximately 100 kDa derived from the wild type was absent 
in the acm2 deletion strain, reconfirming the glycosylation of Acm2. Moreover, the glycans linked 
to these proteins only react with the GlcNAc-specific lectin sWGA but not with Dolichos biflorus 
lectin (specific for α-GalNAc) nor with Lens culinaris lectin (specific for α-mannose) (Figure 2B), 
implying the glycan is most likely GlcNAc. Interestingly, the sWGA blot revealed signals other than 
Acm2 that appeared to be glycosylated that were detected in both wild type- and acm2 mutant-
derived whole cell extracts. All these signals were lost when sWGA blotting experiments were 
performed using samples that were proteinase K treated, indicating that all glycan signals in the 
lectin blotting experiment were derived from proteinaceous molecules (Figure 3). In addition, the 
sWGA blot revealed that deletion of tagE1, tagE2E3, or tagE4 did not affect protein glycosylation, 
since these mutants displayed the same banding pattern as was observed for the wild type strain. 
By contrast, deletion of tagE5 and tagE6 abolished almost all detectable sWGA-specific signals, 
including that of Acm2, indicating that TagE5 and TagE6 play a critical role in the glycosylation of 
Acm2 and the additional proteins detected. Intriguingly, a single band of an apparent molecular 
weight of approximately 125kDa appeared not only unaffected by the ΔtagE5E6 mutation but also 
recognized by Dolichos biflorus and Lens culinaris lectins (Figure 2B), implying that another, TagE5/
E6-independent mechanism of glycosylation may be active for the glycosylation of this particular 
protein. Taken together, these results evidence the essential role of TagE5 and/or TagE6 for protein 
glycosylation in L. plantarum WCFS1. 
Both TagE5 and TagE6 are required for protein glycosylation in L. plantarum WCFS1  
To investigate whether TagE5, TagE6 or their concerted action is required for protein glycosylation 
in L. plantarum WCFS1, the ΔtagE5E6 mutant was complemented with tagE5, tagE6 or both genes. 
Figure 3. The sWGA blot of whole cell extracts derived from wild type and tagE5E6 deletion mutants with 
or without proteinase K treatment for 10, 30, or 60 min. On the left side of the blot the protein size (kDa) 
are indicated based on the Precision Plus Protein™ Dual Color Standards (Bio-Rad) molecular marker. 
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Complementations were achieved by integrating a single copy of the original gene(s) at a specific 
chromosomal site located downstream of the tRNASer locus, under control of the native tagE6-
promoter. Whole cell extracts from the different complemented ΔtagE5E6 derivatives were 
analyzed by SDS-PAGE and sWGA blotting, and compared to extracts derived from the wild 
type, as well as the Δacm2 and ΔtagE5E6 mutants. Complementation with either tagE5 or tagE6 
did not restore protein glycosylation and generated the same banding patterns as observed for the 
ΔtagE5E6 strain (Figure 4). However, complementation with the complete locus, encompassing 
both tagE5 and tagE6, restored not only the glycosylation of Acm2 but also of all other proteins 
that were detected in the wild type banding pattern. These results indicate that glycosylation of 
proteins in L. plantarum WCFS1 requires both TagE5 and TagE6 activities.
Protein glycosylation is a common feature in L. plantarum strains
Using previously generated comparative genome hybridization (CGH) data for 42 L. plantarum 
strains [56, 57], we concluded that the 6 tagE genes recognized in the genome of L. plantarum 
WCFS1 appear to be conserved among all these 42 strains, with the notable exception of strain 
NCIMB12120 that appeared to lack genes that hybridize to the L. plantarum WCFS1 tagE4, tagE5, 
and tagE6 probes. To evaluate glycosylation of proteins in other L. plantarum strains, 9 of the 
42 mentioned strains were selected, including NCIMB12120 and LP85-2 from the subspecies 
argentoratensis, for analysis of whole cell extracts by SDS-PAGE and GlcNAc-specific sWGA 
blotting. Notably, these 9 strains were selected to maximize the coverage of the phylogenetic 
tree based on the whole genome comparative genome hybridization datasets [56], as well as to 
include strains isolated from diverse niches (Table 1). All selected strains, including NCIMB12120, 
displayed sWGA-recognized glycosylated proteins that displayed similar banding pattern on SDS-
PAGE gels (Figure 5). This result strongly suggests that glycosylation of proteins is a common 
feature in the species L. plantarum. 
Figure 4. The sWGA blot of wild type, acm2 and tagE5E6 deletion mutants, and a panel of complemented 
mutants. On the left side of the blot the protein size (kDa) are indicated based on the Precision Plus 
Protein™ Dual Color Standards (Bio-Rad) molecular marker (data not shown). The arrow indicates Acm2. 
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Discussion
Existing information on the protein glycosyltransferase Gtf1 in S. parasanguinis [37, 38, 41], 
enabled us to employ a comparative genomics approach, resulting in the identification of the 6 
TagE orthologues as candidate protein glycosyltransferases in L. plantarum WCFS1. All 6 TagE 
proteins contain a GT1_gtfA_like domain designated cd04949 [58] at their C-terminal ends [46]. 
This domain is named after gtfA in Streptococcus gordonii, where it plays a role in the O-linked 
glycosylation and this family containing this domain is most closely related to GT1 family of 
glycosyltransferases [58]. Limiting the amount of glycosyltransferases (50 annotated in the L. 
plantarum WCFS1 genome [46]) to the six TagE glycosyltransferases as most likely candidates for 
protein glycosylation, enabled us to perform a systematic gene deletion and complementation 
strategy, followed by assessment of the consequences for protein glycosylation. This approach 
revealed that the concerted activity of TagE5 and TagE6 is required for the previously established 
glycosylation of Acm2 [41, 42], as well as other proteins. To the best of our knowledge, these 
results represent the first example of a protein glycosylation machinery in a Lactobacillus species. 
The TagE proteins of L. plantarum WCFS1 are annotated according to their originally predicted 
function in teichoic acid glycosylation (poly[glycerol-phosphate]-α-glucosyltransferases). The 
glucose substitution levels in lipoteichoic acids (LTA) of L. plantarum WCFS1 are very low [59, 
60], while glucose is a backbone constituent into the repeating unit of wall teichoic acids (WTA) 
that does not have additional glucose substitutions in this strain [60, 61]. Neither LTA nor WTA 
of L. plantarum WCFS1 contains N-acetylhexosamine [59, 61], the glycan transferred by TagE5 
and TagE6. Since the glucose substitution level is very low in LTA from L. plantarum WCFS1, 
we have isolated deacylated and dealanylated LTA (dd-LTA) to obtain better nuclear magnetic 
resonance (NMR) spectral resolution for signals from anomeric protons of sugar residues. The 
1-D 1H NMR spectra revealed that dd-LTA isolated from ΔtagE5E6 mutants has the same level of 
glycosylation as LTA isolated from WT (Figure S2A). Moreover, 2-D NMR spectra also showed 
that the glycosylation position of LTA is unaltered in the tagE5E6 deletion mutant (Figure S2B). 
Therefore, with the establishment of TagE5 and TagE6 as dedicated protein glycosyltransferases we 
propose to rename these enzymes (and genes) to GtfA (gtfA) and GtfB (gtfB), respectively. 
Figure 5. Assessment of 9 Lactobacillus plantarum strains for protein glycosylation, using whole cell extract 
SDS PAGE and sWGA lectin-based detection. On the left side of the blot the protein size (kDa) are 
indicated based on the Precision Plus Protein™ Dual Color Standards (Bio-Rad) molecular marker (data 
not shown). The arrow indicates Acm2 of strain WCFS1.
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Currently established bacterial O-linked glycosylation pathways employ either block or sequential 
transfer pathways for the addition of sugars to proteins [26]. The block transfer pathway is 
exemplified by the glycosylation of Neisseria spp. pilin. This pathway assembles an oligosaccharide 
using nucleotide-activated sugars on a lipid anchor at the cytoplasmic side of the inner membrane. 
The assembled oligosaccharide is subsequently translocated across the inner membrane by a 
flippase to the periplasm, where the lipid-linked oligosaccharide is transferred to Ser/Thr residues 
of proteins [26, 33]. On the other hand, the sequential transfer pathway, for example employed 
in flagellar glycosylation of Campylobacter jejuni, transfers nucleotide-activated sugars individually 
onto Ser/Thr residues of proteins at the cytoplasm-inner membrane interface [26]. Acm2 of 
L. plantarum WCFS1 undergoes cytoplasmic O-glycosylation with single N-acetylhexosamine 
moieties, likely GlcNAc, at multiple sites of its AST domain [41, 42]. The fact that this glycosylation 
occurs in the cytoplasm might imply that the machinery responsible for Acm2 glycosylation is 
more similar to the sequential transfer pathway. Moreover, the glycosylation nature of Acm2 is 
similar to the glycosylation found in flagellin from L. monocytogenes, which is glycosylated with 
single GlcNAc at 3 to 6 sites [35], and in Fap1 fimbrial adhesin from S. parasanguinis, of which all 
the oligosaccharides are primed with GlcNAc [37]. Interestingly, since the glycosyltransferases 
responsible for their glycosylations (GmaR for listerial flagellin [62] and Gtf1/Gtf2 for Fap1 [37, 
53]) are predicted to be cytoplasmic proteins, the glycosylation of flagellin from L. monocytogenes 
and Fap1 from S. parasanguinis are also thought to occur in the cytoplasm. Notably, another example 
of a Lactobacillus glycoprotein, Msp1 of L. rhamnosus GG, was found to be glycosylated in the 
supernatant but not in the cytosolic fraction [43], hinting towards species-specific O-glycosylation 
pathways in Lactobacillus species. 
We have successfully identified the glycosyltransferases GtfA/B for the glycosylation of Acm2 
based on the similar glycan moieties found in Fap1. However, the protein property and function 
is completely different between Acm2 and Fap1. Fap1 belongs to serine-rich repeat proteins 
(SRRPs), which are a family of surface exposed adhesion-mediated proteins predominately found 
within the oral Streptococcus species [63]. Currently, seven SRRPs have been researched, including 
Fap1 of S. parasanguinis, Has and GspB of S. gordonii, PsrP of Streptococcus pneumonia, Srr-1 and Srr-2 
of Streptococcus agalactiae, and SraP of Staphylococcus aureus [53]. Each SRRP locus locates at a close 
proximity with a highly conserved core region, consisting of accessory secretory components and 
two essential glycosyltransferases [38]. In this work, we found GtfA and GtfB are required for the 
glycosylation of Acm2 as well as other unidentified proteins other than SRRPs family. Moreover, 
acm2 (lp_2645) locates in a distinct region of the chromosome, not linked to the gtfA/B (lp_2843/
lp_2844) genes (Figure 1), which is also distinct from Streptococcus SRRPs. Recently, the two 
glycosyltransferases, Gtf1 and Gtf2, of S. parasanguinis have been investigated and it was found that 
the glycosylation of Fap1 requires the glycosyltransferase activity from Gtf1 together with the 
chaperon function of Gtf2 to maintain the correct folding of Gtf1 [53]. However, GtfA and GtfB 
in L. plantarum are both homologs of Gtf1 in S. parasanguinis and display much lower similarity 
with the chaperon Gtf2. Although we have not experimentally excluded the possibility that the 
co-expression of GtfA or GtfB of L. plantarum WCFS1 is required for the correct folding of GtfB 
or GtfA, respectively, it does not seem likely that either GtfA or GtfB acts as a chaperon. 
Comparative genome hybridization (CGH) data suggests that 6 orthologous of tagE genes are 
typically present in L. plantarum strains [56], with the notable exception of strain NCIMB12120 
that appears to lack tagE4 and gtfA-gtfB. However, this strain still contains sWGA recognized, 
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glycosylated proteins, similar to the other 7 strains tested (Figure 5). NCIMB12120 belongs to a 
subspecies (argentoratensis) different from the reference strain WCFS1. Strains in this subspecies 
commonly have a smaller genome size [64] and appear to lack homologues of approximately 
20% of the genes present in WCFS1 [57]. Despite the apparent absence of tagE4 and gtfA-gtfB 
in NCIMB12120, the glycosylation of proteins apparently still occurs, suggesting that this strain 
(subspecies) encodes genes with the same function that are of low homology and therefore were 
missed in the CGH analysis. Taken together, our data suggests that glycosylation as well as the 
presence of tagE genes are common features in L. plantarum strains. Moreover, the sequence and 
length of Acm2 is highly similar in all sequenced L. plantarum strains, e.g. WCFS1 [46], ST-III [65] 
JDM1 [66] and NC8 [67] (785 residues) and ATCC14917 (781 residues). This suggests that the 
Acm2 protein of different L. plantarum strains may all have similar sizes as well as similar degrees of 
glycosylation and are represented by the universal abundant protein band around 100kDa (Figure 
5).   
Other Lactobacillus species also harbor genetically coupled gtfA-gtfB homologues, for example, 
tagE2-tagE3 of Lactobacillus casei BL23, lsei_0891-lsei_0892 of L. casei ATCC334 [68] and yohH-
yohJ of L. rhamnosus GG [69]. However, the genomes of other species, including Lactobacillus 
acidophilus NCFM [70], do not appear to contain gtfA-gtfB homologues, while Lactobacillus 
johnsonii NCC533 [71] and Lactobacillus delbrueckii supsp. bulgaricus ND02 [72] harbor a single 
gene displaying similarity with gtfA-gtfB. Although we successfully identified the role of GtfA-
GtfB in glycosylation of proteins based on their sequence homology with Gtf1 of S. parasanguinis, 
sequence similarity alone did not provide a direct identification of this specific glycosyltransferase 
function, since all 6 TagE proteins display a similar degree of sequence homology with Gtf1. The 
role of the other 4 TagE glycosyltransferases in L. plantarum WCFS1 is currently unestablished 
but might involve the transfer of other glycan moieties to proteins or N-glycosylation. Indeed, 
among recently found glycoproteins in L. plantarum WCFS1, glycosylation of hexoses was also 
found in Lp_2162, Lp_3421 and DnaK, besides the HexNAc substitutions already established for 
Acm2 [45]. Moreover, some lectin-based studies suggested the presence of glycoproteins modified 
with glycans other than GlcNAc, such as glycoproteins of L. acidophilus JCM1132T (recognized 
by β-galctoside-specific lectin)[73], SlpA of L. acidophilus NCFM (recognized by fucose- and 
mannose-specific lectins)[19, 74], and Msp1 of L. rhamnosus GG (recognized by glucose- and 
mannose-specific ConA lectin)[43]. Furthermore, many Lactobacillus genomes encode the genes to 
produce multiple nucleotide-activated sugars, including UDP-glucose, UDP-galactose, sialic acid 
and dTDP-rhamnose [6], suggesting the potential capacity to glycosylate proteins with diverse 
sugar moieties. Alternatively, WTA of L. plantarum WCFS1 contains glucose in its backbone [61] 
and biosynthesis of this structure could require the activity of specific TagE proteins, as predicted 
by the current annotation. 
We have conclusively shown that protein glycosylation is a common feature in L. plantarum 
strains and is not targeting a single protein, but modifies a much broader range of proteinaceous 
compounds. One important question remains unanswered: what is the biological role of protein 
glycosylation in lactobacilli? Earlier studies in pathogens showed that glycoproteins are often 
involved in adherence, pathogenicity, flagella assembly and protein stability [23]. A more recent 
example illustrated that the glycans attached on surface layer proteins of Tannerella forsythia, which 
is implicated in periodontitis, modulate the function of DCs and suppress T-helper 17 responses 
[75]. To this end, it is intriguing that glycosylation of Msp1 of L. rhamnosus GG is not essential for 
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its peptidoglycan hydrolyase activity [17, 43], neither for activating Akt signaling in Caco-2 cells 
[43], but does influence Msp1 protein stability and protein localization [43]. Moreover, Lebeer 
et al. suggested the possibility of an indirect modulating role of the Msp1 glycan moieties in Akt 
activation via shielding bacteria and host interaction [43]. Furthermore, the ConA and Aleuria 
aurantia (AAL)-reactive glycans on SlpA of L. acidophilus NCFM is essential for the modulation 
of T cell function and led to more IL-4 production [19]. Importantly, it was recently established 
that O-glycosylation of Acm2 in L. plantarum functions as a major negative modulator of Acm2 
peptidoglycan hydrolase activity [42], which is the first evidence that glycosylation regulates the 
bacterial enzyme activity. In fact, we observed different glycoforms of GlycoII and GlycoVI (Table 
3), which might imply a kinetic modulation of Acm2 hydrolase activity via O-glycosylation [42]. 
Our future work will focus on recognizing the biological roles of glycosylation of other proteins 
in L. plantarum, especially in relation to its possible consequences for host-microbe interactions in 
the gastrointestinal tract. 
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Supplemental Material
Materials and methods
Bacterial strains and growth conditions. Lactobacillus plantarum WCFS1 (wild-type) 
and tagE deletion mutants (see Table 1) were cultured in 20 L MRS broth (Merck, Darmstadt, 
Germany) at 37°C for 20 hours using a Techfors-S bioreactor (Infors, Bottmingen, Switzerland) 
at a constant pH of 6.8 by titration of 6M NaOH with a built-in peristaltic pump and stirrer at 
100 rpm. The cells were collected by centrifugation using an AVANTI J-25 centrifuge (Beckman-
Coulter, Brea, USA) at 9000 × g at room temperature and were subsequently washed once with 
200 ml of phosphate buffer saline.
Preparation of lipoteichoic acid. Lipoteichoic acid (LTA) of the cells cultured was isolated 
and purified by butanol extraction, hydrophobic interaction chromatography (HIC), and anion-
exchange chromatography as described by Morath et al. [1]. Briefly, the cells were disrupted by 
a French press cell (SLM Instruments Inc., Urbana, USA) and supernatants after centrifugation 
(23000 × g for 30 min at 4°C) were collected by pipetting. Subsequently, the supernatants were 
extracted with the same volume of butanol for 30 min at room temperature and the water phase 
was collected and lyophilized after centrifugation at 23000 × g for 30 min at room temperature. The 
lyophilized fraction was then separated on a Octyl-Sepharose 4 FastFlow column (GE Healthcare, 
Little Chalfont, UK) with a stepwise elution of 13-31% 1-propanol in 100 mM sodium acetate 
buffer (pH 4.7). LTA in the fractions was detected by ashing of organic phosphate [2] as described 
by Allen R. J. [3]. For 2D NMR analysis ΔtagE5E6-derived LTA was subsequently purified on a 
DEAE-Sepharose 4 FastFlow column (GE Healthcare) with a linear gradient elution of 0-1.0 M 
sodium chloride in sodium acetate buffer by using an AKTA FPLC system (GE Healthcare). LTA 
in the separated fractions were collected by lyophilisation after dialysis against water.
Preparation of deacylated and dealanylated LTA. To improve NMR spectral resolution 
for signals from anomeric protons of sugar residues, deacylated and dealanylated LTA (dd-LTA) 
were prepared as described by Simpson et al. [4]. Briefly, approximately 10 mg of the isolates of 
the HIC analyses were dissolved in 250 ml water, mixed with the same volume of 30% ammonium 
hydroxide, and incubated overnight at room temperature. The mixtures were extracted with the 
same volume of chloroform-methanol (1:1, v/v) once, followed by two chloroform extractions. 
dd-LTA in the solution was collected by lyophilisation.
NMR spectroscopic analysis of LTA from ΔtagE5E6 mutant. LTA from HIC fractions and 
their dd-LTA were dissolved in 400 ml of D2O and used for measurement of 1D NMR spectra. 
Purified LTA from DtagE5E6 was also used for measurement of 2D NMR spectra. The 1D (1H 
and 13C) and 2D NMR spectra (COSY, H-H correlation spectroscopy; TOCSY, H-H totally 
correlated spectroscopy; HSQC, H-C hetero-nuclear single quantum coherence; HMBC, H-C 
hetero-nuclear multiple-bond connectivity) were recorded on an AVANCE III 500 MHz NMR 
spectrometer (Bruker Daltonics, Bremen, Germany) at 333 K with proton and carbon frequencies 
of 500.13 MHz and 125.77 MHz. The 2D NMR spectra were acquired with 512 increments 
of 8 scans for COSY, 512 increments of 16 scans for TOCSY and HSQC, and 1024 increments 
of 96 scans for HMBC, respectively. Sodium 3-(trimethylsilyl)propionic-2,2,3,3-d4 acid (Sigma-
Aldrich, Zwijndrecht, The Netherlands) was used as an internal reference for chemical shift (δH 
0.00 and δC 0.00).
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Table S1. List of detected Acm2 peptides
Lactobacillus plantarum WCFS1 WT
Start - End
Observed 
m/z 
Mr 
(expected)
Mr 
(calculated)
∆Mr 
(Da) Miss Sequencea
Ions 
score*
42 - 79 3902.26 3901.25 3901.78 -0.53 0
K.GNSAASAASQQVTL-
SAGSQTETTAAGATD-
QSVASDGAK.T; 2 Hex-
NAc 10
80 - 99 2031.62 2030.61 2030.89 -0.28 0
K.TDDQAEST-
STTTATTSATSR.V 112
80 - 99 2234.68 2233.68 2233.97 -0.29 0
K.TDDQAEST-
STTTATTSATSR.V; 1 Hex-
NAc 46
80 - 99 2437.74 2436.73 2437.05 -0.32 0
K.TDDQAEST-
STTTATTSATSR.V; 2 Hex-
NAc 92
128 - 148 2487.75 2486.74 2487.10 -0.36 0
K.DNAATSATADSTTSAVD-
QLDK.T; 2 HexNAc 44
152 - 169 2168.75 2167.74 2167.97 -0.23 0
K.ASAATSQASHSTTNE-
TAK.A; 2 HexNAc 17
170 - 195 2576.86 2575.85 2576.22 -0.37 0
K.ASAAASQDSHVTTD-
QSSVTVTSEVAK.S 17
170 - 195 2779.89 2778.89 2779.30 -0.41 0
K.ASAAASQDSHVTTD-
QSSVTVTSEVAK.S; 1 
HexNAc 20
170 - 195 2982.91 2981.90 2982.38 -0.48 0
K.ASAAASQDSHVTTD-
QSSVTVTSEVAK.S; 2 
HexNAc 38
170 - 195 2982.94 2981.93 2982.38 -0.44 0
K.ASAAASQDSHVTTD-
QSSVTVTSEVAK.S; 2 
HexNAc 50
170 - 195 3185.99 3184.98 3185.46 -0.48 0
K.ASAAASQDSHVTTD-
QSSVTVTSEVAK.S; 3 
HexNAc 19
170 - 195 3186.00 3184.99 3185.46 -0.47 0
K.ASAAASQDSHVTTD-
QSSVTVTSEVAK.S; 3 
HexNAc 29
219 - 236 1821.68 1820.67 1820.88 -0.20 0
K.IETAVAADAVQSSAM-
MAR.S 31
240 - 252 1495.59 1494.58 1494.78 -0.20 0 R.AMTSQEIFLSQIK.A 55
240 - 252 1511.58 1510.57 1510.77 -0.20 0
R.AMTSQEIFLSQIK.A 
Oxidation (M) 34
240 - 252 1511.58 1510.58 1510.77 -0.19 0
R.AMTSQEIFLSQIK.A 
Oxidation (M) 38
253 - 261 903.36 902.36 902.46 -0.11 0 K.AGAISGWNK.Y 73
262 - 295 3589.36 3588.35 3588.86 -0.51 0
K.YQVLPSVTAAQAILES-
GWGQSQLATQGNNLF-
GIK.G 34
296 - 323 3284.08 3283.07 3283.52 -0.45 0
K.GSYQGQSIY-
FPTQEWNGSQYITIQDA-
FR.K 20
296 - 323 3285.07 3284.06 3283.52 0.54 0
K.GSYQGQSIY-
FPTQEWNGSQYITIQDA-
FR.K 11
324 - 344 2385.87 2384.86 2385.19 -0.32 1
R.KYPNWSASVEDHGA-
FLVVNPR.Y 13
325 - 344 2257.78 2256.77 2257.09 -0.32 0
K.YPNWSASVEDHGAFLV-
VNPR.Y 39
345 - 355 1300.50 1299.50 1299.65 -0.15 0 R.YSNLIGVTDYR.R 76
345 - 355 1300.60 1299.59 1299.65 -0.05 0 R.YSNLIGVTDYR.R 18
357 - 384 3016.11 3015.10 3015.54 -0.44 0
R.VASLLQQDGYATAPTY-
ASSLISIIEYNK.L 57
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385 - 420 3860.19 3859.18 3859.73 -0.54 0
K.LHEWDQEALSGQA-
SGGNDNNQVQPDQD-
VTPTSGTHK.F 41
424 - 452 2966.97 2965.97 2965.41 0.56 0
K.TTTIHNAPDATSAVVG-
TYNAGETVNYNGK.L 33
453 - 462 1130.51 1129.50 1129.62 -0.13 0 K.LTVGNATWLR.Y 41
463 - 471 1046.37 1045.36 1045.48 -0.12 0 R.YQSYSGVSR.Y 44
472 - 497 2804.90 2803.90 2804.29 -0.40 0
R.YVMISQTTTNDNNN-
QATVTPASGSYK.F 49
472 - 497 2820.90 2819.89 2820.29 -0.40 0
R.YVMISQTTTNDNNN-
QATVTPASGSYK.F Oxida-
tion (M) 13
511 - 529 2034.68 2033.68 2033.97 -0.29 0
K.TAQVVGTYNAGET-
VYYNGK.I 147
530 - 539 1105.49 1104.48 1104.59 -0.11 0 K.ITTGGTTWLR.Y 15
540 - 573 3551.18 3550.18 3550.67 -0.49 0
R.YLSYSGAQHYVAMS-
GDEVGSVAKPDV-
VATSGSYR.F 13
574 - 581 909.40 908.39 908.53 -0.14 1 R.FTKTTAIK.S 51
606 - 615 1175.48 1174.48 1174.61 -0.13 0 K.VTTNGQTWLR.Y 26
606 - 615 1175.54 1174.54 1174.61 -0.07 0 K.VTTNGQTWLR.Y 18
659 - 682 2417.77 2416.76 2417.11 -0.35 0
K.NTPAGNAPSVGTYSAG-
DTVYYNAK.V 32
683 - 692 1145.52 1144.52 1144.60 -0.08 0 K.VTANGQTWLR.Y 18
683 - 692 1145.52 1144.52 1144.60 -0.08 0 K.VTANGQTWLR.Y 18
683 - 692 1145.53 1144.53 1144.60 -0.07 0 K.VTANGQTWLR.Y 17
683 - 692 1145.54 1144.53 1144.60 -0.07 0 K.VTANGQTWLR.Y 18
728 - 735 951.41 950.40 950.52 -0.12 0 R.FVTTTNIR.T 45
742 - 769 3124.00 3122.99 3122.46 0.53 0
R.ASVVGEYNPGETVYYN-
GTVQAEGYTWLR.Y 10
742 - 769 3124.07 3123.06 3122.46 0.60 0
R.ASVVGEYNPGETVYYN-
GTVQAEGYTWLR.Y 13
774 - 782 933.36 932.36 932.47 -0.12 0 R.SGATHYVAK.L 32
774 - 785 1232.54 1231.53 1231.62 -0.09 1 R.SGATHYVAKLEG.- 34
aThe number of HexNAc were all confirmed by manual de novo sequencing on the MS-MS fragmentation spectra and 
the glycosylated amino-acids that could be identified are bold and underlined. 
Lactobacillus plantarum WCFS1 tagE5E6 deletion mutant
Start - End
Observed 
m/z 
Mr 
(expected)
Mr 
(calculated)
∆Mr 
(Da) Miss Sequence
Ions 
score
80 - 99 2031.67 2030.67 2030.89 -0.22 0
K.TDDQAEST-
STTTATTSATSR.V 55
80 - 99 2031.82 2030.81 2030.89 -0.07 0
K.TDDQAEST-
STTTATTSATSR.V 146
111 - 127 1621.55 1620.54 1620.72 -0.18 0
K.ADSTGPQSQSSASE-
AAK.D 72
128 - 148 2081.81 2080.81 2080.94 -0.13 0
K.DNAATSATADSTTSAVD-
QLDK.T 103
152 - 169 1762.63 1761.62 1761.81 -0.19 0
K.ASAATSQASHSTTNE-
TAK.A 82
152 - 169 1762.78 1761.77 1761.81 -0.04 0
K.ASAATSQASHSTTNE-
TAK.A 124
170 - 195 2576.90 2575.89 2576.22 -0.33 0
K.ASAAASQDSHVTTD-
QSSVTVTSEVAK.S 78
170 - 195 2577.08 2576.07 2576.22 -0.15 0
K.ASAAASQDSHVTTD-
QSSVTVTSEVAK.S 28
219 - 236 1821.83 1820.82 1820.88 -0.05 0
K.IETAVAADAVQSSAM-
MAR.S 64
240 - 252 1495.61 1494.60 1494.78 -0.17 0 R.AMTSQEIFLSQIK.A 28
240 - 252 1495.71 1494.71 1494.78 -0.07 0 R.AMTSQEIFLSQIK.A 92
240 - 252 1511.73 1510.73 1510.77 -0.04 0
R.AMTSQEIFLSQIK.A 
Oxidation (M) 43
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253 - 261 903.41 902.40 902.46 -0.06 0 K.AGAISGWNK.Y 65
253 - 261 903.43 902.43 902.46 -0.03 0 K.AGAISGWNK.Y 58
262 - 295 3589.56 3588.55 3588.86 -0.31 0
K.YQVLPSVTAAQAILES-
GWGQSQLATQGNNLF-
GIK.G 27
296 - 323 3285.01 3284.01 3283.52 0.49 0
K.GSYQGQSIY-
FPTQEWNGSQYITIQDA-
FR.K 13
324 - 344 2386.06 2385.06 2385.19 -0.13 1
R.KYPNWSASVEDHGA-
FLVVNPR.Y 25
325 - 344 2257.98 2256.98 2257.09 -0.12 0
K.YPNWSASVEDHGAFLV-
VNPR.Y 13
345 - 355 1300.50 1299.50 1299.65 -0.15 0 R.YSNLIGVTDYR.R 65
345 - 355 1300.66 1299.65 1299.65 0.00 0 R.YSNLIGVTDYR.R 72
345 - 356 1456.72 1455.71 1455.75 -0.04 1 R.YSNLIGVTDYRR.V 15
357 - 384 3016.32 3015.31 3015.54 -0.23 0
R.VASLLQQDGYATAPTY-
ASSLISIIEYNK.L 62
453 - 462 1130.64 1129.64 1129.62 0.01 0 K.LTVGNATWLR.Y 42
463 - 471 1046.39 1045.38 1045.48 -0.10 0 R.YQSYSGVSR.Y 41
463 - 471 1046.47 1045.46 1045.48 -0.02 0 R.YQSYSGVSR.Y 58
511 - 529 2034.72 2033.71 2033.97 -0.26 0
K.TAQVVGTYNAGET-
VYYNGK.I 75
530 - 539 1105.59 1104.58 1104.59 -0.01 0 K.ITTGGTTWLR.Y 45
574 - 581 909.42 908.41 908.53 -0.12 1 R.FTKTTAIK.S 43
606 - 615 1175.50 1174.49 1174.61 -0.12 0 K.VTTNGQTWLR.Y 18
606 - 615 1175.58 1174.57 1174.61 -0.04 0 K.VTTNGQTWLR.Y 27
651 - 658 909.48 908.47 908.50 -0.02 0 R.FTQTTAIK.N 55
659 - 682 2418.02 2417.02 2417.11 -0.10 0
K.NTPAGNAPSVGTYSAG-
DTVYYNAK.V 26
683 - 692 1145.49 1144.49 1144.60 -0.11 0 K.VTANGQTWLR.Y 29
683 - 692 1145.58 1144.57 1144.60 -0.03 0 K.VTANGQTWLR.Y 31
728 - 735 951.44 950.44 950.52 -0.08 0 R.FVTTTNIR.T 45
728 - 735 951.50 950.49 950.52 -0.03 0 R.FVTTTNIR.T 41
774 - 782 933.40 932.39 932.47 -0.08 0 R.SGATHYVAK.L 28
* Ions score cutt off ≥ 10 
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Supplemental figures
A.
Protein View: Acm2 isolated from wild type
Sequence coverage of mature Acm2 (753 aa): 75%
Sequence coverage of Acm2 AST domain (211 aa): 69%
1   MKIGMTKKVV TSLLLSTALL PMLSGKADTA SANQKPAAAT KGNSAASAAS
51  QQVTLSAGSQ TETTAAGATD QSVASDGAKT DDQAESTSTT TATTSATSRV
101 TVRAASQAAK ADSTGPQSQS SASEAAKDNA ATSATADSTT SAVDQLDKTA
151 KASAATSQAS HSTTNETAKA SAAASQDSHV TTDQSSVTVT SEVAKSAASS
201 AAPKQATEQA VAAKISPKIE TAVAADAVQS SAMMARSTRA MTSQEIFLSQ
251 IKAGAISGWN KYQVLPSVTA AQAILESGWG QSQLATQGNN LFGIKGSYQG
301 QSIYFPTQEW NGSQYITIQD AFRKYPNWSA SVEDHGAFLV VNPRYSNLIG
351 VTDYRRVASL LQQDGYATAP TYASSLISII EYNKLHEWDQ EALSGQASGG
401 NDNNQVQPDQ DVTPTSGTHK FTKTTTIHNA PDATSAVVGT YNAGETVNYN
451 GKLTVGNATW LRYQSYSGVS RYVMISQTTT NDNNNQATVT PASGSYKFTA
501 KTNIRSAASK TAQVVGTYNA GETVYYNGKI TTGGTTWLRY LSYSGAQHYV
551 AMSGDEVGSV AKPDVVATSG SYRFTKTTAI KSSPATSATT VGSYNAGDTV
601 YYNGKVTTNG QTWLRYMSYS GAQHYVQISG ESTSTNVDKP QVTPQSGSYR
651 FTQTTAIKNT PAGNAPSVGT YSAGDTVYYN AKVTANGQTW LRYLSYSGAQ
701 HYVAISGNAA TGNTTSKPVT NSQGAFRFVT TTNIRTAPST RASVVGEYNP 
751 GETVYYNGTV QAEGYTWLRY LSRSGATHYV AKLEG
B.
Protein View: Acm2 isolated from ΔtagE5E6
Sequence coverage of mature Acm2 (753 aa): 52%
Sequence coverage of Acm2 AST domain (211 aa): 59%
1     MKIGMTKKVV TSLLLSTALL PMLSGKADTA SANQKPAAAT KGNSAASAAS
51   QQVTLSAGSQ TETTAAGATD QSVASDGAKT DDQAESTSTT TATTSATSRV
101 TVRAASQAAK ADSTGPQSQS SASEAAKDNA ATSATADSTT SAVDQLDKTA
151 KASAATSQAS HSTTNETAKA SAAASQDSHV TTDQSSVTVT SEVAKSAASS
201 AAPKQATEQA VAAKISPKIE TAVAADAVQS SAMMARSTRA MTSQEIFLSQ
251 IKAGAISGWN KYQVLPSVTA AQAILESGWG QSQLATQGNN LFGIKGSYQG
301 QSIYFPTQEW NGSQYITIQD AFRKYPNWSA SVEDHGAFLV VNPRYSNLIG
351 VTDYRRVASL LQQDGYATAP TYASSLISII EYNKLHEWDQ EALSGQASGG
401 NDNNQVQPDQ DVTPTSGTHK FTKTTTIHNA PDATSAVVGT YNAGETVNYN
451 GKLTVGNATW LRYQSYSGVS RYVMISQTTT NDNNNQATVT PASGSYKFTA
501 KTNIRSAASK TAQVVGTYNA GETVYYNGKI TTGGTTWLRY LSYSGAQHYV  
551 AMSGDEVGSV AKPDVVATSG SYRFTKTTAI KSSPATSATT VGSYNAGDTV
601 YYNGKVTTNG QTWLRYMSYS GAQHYVQISG ESTSTNVDKP QVTPQSGSYR
651 FTQTTAIKNT PAGNAPSVGT YSAGDTVYYN AKVTANGQTW LRYLSYSGAQ
701 HYVAISGNAA TGNTTSKPVT NSQGAFRFVT TTNIRTAPST RASVVGEYNP 
751 GETVYYNGTV QAEGYTWLRY LSRSGATHYV AKLEG
Figure S1. Protein view (Mascot, Matrix Science) and coverage of the LC/MS spectra of Acm2 isolated from (A) 
Lactobacillus plantarum WCFS1 and (B) the tagE5E6 deletion mutant strain. Detected peptides are shown in red. The 
predicted signal peptide and the AST domain are presented in bold and underlined, respectively [5].
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Figure S2. The nuclear magnetic resonance (NMR) analysis of purified 
LTA and deacylated dealanylated LTA (dd-LTA) from wild-type and 
ΔtagE5E6 mutant. (A) Comparison of 1H NMR spectra of dd-LTA 
from wild-type (upper panel) and ΔtagE5E6 (lower panel). (B) COSY 
(upper panel) and HSQC (lower panel) spectra of purified LTA from 
ΔtagE5E6.
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Abstract 
Lactobacilli are found in diverse environments and are widely applied as probiotic, health-
promoting food supplements. Polysaccharides are ubiquitously present on the cell surface of 
lactobacilli and are considered to contribute to species- and strain-specific probiotic effects that are 
typically observed. The two L. plantarum strains SF2A35B and Lp90 have obvious ropy phenotypes, 
implying high extracellular polysaccharide (EPS) production levels. In this work, we set out to 
identify the genes involved in EPS production in these L. plantarum strains and demonstrate their 
role in EPS production by gene deletion analysis. A model L. plantarum strain WCFS1 and its 
previously constructed derivative that produced reduced levels of EPS were included as a reference. 
The constructed EPS-reduced derivatives were analyzed for the abundance and sugar composition 
of their EPS, revealing cps2-like gene clusters in SF2A35B and Lp90 responsible for major EPS 
productions. Moreover, these mutant strains were tested for phenotypic characteristics that are of 
relevance for their capacity to interact with the host epithelium in the intestinal tract, including 
bacterial surface properties as well as survival under the stress conditions encountered in the 
gastrointestinal tract (acid and bile stress). In addition, TLR2 signaling and immunomodulatory 
capacities of the EPS negative derivatives and their respective wild-type strains were compared, 
revealing strain-specific impacts of EPS on immunomodulatory properties. Taken together, these 
experiments illustrate the importance of EPS in L. plantarum strains as a strain-specific determinant 
in host interaction.
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Introduction
Lactobacilli are lactic acid bacteria (LAB) found in diverse environments ranging from fermented 
food to the human gastrointestinal tract, and are widely applied in the food industry as well as in 
probiotic products [1]. Probiotics are live microorganisms that, when administered in adequate 
amounts, confer a health benefit on the host [2]. The beneficial effects attributed to probiotic 
bacteria are often considered species- and strain-specific and have been proposed to at least 
involve cell-surface components, including peptidoglycan, teichoic acids, (glyco)proteins and 
polysaccharides [3]. 
Polysaccharides are ubiquitously present on the Lactobacillus cell surface [4], and have been assigned 
different nomenclature, including wall polysaccharide (WPS), extracellular polysaccharide (EPS), 
and capsular polysaccharide (CPS), which refers to the mechanism by which the polysaccharide 
molecule is connected to the cell. However, the distinction between these terms remains a matter 
of debate because in many cases the mechanism(s) involved in (covalent) cell-wall linkage are 
unknown, and growth conditions and physiology status of the bacteria can greatly influence the 
localization of surface polysaccharides [4-6]. Therefore, in this work we use the term extracellular 
polysaccharides (EPS) to consider WPS, EPS and CPS combined, irrespective of the linkage type 
to the cell wall. The EPS are mostly heteropolysaccharides formed with repeating oligosaccharide 
units that consist of considerably variable sugar compositions, sugar-linkages and -branching, and 
non-sugar modifications [7, 8], but commonly contain d-glucose, d-galactose and/or L-rhamnose, 
and in some cases N-acetylglucosamine, N-acetylgalacotsamine or glucuronic acid [3]. The 
high EPS diversity is reflected by the variability of the glycosyltransferases in the gene clusters 
involved in EPS biosynthesis [9, 10]. The complexity of EPS structure is exemplified further by 
the observation that one bacterial genome could possess multiple polysaccharide biosynthesis 
encoding gene clusters. As an example, the Lactobacillus plantarum WCFS1 genome encodes 4 CPS 
biosynthesis gene clusters [11, 12]. 
EPS of lactobacilli have been reported to be involved in various biological functions, such as phage 
absorption [13, 14], adhesion to human cells or to other bacteria [15, 16], and immunomodulation 
[17, 18]. Various studies have employed gene deletion mutation of EPS associated genes as a 
strategy to investigate the biological roles of EPS. For example, the deletion of the entire EPS 
gene cluster in Lactobacillus johnsonii NCC533 resulted in loss of bacterial (fuzzy) encapsulation 
and slightly increased gut persistence in a murine model [19]. In addition, deletion of the priming 
glycosyltransferase encoding gene, welE, in the EPS biosynthesis gene cluster of Lactobacillus 
rhamnosus GG strongly reduced the strain’s capacity to produce high-molecular-weight, galactose-
rich polysaccharides while small glucose-rich EPS remains, and resulted in enhanced adhesion to 
mucus and an epithelial cell line [16]. However, the enhanced adhesion did not translate to a better 
gastrointestinal persistence of the welE deletion mutant. A further study found that EPS plays a 
protective role against intestinal antimicrobial and complement factors [20]. In Lactobacillus casei 
Shirota, deletion of part of the WPS encoding gene cluster led to a reduction of high molecule 
weight polysaccharides associated to the bacterial cell surface, and the thermally inactivated mutant 
strain induced higher levels of TNFα, interleukin-12 (IL12), IL10, and IL6 production in mouse 
macrophage and spleen cell lines in vitro. Notably, whereas the wild-type L. casei Shirota strain has 
been reported to suppress lipopolysaccharide-induced IL6 production in mouse macrophage-like 
cells, its WPS deletion derivative lacked this suppressive ability [17]. Mutation analysis of the 4 cps 
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gene clusters in L. plantarum WCFS1 revealed pronounced differential impacts of the mutation of 
the different clusters, illustrated by the differential impact of these mutations on the transcriptome 
profile in the mutant strain, and on the surface glycan composition. Moreover, the differential 
characteristics of the individual, and combined cps gene cluster mutants was also observed in 
their capacity to stimulate TLR2 activation, where cps1 and cps3 deletions did not impact on TLR2 
activation while cps2 and cps4 deletions led to mild but significant TLR2 activation, but mutation 
of 3 or all 4 cps gene clusters induced a strong increase of the TLR2 signaling capacity of the strain 
that also lost most of its surface glycan structure production capacity [12]. 
The work related to the species L. plantarum was performed using the type strain WCFS1, which 
does not produce large amounts of EPS and does not have a ropy phenotype. We found two L. 
plantarum strains SF2A35B and Lp90, by contrast, have an obvious ropy phenotype, implying 
much higher EPS production levels as compared to strain WCFS1. In this work we set out to 
identify the genes involved in EPS production in these L. plantarum strains and demonstrate their 
role in EPS production by mutation analysis. Based on the comparison between the genome of 
SF2A35B and Lp90 and other sequenced L. plantarum strains, both of the ropy strains SF2A35B 
and Lp90 possesses its own unique polysaccharide gene clusters. The gene clusters were deleted 
and the resulting mutants were analyzed for the abundance and sugar composition of their EPS. 
Moreover, these mutant strains were tested for phenotype characteristics that are of relevance for 
their capacity to interact with the host intestinal tract, including bacterial surface properties and 
survival under acid and bile stresses. In addition, TLR2 and immunomodulatory capacities of the 
wild-type and respective mutant strains were compared, illustrating strain specific and varying 
impacts of the removal of the EPS in individual strains of the L. plantarum species. 
Materials and methods
Bacterial strains and culture conditions. Bacterial strains used in this work are listed in Table 
1. Lactobacillus plantarum strains were grown at 37°C in MRS broth (Difco, West Molesey, United 
Kingdom) without aeration. Escherichia coli strain TOP10 (Invitrogen, Bleiswijk, The Netherlands) 
was used as an intermediate cloning host, and was grown at 37°C in TY broth [21] with aeration 
[22]. Solid media were prepared by adding 1.5% (w/v) agar to the broths. Antibiotics were added 
where appropriate and concentrations used for L. plantarum and E. coli strains were 10 μg/ml 
chloramphenicol (Cm), and 30 and 200 μg/ml erythromycin (Ery), respectively. 
DNA manipulations. Plasmids and primers used are listed in Table 2. Standard procedures 
were used for DNA manipulations in E. coli [22]. Plasmid DNA was isolated from E. coli using 
a JETSTAR kit (Genomed GmbH, Bad Oberhausen, Germany). L. plantarum DNA was isolated 
and transformed as described previously [23]. PCR amplifications were performed using hot-
start KOD polymerase (Novagen, Madison, USA). Amplicons were purified using Wizard®SV 
Gel and PCR Clean-Up System (Promega, Leiden, The Netherlands). Restriction endonucleases 
(Fermentas GmbH, St. Leon-Rot, Germany), MSB® Spin PCRapace (Invitek GmbH, Berlin, 
Germany), PCR Master Mix (Promega) and T4 DNA ligase (Invitrogen) were used as specified by 
the manufacturers. 
Construction of cps deletion mutants. The cps deletion mutants were constructed as 
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described previously [24], using a double crossing-over strategy to replace the target cps gene 
cluster by a chloramphenicol resistance cassette (lox66-P32cat-lox71)[24] . In this study, a derivative 
of the mutagenesis vector pNZ5319 [24], designated pNZ5319TAG was used to introduce a 
unique 42-nucleotide tag into chromosome during gene deletion, which can be employed for 
mutant tracking purposes in mixed populations (not relevant for the study presented here). The 
upstream and downstream flanking regions of each cps gene cluster (lpSF_837-853 in SF2A35B 
strain, and lp90_1067-1077 in Lp90 strain) were amplified by PCR using targets-Up-F/R and 
targets-Down-F/R primers, respectively (Table 2). Each amplicon generated was subsequently 
joined by a second PCR to lox66-P32cat-lox71-tag by a splicing by overlap extension strategy [25], 
using targets-Up-F/targets-Down-R primer pairs (Table 2). The resulting PCR products were 
digested with SwaI and Ecl136II, and cloned into similarly digested pNZ5319TAG. The obtained 
mutagenesis plasmids were transformed into L. plantarum strains as described previously [23]. 
The resulting transformants were assessed for a double cross over integration event by selecting 
individual colonies that displayed a Cm resistant and Ery sensitive phenotype. The selected colonies 
were further confirmed by PCR using targets-out-F/R primers (Table 2). For each of the mutant 
constructions a single colony displaying the anticipated phenotype and genotype was selected, 
yielding the mutants NZ3561BCm (ΔlpSF_837-853), and NZ8220Cm (Δlp90_1067-1077). 
Transmission electron microscopy (TEM). The production of EPS in WCFS1, SF2A35B 
and Lp90 was analyzed by TEM. A half milliliter of overnight cultures of L. plantarum strains were 
centrifuged at 12,000 x g for 2 min at 20 °C and resuspended in 100 µl of PBS at pH 7.0 before 
the analysis. For the analysis, electron microscopy grids commercially copper-coated Formvar 
300 holes and carbon (Electron Microscopy Sciences, Hatfield PA) were used. Immediately before 
use, the grids were subjected to an ion discharge for one minute to make the carbon film more 
hydrophilic thus favoring adsorption of the sample. Subsequently, 10 µl of sample was added on the 
grid for 1 min. The excess solution was removed using filter paper, followed by negative staining 
by 2% uranyl acetate for 40 sec. Finally, excess staining agent was removed and the samples were 
observed by transmission electron microscope JEOL JEM1011 stabilized at 100 kV. 
Surface polysaccharide isolation and sugar composition determination. EPS was 
Table 1. Bacterial strains and plasmids used in this study
Strains Characteristicsa Reference
L. plantarum
WCFS1 Single-colony isolate of L. plantarum NCIMB8826. Originally isolated from 
human saliva, UK. 
[11]
SF2A35Bb Isolate from sour cassava, South America; synonym NIZO1839 [57]
Lp90 Isolate from a red must, Italy [58]
NZ3550Cm Cmr; derivative of WCFS1 containing a lox66-P32-cat-lox71-tag2.2 replacement of cps1A-3J (cps1A-3J::lox66-P32-cat-lox71-tag2.2)
[59]
NZ3561BCm Cmr; derivative of SF2A35B containing a lox66-P32-cat-lox71-tag9.3 replacement of lpSF_839-853 ( lpSF_839-853:: lox66-P32-cat-lox71-tag9.3
）
this work
NZ8220Cm Cmr; derivative of Lp90 containing a lox66-P32-cat-lox71-tag10.3 replacement of lp90_1067-1077 (lp90_1067-1077::lox66-P32-cat-lox71-tag10.3)
this work
E. coli
TOP 10 Cloning host; F- mcrA Δ(mrr-hsdRMS-mcrBC) φ80lacZΔM15 ΔlacX74 recA1 
araD139 Δ(ara-leu)7697 galU galK rpsL (StrR) endA1 nupG
Invitrogen
a Cmr , chloramphenicol resistant; Emr, erythromycin resistant
b Putative subspecies argentoratensis
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isolated and analyzed according to previously described methods [12]. L. plantarum strains and 
their mutant derivatives were grown in 50 ml 2 × CDM until late stationary phase. After growth, 
cultures were incubated at 55°C for 1 h, followed by pelleting of the bacterial cells (6000 × 
g, 15 min, room temperature). The supernatants were supplemented with erythromycin and 
lincomycin (10 μg/mL each) to avoid growth during dialysis, which was performed in dialysis 
tubes (molecular weight cutoff of 12–14000 Da, Fisher Scientific, Landsmeer, The Netherlands) 
incubated overnight against running tap water, followed by dialysis for 1 h against deionized water. 
The dialyzed samples were freeze-dried, weighted, and stored at −20°C until further analysis. 
Abundance and sugar compositions of EPS were analyzed as described previously [12]. Freeze-
dried samples were dissolved in eluent (100 mM NaNO3 + 0.02% NaN3), and then were separated 
by Size Exclusion Chromatography (SEC) with refractive index (dRI), UV (280 nm), viscosity and 
MALLS detection (ViscoStar, Wyatt Technologies, Santa Barbara, USA), using columns of TSK gel 
PWXL Guard, TSK gel G6000 PWXL, and TSK gel G5000 PWXL. During SEC, polysaccharide 
peaks were collected and hydrolyzed with 2 M trifluoroacetic acid (TFA) at 120°C for 75min, then 
dried and dissolved in water. The quantitative monosaccharide composition of the polysaccharide 
fractions was analyzed using High Performance Anion Exchange Chromatography with Pulsed 
Table 2. Plasmids and primers used in this study
Plasmids Descriptiona Reference
pNZ5319 Cmr Emr; Mutagenesis vector for gene replacements in L. plantarum [24]
pNZ3561 Cmr Emr; pNZ5319 derivative containing homologous regions up- and 
downstream of lpSF_839-853
this work
pNZ8220 Cmr Emr; pNZ5319 derivative containing homologous regions up- and 
downstream of lp90_1067-1077
this work
Primers Sequenceb Reference
is128 tag-lox66-F3 5’-AAATCTACCGTTCGTATAATGTATG-3’ [60]
is129 tag-lox71-R3 5’-CTCATGCCCGGGCTGTAACCG-3’ [60]
IS169 5’-TTATCATATCCCGAGGACCG-3’ [31]
87 5’-GCCGACTGTACTTTCGGATCC-3’ [24]
CreF 5’-CGATACCGTTTACGAAATTGG-3’ [24]
CreR 5’-CTTGCTCATAAGTAACGGTAC-3’ [24]
EryintF 5’-TCAAATACAGCTTTTAGAACTGG-3’ [24]
EryintR 5’-ATCACAAACAGAATGATGTACC-3’ [24]
lpSF-Up-F 5’-AAATCACCGACCACGTAAGG-3’ this work
lpSF-Up-R 5’-GCATACATTATACGAACGGTAGATTTTGAAGTATGCAAATGTT-
TCGGTTTTGATGTC-3’
this work
lpSF-Down-F 5’-CGGTTACAGCCCGGGCATGAGTGGCATAATGAAGTTCCTT-
TCAGATTTCACAAAGTCC-3’
this work
lpSF-Down-R 5’-GACATGGCAATATTCCACATGAG-3’ this work
lpSF-out-F 5’-GTCCGTACAACCATCTTACC-3’ this work
lpSF-out-R 5’-GCGACAACAAGGTCAAAACC-3’ this work
lp90-Up-F 5’-AGTATCGGGTGCGACCGATG-3’ this work
lp90-Up-R 5‘-GCATACATTATACGAACGGTAGATTTTGCTTGATCCATCAT-
TCACTCTCC-3‘
this work
lp90-Down-F 5’-CGGTTACAGCCCGGGCATGAGTGCACAGTGTTTCCGACT-
GAG-3’
this work
lp90-Down-R 5‘-GCTATCGCCGCTTTACATGC-3‘ this work
lp90-out-F 5’-GCCATAGCTGTACGCTAAAAGG-3’ this work
lp90-out-R 5’-CGGCTTACCATATCTCATCG-3’ this work
a Cmr , chloramphenicol resistant; Emr, erythromycin resistant
b Underlined nucleotides indicate parts of the primers that are complementary to the is128-lox66-F3 and is129-
lox71-R3 primers.
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Amperometric Detection (HPAEC-PAD) with PA-1 column. The monosaccharides were eluted 
isocratically with 16 mM sodium hydroxide followed by the elution of the acid monosaccharides 
starting at 20 min with a linear gradient to 200 mM sodium hydroxide + 500 mM sodium 
acetate in 20 min. Data analysis was performed with Dionex Chromeleon software version 
6.80. Quantitative analyses were carried out using standard solutions of the monosaccharides 
(rhamnose, galactosamine, glucosamine, galactose, glucose, mannose, xylose, galacturonic acid, 
and glucuronic acid) (Sigma-Aldrich, St. Louis, USA).
Zeta potential and hydrophobicity. Overnight cultures were washed twice with 10 ml PBS 
and bacteria were resuspended in PBS at an optical density at 600 nm (OD600) of 1. Zeta potential 
was measured at 20°C using ZetaSizer cuvettes DST1070 (Malvern Instruments, Malvern, UK) in 
a Zetasizer nano series (Malvern Instruments). 
Surface hydrophobicity was determined using microbial adhesion to solvents (MATS) method 
[26]. Briefly, overnight cultures of L. plantarum strains were harvested by centrifugation 5,000 x 
g, 10 min, washed twice and resuspended to OD600 of 1 (A0) in PBS. 5 ml of bacterial suspension 
was mixed by 2 min vortexing with 2 ml petroleum ether (the solvent) in a 10 ml glass tube. 
The tubes were incubated statically for 15 min at room temperature to allow phase separation of 
the mixture. The aqueous phase was collected and its OD600 was measured (A1). The cell surface 
hydrophobicity (CSH) was presented as the percentage of microbial retained in the solvent, and 
calculated as (1 − A1/ A0) × 100.
In vitro Caco-2 adhesion assay. For adhesion tests, Caco-2 cells were seeded in 96-well tissue 
culture plates (Falcon Microtest, Becton Dickinson, NJ, USA) at a concentration of 1.6×104 cells 
per well and cultured for 12-15 days, as previously described [27]. The L. plantarum cells were 
harvested at late stationary phase, pelleted by centrifugation, and resuspended in antibiotic-free 
DMEM. The obtained monolayers (about 5.0×104 cells/well as counted in a Bürker chamber) 
of differentiated cells that mimic small intestine mature enterocytes [28, 29] were overlaid with 
stationary phase cells of L. plantarum (OD600 of 5.0), at a multiplicity of exposure (MOE) of 
1:1000, Caco-2 cells to bacteria.
After 1 h of incubation at 37 °C under 5% CO2 atmosphere, adhesion determination-wells were 
washed three times with PBS, pH 7.4 to remove unbound bacteria. No washing was performed 
on control wells, with the aim to recover both adherent and not adherent bacteria. Caco-2 cells 
and adherent bacteria were then detached by trypsin-EDTA 0.05% (GIBCO) for 10 min at 37 °C 
and resuspended in sterile PBS (GIBCO). Serial dilutions of samples were plated onto MRS agar 
plates to determine the number of cell-bound bacteria (viable counts) expressed as CFUs, which 
was corrected by the measurement of total bacterial load obtained from the unwashed control 
wells (i.e. both adherent and not adherent bacteria). All adhesion experiments were performed 
in triplicate.
Biofilm formation. The ability of L. plantarum strains to adhere to a glass surface, thereby 
forming a biofilm, was assessed according to [30], with minor modifications. Briefly, 5 ml of MRS 
broth were inoculated with 2% (v/v) of overnight cultures of L. plantarum strains and incubated 
for 1, 2 and 7 days at 37 °C, in an orbital shaker at 200 rpm. Residues were washed twice with 
distilled water, air-dried and then it was stained with crystal violet solution (5 g/L, 0.5% w/v). 
The biofilm ring was solubilized with acetic acid (30% v/v) and optical density was measured at 
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570 nm. Each experiment was performed in triplicate. 
In vitro GI tract survival assay. The assay was performed as described previously [31]. 
Briefly, stationary-phase bacterial cultures were harvested, and treated 60 min in stomach-
like environment at pH 2.4, followed by neutralization and 60 min in intestine-like condition. 
Samples were collected before treatments, and after stomach-like and intestine-like conditions to 
determine colony forming unit (CFU) counting using spot-plating [32]. The survival results were 
presented as relative survival, which is the log-scale CFU per volume, divided (normalized) by the 
log-scale CFU at the start of the experiment. 
Toll-like receptor (TLR) assay. The assay was performed as described previously [12]. 
Briefly, human embryonic kidney (HEK)-293 TLR reporter cell lines expressing human TLR1/2, 
TLR2/2, TLR2/6 or TLR4, and pNIFTY, an NF-κB luciferase reporter construct (Invivogen, 
Toulouse, France) [33], were used. The HEK-293 reporter cell lines were seeded at 6 × 104 cells 
per well in 96-well plates and incubated overnight under standard culture conditions. Cells were 
then stimulated with 2 independently grown bacterial cultures of the L. plantarum wild-type strains 
(WCFS1, SF2A35B, and Lp90) or their cps deletion mutants (NZ3550Cm, NZ3561BCm, and 
NZ8220Cm) at a MOE of 1:10, HEK cell to bacteria, while the TLR1_2 agonist Pam3CSK4 (5 
μg/mL, Invivogen) and TLR2_6 agonist Pam2CSK4 (5 μg/mL, Invivogen) was used as positive 
control and PBS served as the negative control. Following a 6 hr incubation period, the medium 
was replaced with Bright-Glo™ (Promega Benelux BV, Leiden, The Netherlands), the plate was 
vortexed for 5 min, and the luminescence was measured using a Spectramax M5 (Molecular 
Devices, Sunnyvale, USA).   
Peripheral blood mononuclear cells (PBMC) assay. The assay was performed as described 
previously [34] and was approved by Wageningen University Ethical Committee and was performed 
according to the principles of the Declaration of Helsinki. Peripheral blood of healthy donors 
was from the Sanquin Blood Bank, Nijmegen, The Netherlands. PBMCs were separated from the 
blood using Ficoll-Paque Plus gradient centrifugation according to the manufacturer’s description 
(Amersham biosciences, Uppsala, Sweden). The mononuclear cells were collected, washed in 
Iscove’s Modified Dulbecco’s Medium (IMDM) + glutamax (Invitrogen, Breda, The Netherlands) 
and adjusted to 1 × 106 cells/ml in IMDM + glutamax supplemented with penicillin (100 U/ml) 
(Invitrogen), streptomycin (100 μg/ml) (Invitrogen), and 1% human AB serum (Lonza, Basel, 
Switzerland). PBMCs (1 × 106 cells/well) were seeded a night prior to the experiment in 48-well 
tissue culture plates and incubate at 37°C in 5% CO2. Bacteria from late-stationary phase were 
added to PBMCs at a MOE of 1:10, PBMC to bacteria. PBMCs from 3 different donors were used 
in the assay. Following 24 hr incubation at 37°C in 5% CO2, culture supernatants were collected 
and stored at -20°C until cytokine analysis. Cytokines were measured using a FACS CantoII flow 
cytometer (BD Biosciences, New Jersey, USA) and BD Cytometric Bead Array Flexsets (BD 
Biosciences) for interleukin (IL)10 and IL12p70 (henceforth referred to as IL12), TNFα, IL6, 
IL1β, and IL8 according to the manufacturer’s procedures. Concentrations of cytokines were 
calculated based on the standard curves in the BD Biosciences FCAP software. 
Statistical analysis. All analyses were performed in triplicate except zeta potential measurements 
were done in quadruple. The One-way ANOVA followed by Tukey’s multiple comparison test 
was used to compare the means of adhesion, biofilm formation, and TLR2 activations between 
strains. The cytokine productions in PBMC assays were transformed to Log values to compare the 
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stimulation between wild-type and mutant strains using the paired t test with respects to individual 
donors. The differences in surface properties among strains were determined by Kruskal-Wallis 
analysis of variance (ANOVA) on Ranks and Dunn’s test for multiple comparisons. GraphPad 
Prism 5 software (GraphPad Software, San Diego, CA) was used for all determinations, and a P 
value of <0.05 was considered significant.  
Result 
Identification of genes responsible for the ropy phenotype of SF2A35B and Lp90
Under normal laboratory conditions of growth, the strains SF2A35B and Lp90 display an obvious 
ropy-phenotype in comparison to the model strain WCFS1 (Figure S1), which implies a substantially 
higher level of surface polysaccharide production in these strains as compared to WCFS1. To 
explore the gene cluster(s) that is (are) responsible for this ropy phenotype, the genomes of both 
strains were sequenced [35] and the genes that could be related to capsular polysaccharide (CPS) 
biosynthesis were annotated in detail. The genomes of the SF2A35B and Lp90 strains encode 3 
and 4 recognizable and apparently complete cps clusters, respectively. Comparison of the genomes 
of the ropy strains with that of strain WCFS1, indicates that the polysaccharide synthesis cluster 
assigned cps cluster 4 in strain WCFS1 is most conserved among the L. plantarum strains (data not 
shown), and particularly the gene cluster assigned cps cluster 2 in strain WCFS1 appears to be 
variable, and contains genes that are present only in the ropy strains SF2A35B and Lp90 (Figure 
1). In addition, strain SF2A35B appears to lack the entire cps cluster 1 (nomenclature according to 
strain WCFS1 genome) but contains 5 unique genes within its cps cluster 2, which were assigned 
the gene identifiers lpSF_846, lpSF_847, and lpSF_849-851. While both LpSF_847 and LpSF_850 
Figure 1. Genetic organization of cps2 gene cluster of L. plantarum WCFS1 across other strains of this species 
for which the genome sequence was published [11, 35, 61-63]. The grey arrows indicate conserved genes, 
while orange and green colored arrows indicate different sets of genes uniquely found in the SF2A35B and 
Lp90 strains, respectively. Grey colored connecting blocks indicate regions of high sequence conservation 
identified in the genomes of the indicated strains
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are hypothetical proteins with unknown function, the other 3 proteins have functions related to 
polysaccharide biosynthesis, including a putative polysaccharide polymerase protein (LpSF_846), 
and two glycosyltransferases (LpSF_849 and LpSF_851). Analogously, also the cps cluster 2 of strain 
Lp90 encompassed 4 genes that are specific for that strain, i.e., lp90_1073-1075 and lp90_1077. 
Lp90_1073 is annotated as a hypothetical membrane protein. Moreover, Lp90_1074 is a family 
2 glycosyltransferase, Lp90_1075 is a polysaccharide pyruvyl transferase, and Lp90_1077 is a 
putative mannosyltransferase, and thus are possible involved in polysaccharide biosynthesis. 
Thereby, the cps 2 cluster assigned in strain WCFS1 appears to be highly diverse among different 
strains of the species L. plantarum, which is corroborated by the observation that the genes 
specifically present in the cps clusters of strains SF2A35B and Lp90 are not orthologs of each other 
and each represent the typical cps gene cluster mosaic-like reorganizations. 
Deletion of the SF2A35B and Lp90 unique cps clusters abolishes the ropy phenotype
In order to investigate whether the unique cps cluster 2 associated gene sets are responsible for 
the ropy phenotype in strains SF2A35B and Lp90, the cps clusters containing these genes were 
deleted using a double cross-over gene-replacement strategy, resulting in the strains NZ3561BCm 
(ΔlpSF_837-853 derivative of SF2A35B) and NZ8220Cm (Δlp90_1067-1077 derivative of Lp90). 
Both cps cluster mutations led to a loss of the ropy phenotype. Moreover, transmission electron 
micrographs clearly established that the deletion mutants constructed produce much less surface-
associated polysaccharide-like structures (grey net-like substances) around the cells as compared 
to their parental strains (Figure 2). Taken together these data illustrate that the unique cps clusters 
found in SF2A35B and Lp90 are responsible for the ropy phenotype and encode for surface 
polysaccharide production, both of which are much less apparent in cps cluster mutant derivatives.
Figure 2. TEM analysis of L. plantarum strains and their deletion mutant derivatives. L. plantarum strains 
were negatively stained with 2% uranyl acetate to visualize surface polysaccharides that are visible as the 
grey, net-like substances surrounding the cells, and were directly observed using TEM without section. 
The upper panel shows the overview (scale bar is 5 µm) and the lower panel shows a higher magnification 
(scale bar is 1 µm). 
Abundance and sugar compositions of EPS diverse in three L. plantarum and their cps 
deletion mutants produces much less EPS   
The ropy strains, SF2A35B and Lp90, and their cps2-like gene cluster deletion mutants, NZ3561BCm 
and NZ8220Cm, were further studied for the effect of EPS in relation to probiotic properties. The 
model strain L. plantarum WCFS1 and its cps deletion mutant NZ3550Cm (∆cps1A-3J) were also 
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included as references. First, to confirm the reduction in EPS production in the deletion mutants, 
the polysaccharides were isolated for quantification and determination of the sugar compositions 
by High Performance Anion Exchange Chromatography with Pulsed Amperometric Detection 
(HPAEC-PAD). SF2A35B and Lp90 both produce high amounts of EPS, which are approximately 
15- and 20-fold higher than EPS isolated from WCFS1 strain, respectively (Table 3). Besides a large 
difference in abundance, the sugar compositions of EPS also diverse in 3 L. plantarum. The EPS 
from WCFS1 composed of high percentages of glucose while the EPS from SF2A35B composed 
of high percentages of galactose and galactosamine but low in glucose and glucosamine. The EPS 
from Lp90 consists of similar percentages of glucosamine, galactose, galactosamine and rhamnose 
but with a low percentage of glucose (Table 3). Moreover, the EPS isolated from WCFS1 has a 
molecular weight larger than 5500 kDa; the EPS from SF2A35B is about 500 kDa, while EPS of 
Lp90 is about 280 kDa, the smallest in molecular weight (Table 3).   
The cps deletion mutants of the ropy strains produces much less polysaccharides around the cells. 
The deletion of the cps2-like cluster in SF2A35B and Lp90 resulted in more than 95% reduction 
in total amount of EPS, and yielding an overall amount of EPS that is comparable to that isolated 
from the non-ropy WCFS1. The reduction of EPS production in the mutants was confirmed by 
microscopy observations that establish much less surface associated polymer structures in the 
mutants as compared to their cognate wild-types. Unfortunately, the EPS levels in cps deletion 
mutants of SF2A35B and Lp90 appeared too low to determine the sugar compositions. The CPS-
negative derivative of WCFS1 produced a similar amount of EPS as the wild type; and the sugar 
composition percentages are also comparable between the two strains. However, the molecular 
weight is 60%-reduced in cps mutant, suggesting the impact of cps deletion in polysaccharide 
structures (Table 3).  
These results clearly establish that cps 2-like cluster in both SF2A35B and Lp90 plays a dominant 
role in EPS production of both strains, and these clusters support a substantially higher 
polysaccharide production as compared to its related gene cluster in strain WCFS1 (cps2-gene 
cluster). Variations in abundance, glycan composition, and molecular weight support the typical 
mosaic-like genetic organization of the cps clusters, which are apparently subject to high frequency 
evolutionary adaptation [36].
Table 3. The sugar composition of surface polysaccharides isolated from L. plantarum strains and their cps 
cluster deletion derivatives
Sugar (% of total 
sugars) L. plantarum strains
WCFS1 NZ3550Cm SF2A35B NZ3561BCm Lp90 NZ8220Cm
Glucose 65.8 69.2 2.0 n.d. 3.9 n.d.
Glucosamine 21.7 24.7 0.1 n.d. 24.5 n.d.
Galactose 12.5 6.1 66.6 n.d. 22.2 n.d.
Galactosamine n.d. n.d. 31.3 n.d. 24.4 n.d.
Rhamnose n.d. n.d. n.d. n.d. 25.0 n.d.
Mw (kDa) 5652 3606.1 506.2 n.d. 280.6 n.d.
Total polysaccharide 
isolated (mg/L) 4.0 7.0 59.5 1.1 85.7 2.6
*n.d; ‘not detected’
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Impact of the cps2-like gene cluster on surface physicochemical properties 
Surface physicochemical properties are important for bacterial physiology and interaction with 
their environment [37]. The influence of deletion of the cps2-like gene cluster in terms of surface 
charge and hydrophobicity were investigated. The surface charges were assessed by zeta potential 
measurement, which determines the mobility of cells in an electric field which is determined by 
cell-surface charge. SF2A35B strain is the most negatively-charged among the wild-type strains 
tested, whereas WCFS1 and Lp90 have moderate negative surface charge (Figure 3A). Comparative 
analysis of the cps-deletion mutants and their corresponding wild-type strains, revealed quite 
distinct consequences in the 3 strains. Deletion of cps-2 associated functions in SF2A35B led to 
a significant reduction of negative cell-surface charge. Conversely, deletion of the cps1-3 clusters 
in WCFS1 led to an increased negative surface charge, whereas the mutation of cps-2 associated 
functions in Lp90 did not significantly affect the surface charge in this strain (Figure 3A).
Cell surface hydrophobicity is another physicochemical feature of the cell surface that can be 
readily determined. Although the hydrophobicity of the different L. plantarum strains were 
somewhat variable, there was no significant difference observed between the 3 wild type strains 
tested (Figure 3B). Mutation of the cps-2 like clusters in the 3 genetic backgrounds only elicited 
a significant affect in surface hydrophobicity in strain SF2A35B where the deletion of the cps-
2 associated genes led to a strong increase in surface hydrophobicity (Figure 3B). Notably, the 
analogous mutations in the WCFS1 and Lp90 genetic background did not appear to influence the 
surface hydrophobicity in a significant manner. 
Taken together, these measurements underpin the impact of EPS on physicochemical surface 
properties of bacteria. However, the impact of cps-mutation on surface charge and hydrophobicity 
appears to strongly vary between strains. 
Impact of the cps2-like gene cluster on adhesion and biofilm formation 
Adhesion and colonization are considered important aspects of probiotics to deliver their health 
beneficial functions, such as pathogen exclusion and immunomodulation [38, 39]. We further 
investigated the impact of cps deletion on adhesion and biofilm formation of the same set of L. 
Figure 3. (A) Zeta potential and (B) cell surface hydrophobicity (CSH) of L. plantarum strains and their 
deletion mutant derivatives. All individual data points are shown (n = 4 for zeta potential and n = 3 for 
hydrophobicity measurements) as well as the median (bar). Closed symbols represent wild-type strains, 
while open symbols represent their cps deletion derivatives. Statistical significance of observed differences 
was determined by applying Kruskal-Wallis test; P ≤ 0.05 (overall ANOVA); ***, P ≤ 0.001; *, P ≤ 0.05. 
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plantarum strains. The adhesive capacity was tested in vitro using human intestinal cell line Caco-2. 
Among the 3 tested L. plantarum strains, WCFS1 has higher adhesion to the intestinal cells while 
SF2A35B and Lp90 strains have similar level of adhesion, which is about 2-fold lower than that 
of WCFS1 (Figure 4A). The impact of the cps-2 like gene cluster on adhesion was investigated 
by comparing the cps mutant with the corresponding parental strains. The cps mutant of Lp90, 
NZ8820Cm strain has improved adhesion to Caco-2 comparing to Lp90 wild-type strain (Figure 
4A), suggesting the EPS hinders the adhesion of Lp90 to Caco-2 cells. On the other hand, the 
deletion of cps clusters WCFS1 and SF2A35B strains have no significant influence on adhesion 
(Figure 4A), which again demonstrates the impact of the cps gene clusters on adhesion follows 
a strain-dependent manner. The biofilm formation was monitored for 7 days. The cps deletion 
mutant of Lp90, NZ8220Cm strain, has a clear increases in biofilm formation (Figure 4B); the 
difference is largest during the first 2 days (Figure S2). In cases of the strain WCFS1 and SF2A35B, 
the cps deletion appears to only have a transient effect on biofilm formation, illustrated by the 
enhanced biofilm formation only on day 2 and day 1, respectively (Figure S2), and followed 
by decreased biofilms of the mutant. Nevertheless, the biofilm formation in these cases mostly 
appeared unaffected. Overall, the cps deletion has the clearly the greatest impact on adhesion 
and biofilm formation in the Lp90 background, and impacts much less profoundly on these 
characteristics of the other two strains. 
Reduction of EPS does not alter gastrointestinal survival
The capability to survive digestive tract passage is an important characteristic for probiotic bacteria 
[31, 40]. To test whether the reduction in EPS impacts on the survival of the SF2A35B and Lp90 
strains under gastrointestinal (GI) conditions, an in vitro GI survival assay was performed, which 
was shown to qualitatively reflect the actual in vivo persistence in the human intestine [31]. This 
assay monitors the relative survival of bacteria under conditions that mimic those encountered 
Figure 4. (A) adhesion to Caco-2 cells and (B) biofilm formation on day 7 of L. plantarum strains and their 
cps mutant derivatives. Adhesion to Caco-2 of L. plantarum strains was performed in triplicate and done by 
applying washed L. plantarum cells to Caco-2 at MOE 1:1000, following by plating to determine the CFU of 
adherent and non-adherent cells. Biofilm formation was monitored for 7 days and performed in triplicates. 
The biofilm was washed, air-dried, and then stained with a crystal violet solution. The quantification of the 
biofilm formation was done by solubilizing the biofilm in acetic acid and measuring the optical density at 
570 nm. All data points are shown and bar indicates median. Closed symbols represent wild-type strains, 
while open symbols represent cps deletion mutants. Statistically significant differences between wild-type 
and corresponding cps deletion mutant, as well as between the three wild-type strains, in adhesion and 
biofilm formation were determined by one-way ANOVA followed by Tukey’s multiple comparison; P ≤ 
0.001 (overall ANOVA); ***, P ≤ 0.001; **, P ≤ 0.01; * P ≤ 0.05.
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in the stomach, including acid pH and enzyme exposure, followed by those resembling the small 
intestine, i.e., neutral pH, exposure to pancreatic digestive enzymes, and bile [31]. Comparative 
evaluation of survival characteristics of the strains revealed no difference in GI survival between 
cps deletion mutants and their parental wild-type (Figure 5), suggesting the reduction of EPS does 
not alter the survival under in vitro GI stresses. However, the GI survival is significantly different 
for the 3 wild-type L. plantarum strains (Figure 5). Strain SF2A35B (and its corresponding cps 
mutant) display the poorest survival among the three strains, and is approximately a 1000-fold 
more sensitive for the stomach mimicking conditions as compared to WCFS1, which corroborates 
previous results reported by van Bokhorst-van de Veen et al. [41]. The Lp90 strain displays 
approximately equal survival characteristics as compared to strain WCFS1 (Figure 5) and thereby 
classifies among the better surviving strains of L. plantarum [41]. Next to the strain specific survival 
Figure 5. Relative survival of L. plantarum strains and the deletion mutant derivatives during an in vitro 
gastrointestinal assay. The survival was measured in 3 independent assays, each using triplicate enumerations 
for CFU. Data shown are means ± standard deviations. Statistical differences were determine by one-way 
ANOVA followed by Tukey’s multiple comparison correction. 
Figure 6. Effects of L. plantarum strains and the deletion mutant derivatives on TLR1_2 (A) and TLR2_6 (B) 
signaling using TLR-expressing HEK cell lines, containing a NF-κB responsive luciferase reporter system. 
Measurements were performed in triplicate and are presented as Log luminescence units, and individually 
displayed (n=3) and the bar indicates the median. PBS serves as negative control, and Pam3CysSK4 and 
Pam2CysSK4 are the positive stimulant of TLR1_2 and TLR2_6 activation, respectively. Data comparison 
of the wild-type strains and their corresponding cps deletion derivatives as well as the 3 wild-type strains 
were tested for significant differences using one-way ANOVA followed by Tukey’s multiple comparison 
correction and significant differences are indicated; ***, P ≤ 0.001; **, P ≤ 0.01; *, P ≤ 0.05.
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capacities, these experiments clearly establish that the intrinsic capacity to produce EPS does not 
contribute to survival under GI-tract mimicking conditions. 
Deletion of cps gene clusters alters TLR2 signaling in WCFS1 and SF2A35B strains
The effect of cps gene clusters deletion of WCFS1, SF2A35B, and Lp90 strains on host cell 
signaling was investigated using an established TLR2 signaling assay [12] that employs HEK-
293 reporter cell lines. HEK-293 reporter cells expressing TLR4 were employed as a negative 
control to illustrate the signaling is TLR2 specific (Figure S3B). The signaling of TLR1_2, TLR2_6 
(Figure 6A and 6B, respectively), and TLR2 (Figure S3A) were determined and displayed as Log 
values of bioluminescence units, and the experiments were performed in triplicate. The results 
obtained from the 3 TLR reporter cell lines are consistent. The wild-type L. plantarum strains 
elicited different TLR2 mediated signaling intensities, and strain SF2A35B showed consistently 
the lowest signaling among the three strains tested (Figure 6). The cps deletion derivatives of 
WCFS1 and SF2A35B displayed approximately 3-fold increased TLR1_2 and TLR2_6 signaling 
as compared to their respective wild-type strains (Figure 6), implying that removal of EPS led to 
more effective exposure of microorganism-associated molecular patterns (MAMPs) molecules 
that are recognized by TLR2. Notably, deletion of cps2-like gene cluster in the SF2A35B strain’s 
background (strain NZ3561BCm) led to levels of TLR2 signaling are resembling those of the 
WCFS1 strain (Figure 6). In contrast, cps deletion in the Lp90 strain did not affect TLR2 mediated 
signaling and both wild type and cps derivative strains stimulate a moderate TLR2 signaling as 
compared to the other strains (Figure 6). The relative NF-κB pathway activation measured in 
the three TLR2 expressing reporter cell lines (TLR1_2, TLR2_6, and TLR2) were very similar, 
suggesting that the WCFS1 and SF2A35B strains possess MAMPs, which can interact with the 3 
receptors. These MAMPs could be undistinguishably recognized by TLR2, TLR1_2 and TLR2_6 
or the TLR2-, TLR1_2-, and TLR2_6-specific MAMPs are present in a similar amount in WCFS1 
and the SF2A35B strain (Figure 6 and S3A). Taken together, although both SF2A35B and Lp90 
produce large amounts of EPS, their influence on human TLR2 signaling is not the same in these 
two strains, suggesting that the possible TLR2-ligand shielding effect of EPS is not generic and 
appears strain- or polysaccharide-specific. 
The cps gene cluster deletions alter cytokine productions of PBMC
We further explored the impact of cps gene cluster deletions on general immune responses 
using cytokine production by human peripheral blood mononuclear cells (PBMCs) following 
stimulation with the different bacterial strains. These experiments clearly illustrate the strain-
dependent impact of EPS removal on the immunomodulation of different L. plantarum strains: 
in strain WCFS1, EPS removal results in slightly more anti-inflammatory cytokine profiles, by 
reducing the stimulation of IL12 and/or by elevating the induction of IL10 in some donors (Donor 
2, Figure 7A); in SF2A35B, EPS removal increased the general immune-stimulations regardless 
of pro- or anti-inflammatory responses (Figure 7B); in Lp90, the EPS has the least pronounced 
influence on immunomodulatory properties of the strain (Figure 7C). Taken together, besides the 
role of EPS in modulation of TLR-signaling capacity, these surface molecules also impact on the 
bacterial capacity to elicit a general immune response. Moreover, analogous to what was observed 
for TLR-signaling the impact of EPS interference by cps mutation appears to be strain specific, and 
may play a prominent role in strain-specific immunomodulatory properties.
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Discussion 
The protective nature as well as the relevance for virulence made EPS a target for extensive 
researches in pathogenic bacteria. EPS can form a physical barrier for pathogens to obstruct anti-
microbial substances [42, 43]. The capsule-forming polysaccharides in pathogenic bacteria are often 
immune-inert and provide a strategy for the bacteria to escape from the host immune defenses 
[42]; therefore, EPS is often a determinant of pathogenicity. Furthermore, the EPS exhibits large 
diversity, even within in one species, which is the basis for the determination of serogroups/
serotypes [44]. For example, over 90 serotypes of Streptococcus pneumoniae have been identified 
based on the CPS structures [44, 45]. For some species, such as Vibrio cholera and Escherichia coli, 
only certain serotypes are disease-causing [44]. Overall, although the production of EPS is not 
essential under laboratory settings, EPS of pathogens is a key determinant for surviving in natural 
habitats as well as for different life-styles, i.e. (lack of) virulence. [42, 44].
In contrast to pathogens, EPS has been studied to a much less extent in probiotic bacteria such 
as lactobacilli. Although EPS production, composition, the genes involved in EPS biosynthesis, 
and the biological functions of EPS have been reported, so far less attention has been paid to 
EPS as a determinant for strain-specific features of probiotics. The probiotic function is conveyed 
through probiotic-host interactions, which are affected by many factors including bacterial surface 
physicochemical (charge and hydrophobicity), adhesion, and immunomodulatory properties. The 
surface charges of Gram-positive bacteria arise from various components, e.g., ionized phosphate, 
Figure 7. Comparison of immunomodulatory effect of L. plantarum strains and their cps deletion derivatives, 
(A) NZ3550Cm/WCFS1, (B) NZ3561BCm/SF2A35B, and (C) NZ8220Cm/Lp90, in the production of 
inflammation-related cytokines by PBMC (n=3 donors). The results from donor 1, 2, and 3 were shown 
as blue-, red-, and green-line, respectively. The productions of pro-inflammatory cytokines (shaded red) 
IL12p70, TNFα, IL1β, IL8 and IL6  and anti-inflammatory cytokine IL10 (shaded blue) are presented as 
fold changes in cytokines productions stimulated by the cps deletion mutants verse parental wild type L. 
plantarum strains. Significant differences between cytokine levels induced by wild-type strains and mutants 
(paired t-test) are indicated; *, P ≤ 0.05; **, P ≤ 0.01. 
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amino, and carboxylate groups of surface polymers; mainly teichoic acids, but also proteins 
and polysaccharides [46]. Notably, our sugar composition analysis is not designed to detect the 
presence of charged glycans, such as glucuronic and galacturonic acids, in EPS isolated from the 3 
L. plantarum strains (Table 3), suggesting the effect of EPS on surface charges may result in more 
exposure of other charged molecules, most likely teichoic acids, on the bacterial cell surface, 
which may be reflected in the increased zeta potential measurement observed in the mutant 
relative to the parental strain (Figure 3A). Additionally, the deletion of the cps gene clusters in 
strain WCFS1 has previously been shown to have global effects on gene expression in this strain, 
including altered expression levels of genes encoding extracellular proteins and teichoic acid 
decoration [12]. These transcriptional changes may alter surface molecules and thereby contribute 
to the changes in surface charges.
Adhesion is an important feature for appropriate persistence the in human gut and delivery of 
probiotics to exert their health-promoting effects [5, 47]. There is conflicting data in literature 
whether there is a correlation between ability to adhere to host mucosal tissues and surface 
hydrophobicity [48, 49] or not [50, 51]. In our experiments we could not correlate hydrophobicity 
and cell-adhesion, e.g., cps deletion in SF2A35B increased hydrophobicity but did not affect 
adhesion to Caco-2 (Figure 3B and 4A). Moreover, cps deletion in strain Lp90 did not significantly 
impact on hydrophobicity and if anything appeared to slightly reduce hydrophobicity in this strain 
background, whereas it drastically increased the capacity to adhere to Caco2 cells (Figure 3B and 
4A). The latter finding may imply that adhesion to Caco-2 of Lp90 is mediated by specific ligand 
receptor interaction rather than by generic hydrophobic interactions, and that the ligand-receptor 
interactions are shielded or prevented by the large amounts of surface polysaccharides produced 
in this strain. To confirm these more specific interactions between this bacterial strain and these 
epithelial cells actually occur would require further study, but may reveal specific adhesion factors 
that are of interest in the field of host-microbe interactions.  
Immunomodulation is one important mechanism underlying the proposed health-beneficial 
effects of probiotic bacteria [52, 53]. EPS have been suggested to affect the immune responses 
of lactobacilli. For example, the EPS-deficient mutant of L. casei Shirota stimulates more pro-
inflammatory cytokine production in mouse macrophages and spleen cells than the parental strain 
[17]. Ghadimi et al. also suggested that the presence of genes to synthetize polysaccharide might 
potentially modulate the immunomodulatory property of Lactobacillus fermentum strains toward 
Th1-inducing cytokine secretion in PBMCs, while the strain lacks the genes led to Th1/Th2-
suppressing cytokine productions  [18]. Interestingly, L. plantarum strain SF2A35B was shown 
previously to elicit very limited immune responses in PBMCs as well as blood-monocyte derived 
dendritic cells [34, 54]. The observation that this phenotypic trait is combined with the strain’s 
ropy phenotype, could imply that the high level polysaccharide production by this strain impacts 
on its immunomodulatory capacity, e.g., by shielding specific cell envelope associated signaling 
molecules thereby suppressing its immunomodulatory stimulation. The shielding effect of EPS 
has been reported also in L. plantarum WCFS1 [12] and L. rhamnosus GG [20]; we confirmed this 
observation in WCFS1 with the cps deletion mutant, NZ3550Cm, which stimulates higher TLR2 
signaling  than wild type strain (Figure 7). The data presented here appear to be at least partially 
in agreement with this proposed role of EPS, in the sense that the SF2A35B strain stimulates 
low TLR2 signaling (Figure 6) and induces the production of low amounts of IL10 and IL12 in 
PBMCs as compared to the WCFS1 strain (Figure S5A and B, respectively) [34]. One of these 
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earlier studies also reported induced low amounts of IL10 and IL12 in PBMCs stimulated with 
SF2A35B compared to those stimulated by other L. plantarum strains, including WCFS1 [34], 
which has been suggested as an indicative marker for the prediction of in vivo inflammation-
suppressive effects of different probiotics in a mouse colitis model [55]. However, the PBMC 
stimulation data obtained here do not corroborate this finding, since the IL10/IL12 ratio elicited 
in PBMCs was not significantly different after stimulation with either WCFS1 or SF2A35B, which 
is in agreement with a previous study [34]. In addition, the higher TLR2-activating NZ3550Cm, 
however, stimulated significantly lower productions of IL12, TNFα and IL1β in the PBMC assay 
as compared to WCFS1 (Figure 7 and S3ABD). These observations clearly establish that although 
the simplified assay models like the HEK-TLR reporter cell systems may provide very relevant 
information related to receptor specific signaling capacities, their predictive value in relation 
to immune-cell stimulation and cytokine production profiles elicited in immune cells is quite 
limited. The complexity of immune cell modulation, which is driven by a plethora of different 
input signals that are translated by highly integrative signal transduction pathways into cellular 
response patterns are not appropriately understood to adequately predict the role and hierarchical 
importance of a single receptor stimulation.   
We demonstrated in this work that EPS is an important surface molecule influencing in a strain-
specific manner on many aspects important for probiotic-host interaction, including surface 
properties, adhesion and biofilm formation, and immunomodulation. The strain-dependent effects 
of EPS are in good agreement with the previously reported notion that structural differences in 
EPS are a key determinant of strain specificity in pathogens [56]. Some of the measurements 
appear to be in agreement with the postulated role of surface polysaccharide as a shielding layer 
for cells, but such shielding function may not be valid for all strains, and specific bacterial adhesins 
and other surface molecules may influence the shielding role of EPS. Moreover, EPS of bacteria 
may by themselves have specific (yet undefined) interactions with host cells, for example through 
interaction with C-type lectin receptors (CLRs), which is a class of pattern recognition receptors 
(PRRs) that recognize specific glycan moieties by means of their lectin domains. Although the 
human genome encodes many CLRs, only very limited information is available for their ligand 
recognition specificity or their precise role in signaling and immunomodulation. Overall, what is 
becoming clear is that EPS, in combination with other cell envelope components, can contribute 
to the strain-specific interaction with the host mucosal surfaces, which may likely be underlying 
probiotic mechanisms of action. Further studies on the diversity and complexity in the structure 
of EPS as well as on the identification specific lectin receptors of immune cells, which interact 
with polysaccharides, are essential to understand this strain-dependence at the molecular level. 
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Supplemental Material
Figure S1. Ropy phenotype of (A) SF2A35B and (B) Lp90 strains. The strains were cultured on MRS agar plate. 
Figure S2. Biofilm formation of L. plantarum strains and their cps mutant derivatives, showing in (A) OD values and 
in (B) pictures of biofilm. Biofilm formation was measured on day 1, day 2 and day 7 in triplicates. In panel (A), 
the biofilm formation was shown as mean ± SD, with open, hatched, and black bars represent day 1, day 2, and 
day 7 OD measurements, respectively. Statistically significant differences between wild-type and corresponding cps 
deletion mutant, as well as between the three wild-type strains, were determined by one-way ANOVA followed by 
Tukey’s multiple comparison; P ≤ 0.001 (overall ANOVA); ***, P ≤ 0.001; * P ≤ 0.05.
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Figure S3. Effects of L. plantarum strains and the deletion mutant derivatives on host TLR signaling presented as Log 
luminescence units using (A) TLR2-expressing and (B) TLR4-expression HEK reporter cell lines. All data points 
are shown and bar indicates median (n=3). PBS serves as negative control while Pam3CysSK4 and LPS are the 
positive stimulants of TLR2 and TLR4 activation, respectively. Differences between wild-type and corresponding 
cps deletion mutant as well as between 3 wild-type strains were compared. The statistical differences were 
determine by one-way ANOVA followed by Tukey’s multiple comparison. P ≤ 0.05 (overall ANOVA). ***, P ≤ 
0.001; *, P ≤ 0.05.
Figure S4. Immunomodulatory effect of L. plantarum strains and the deletion mutant derivatives on the cytokine 
production of human PBMCs (n=3 donors). The (A) IL12, (B) TNFα, (C) IL10, (D) IL1β, (E) IL6, and (F) IL8 
cytokine productions presented as Log pg/ml values. The cytokine levels for individual donors stimulated with 
wild-type and corresponding mutant bacteria were connected by a line to focus the read-outs on changes elicited 
by the cps mutation. Significant differences between cytokine levels induced by wild-type strains and their corre-
sponding mutants (paired t-test) are indicated; **, P ≤ 0.01; *, P ≤ 0.05.
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Figure S5. Comparison of (A) IL10 and (B) IL12 production of PBMCs (n = 6 donors) stimulated by L. plantarum 
WCFS1 and SF2A35B strains and (C) IL10/IL12 was also compared of the same strains. The cytokine levels 
for individual donors stimulated with WCFS1 and SF2A35B were connected by a line to focus the read-outs on 
changes elicited by the strains. The differences between wild-type and corresponding mutant were statistically 
analyzed by using paired t test. **, P ≤ 0.01; *, P ≤ 0.05.
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This thesis focuses on potential effector molecules, including lipoteichoic acids (LTA), lipoproteins, 
glycoproteins, and extracellular polysaccharides (EPS), in the probiotic model strain Lactobacillus 
plantarum WCFS1, and their role as first line interactors with host cells. Genetic engineering 
strategies were employed to delete or modify these molecules and study the consequences of 
these modulations on the biochemical properties of the molecules themselves, and on general 
bacterial physiology, as well as their impact on TLR2-signaling in reporter cell lines, and 
immunomodulation in peripheral blood mononuclear cells (PBMCs). This chapter will discuss the 
main findings presented in the thesis and position them in the context of host-bacteria interaction 
and species/strain specificity.  
Host receptors interact with bacterial molecules
The gastrointestinal (GI) mucosa is an important site where bacteria encounter the host and vice 
versa. The intestinal epithelial cells (IECs) and dendritic cells (DCs) in the mucosa are among the 
major players in the interaction with bacteria. Host cells express pattern recognition receptors 
(PRRs) that recognize ligands of microbial origin, named microorganism-associated molecular 
patterns (MAMPs). These ligands can be considered to be conserved among many microorganisms 
and are often bacterial surface molecules [1]. 
Toll-like receptors 
Toll-like receptors (TLRs) are transmembrane receptors, which are integral membrane proteins 
located in the cytoplasmic or intracellular membranes. They consist of an leucine-rich repeat (LRR) 
domain and an Toll/IL-1 receptor (TIR) domain [2]. There are 10 members of TLR family known 
Figure 1. Ligand specificity of TLRs. Toll-like receptors (TLRs) recognize various microorganism 
components. TLR2 is able to form heterodimers with TLR6 or TLR1 and binds to diverse molecules 
including lipoteichoic acids from Gram-positive bacteria (G+), lipoproteins, and zymosan from Yeast. 
TLR4 recognizes lipopolysaccharide (LPS) of Gram-negative bacteria (G-) and viral proteins. TLR5 is 
specific for bacterial flagellin while TLR9 recognizes unmethylated CpG motif in bacterial and viral DNA. 
GPI, glycosylphosphatidylinositol. 
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in human [3]. The sequence variation in LRR domains determines the ligand specify of TLRs. For 
example, TLR4 recognizes lipopolysaccharides of Gram-negative bacteria, while TLR9 recognizes 
unmethylated CpG from bacterial and viral DNA (Figure 1) [2]. Upon ligand recognition, TLRs can 
assemble into a homodimer or heterodimer configuration, allowing the intracellular TIR domains 
to interact with cytoplasmic adaptors, including myeloid differentiation primary response protein 
(MyD88) and TIR domain-containing adaptor protein (TIRAP), to initiate signaling [3]. TLR1-5 
and 9 can all be expressed by IECs in human small intestine and colon but at varying levels and 
polarized distribution in the apical and basolateral side of the epithelial cell layer [4]. TLR1, 2, 4, 
and 5 have been shown to be expressed in immature DCs but their expression decreases upon DC 
maturation, whereas TLR3 was found to be only expressed in matured DCs [5, 6]. Besides mucosal 
tissues, TLRs are also expressed in monocytes, mast cells, and PBMCs [3]. 
In this thesis, we focus on TLR2 signaling because it has been reported to recognize various 
microbial molecules, including LTA, and lipoproteins/lipopeptides (Figure 1). TLR2 is able to 
form heterodimers with TLR1 or TLR6 that recognize tri- or di-acyl lipoproteins/ lipopeptides, 
respectively. The minimal structure required for TLR2 recognition was determined to be a 
Cys-Ser/Thr/Gly/Ala lipopeptide, containing at least one-ester-bound fatty acid acyl chain 
with an optimal length of C16 [7-9]. The structural analysis of TLR2/6-Pam2CSK4 (a synthetic 
TLR2/6 lipopeptide agonists; Figure 2A) has shown that the cysteine contributes strongly to the 
hydrophobic interaction with TLR2/6 dimer, while the hydroxyl side chain of the second serine 
forms a hydrogen bond with F325 residue of TLR2 [10]. LTA, in comparison to lipopeptides, does 
not consist of amino acids but contains a glycan backbone. The structural analysis of the TLR2-LTA 
interaction, using LTA derived from Streptococcus pneumoniae, has shown that the hydrophilic oxygen 
atoms in the LTA glycan backbone repel the hydrophobic residues of the TLR2 binding pocket, and 
fail to form hydrogen bonds with TLR2. This structural difference hinders the heterodimerization 
of TLR2 and as a consequence prevents downstream signaling [10]. In chapter 3, we conclude 
that the purified LTAs from L. plantarum WCFS1 and Bacillus subtilis 168 (LTA-Lp and LTA-Bs, 
respectively) have distinct TLR2 signaling capacity in TLR2-reporter HEK 293 cell lines, where 
LTA-Bs is a potent TLR2 activator and LTA-Lp barely signals via TLR2. The structural difference 
of the LTA glycan backbone (LTA-Lp is Glu1→6Gal1→2Glu and LTA-Bs is Glu1→6Glu) may 
Figure 2. The structures of synthetic lipopeptides Pam2CSK4 (A) and Pam3CSK4 (B); figure adapted from 
Kang et al. [10].
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be an important contributor to the difference in activation of TLR2 signaling. Moreover, previous 
work has shown that LTA isolated from L. plantarum NCIMB8826 (the parental strain of WCFS1, 
which is a single colony isolate of NCIMB8826; [11]) induces Tumor necrosis factor (TNF)-α 
production in mouse bone marrow cells, in a TLR2-dependent manner [12]. Analogously, we 
observed that LTA-Lp induces pro-inflammatory cytokine production in PBMCs (Chapter 3). 
These observations suggest that co-receptors are required for TLR2 signaling by LTA from L. 
plantarum, which are absent in HEK cells. Potential co-receptors are CD14 and CD36 given that 
blocking these receptors inhibits Staphylococcus aureus LTA-induced TNF-α production from human 
monocytes [13]. Another argument concerning the TLR2 signaling capacity of LTA is the possible 
contamination of LTA preparations with lipoproteins. Our LTA purification procedure employed 
three sequential steps, i.e., 1-butanol extraction, hydrophobic interaction chromatography, and 
anion exchange chromatography, to minimize contamination and obtain pure LTA. However, 
when applied in a high concentration (10 µg/ml), the purified LTA-Lp could induce a low level 
of TLR1_2 activation, but failed to induce any TLR2_6 activation. The data presented in chapter 
4 imply that the lipoproteins of WCFS1 may be tri-acylated and signal via TLR1/2 heterodimers, 
and not via TLR2/6 heterodimers, and that TLR1/2 signaling can be abolished by removal of 
lipid moiety of lipoproteins (i.e., by lgt mutation). These observations may suggest that TLR1/2 
signaling observed with high dose LTA-Lp may be due to trace contamination of the LTA fractions 
by lipoproteins. In conclusion, LTA of Lactobacillus plantarum WCFS1 is a much weaker inducer 
of TLR2 (hetero-) dimerization and signaling than lipoproteins/lipopeptides of the same strain. 
The glycan backbone of LTA could play a determining role in TLR2 signaling, which may depend 
on the presence and activity of other co-receptors, such as CD14 and CD36. A different degree 
of lipoprotein contaminations in purified LTA preparations (in different laboratories) further 
confounds the multifactorial process of LTA-induced TLR2 signaling, resulting in inconsistent 
observations in the studies that evaluate TLR2 signaling by LTA.  
C-type lectin receptors
Another important PRR family is the C-type lectin receptors (CLRs). CLRs contain at least one 
carbohydrate recognition domain, which determines their glycan-ligand specificity [14]. Based 
on studies with pathogens, CLRs play an important role in immune system modulation. They 
recognize diverse glycans and activate varying downstream signaling pathways, many of which 
cross-talk with TLR signaling pathways [14]. A well-studied example in DCs and macrophages is 
the cell-type specific intracellular adhesion molecule-3 grabbing non-integrin (DC-SIGN), which 
recognizes (polymeric) mannose and fucose glycans. DC-SIGN plays an important role in DCs 
maturation, and mediates DCs migration and T cell activation [15]. For example, Lactobacillus 
casei NIZO B255 and Lactobacillus reuteri ASM20016 have been shown to induce regulatory T cell 
development through modulating DCs maturation via DC-SIGN interaction [16]. Subsequent 
work showed that surface layer protein A (SlpA) of Lactobacillus acidophilus NCFM binds to DC-
SIGN and modulates DCs functions and thereby stimulates regulatory differentiation in naive 
T-cells [17]. We have detected components, likely to be proteins, in the secreted fraction of L. 
plantarum WCFS1 that are recognized by Concanavalin A (ConA), a mannose- and glucose-specific 
lectin (Figure 3B), which may also be recognized by DC-SIGN and could fulfill a similar role 
as SlpA of L. acidophilus. Interestingly, these ConA-recognized glycan-conjugate components 
are more abundantly present in the supernatants of L. plantarum WCFS1 derivatives that lack a 
functional LTA synthase gene (ltaS), in particular a high molecular weight (MW) band (>250 kDa) 
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is uniquely present in supernatants of the mutants (Figure 3B). Based on its MW, this band is likely 
to represent Sdr (lp_1303a), a 3,378-residue transmembrane protein containing a Ser-Asp-repeat 
domain of more than 1,600 residues [11], which possibly is selectively released from the cell 
membrane due to cell envelope instability caused by LTA-deficiency in the mutants. Intriguingly, 
the expression of sdr is down-regulated in both ltaS mutants, suggesting that erroneous subcellular 
localization (i.e., secretion versus membrane anchored) elicits a downregulating feed-back 
mechanism (chapter 3). Extracellular proteins containing a similar serine-repeat domain have 
been found in other Gram-positive bacteria, and the serine residues have been proposed to be 
subjected to O-glycosylation by adjacent glycosyltransferase genes [18]. In L. plantarum WCFS1, 
sdr is genetically linked to 3 glycosyltransferase encoding genes, tagE1-3, which are annotated 
as poly(glycerol-phosphate) α-glucosyltransferases. In chapter 5, we identified the first protein 
glycosyltransferases GtfA and GtfB in L. plantarum, which were originally annotated as TagE5 and 
TagE6 and were predicted to play a role in lipoteichoic acid glycosylation. Moreover, our work 
illustrated that protein glycosylation is a conserved feature in the species L. plantarum (chapter 
5), revealing very limited variation in glyco-protein patterns produced by different strains. The 
finding that the tagE-annotated genes may be involved in protein glycosylation could support 
the postulated role of TagE1-3 in protein glycosylation rather than LTA glycosylation. Although 
our primary result shows no changes in the pattern of ConA-reactive components in the whole 
cell extracts of tagE1, tagE2E3, and tagE4 deletion mutants compared to L. plantarum WCFS1 
wild type (Figure 4), future investigation using Sdr-containing envelope fraction is still required 
to investigate the possible role of TagE1-3 in protein glycosylation. In addition, evaluating the 
possible role of the secreted fraction of the ltaS1 and/or ltaS2 strains in DC-SIGN modulation 
using monocyte-derived immature dendritic cells in naive T-cell differentiation assays in vitro are 
important to evaluate the postulated role of the L. plantarum Sdr as DC-SIGN ligand. Moreover, 
deletion of the sdr gene in both wild-type and ltaS mutant backgrounds of L. plantarum may further 
establish this role. 
Figure 3. Secreted proteins extracted from ltaS deletion mutants (ΔltaS1 and ΔltaS2) as well as from wild 
type (WT) visualized by (A) silver stain stained or by (B) concanavalin A lectin in SDS-PAGE. On the right 
side, the protein size (kDa) are indicated based on the Precision Plus Protein™ Dual Color Standards 
(Bio-Rad). 
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Next to glycan moieties on proteins, also extracellular polysaccharides (EPS) can interact with 
CLRs. Generally, EPS seems to play an indirect role in host interaction and immunomodulation 
by shielding other surface molecules. The shielding effect is supported by the enhanced TLR2 
signaling activation upon deleting gene clusters responsible for surface polysaccharide biosynthesis 
in L. plantarum WCFS1 [19] and SF2A35B (chapter 6). In L. rhamnosus GG, deletion of high-MW, 
galactose-rich EPS led to an increased adhesive capacity to intestinal epithelial cells, which implies 
shielding of surface adhesins by the EPS [20]. In addition, this galactose-rich EPS of L. rhamnosus 
GG has a protective effect against host immune defense molecules, such as LL-37 antimicrobial 
peptide and complement factors [21]. On the other hand, recent studies have evidenced a direct 
role in host signaling of EPS. EPS isolated from L. acidophilus NCFM was shown to stimulate gene 
expressions of interleukin-1α (IL-1α), chemokine C-C motif 2 (CCL2), TNF-α, and pentraxin 
3 (PTX3) in vitro (Caco-2 cell) and in vivo (mice cecum and colon) [22]. High-MW cell wall 
polysaccharides of L. casei Shirota has been proposed to elicit a suppressive effect on macrophage 
activation and on lipopolysaccharide (LPS)-induced production of IL6 in mouse macrophage-like 
cells [23, 24]. Another bacterial carbohydrate, polysaccharide A (PSA) from the human commensal 
Bacteroides fragilis, was shown to modulate cytokine production of DCs and active CD4+ T cells 
in a TLR2-dependent manner [25], which could involve CLRs by their interaction with PSA-
derived carbohydrate ligands. Moreover, the acidic EPS fraction isolated from L. plantarum N14 
[26] and EPS isolated from Lactobacillus delbrueckii TUA4408L [27] have been shown to mediate 
the inhibitory effect on pro-inflammatory responses in porcine intestinal epithelial (PIE) cells 
upon enterotoxigenic Escherichia coli (ETEC). Besides acting as a solitary immune modulator, EPS 
isolated from L. rhamnosus LOCK 0900 has the ability to tune the immune response elicited by L. 
plantarum WCFS1 in mouse bone marrow-derived dendritic cells (BM-DCs) but does not induce 
cytokine production when applied alone [28]. Different fractions of the EPS from L. rhamnosus 
LOCK 0900 show distinct immunomodulatory capacities: a branched heteropolysaccharide 
with high-MW of 830 kDa enhanced anti-inflammatory IL10 production induced by L. plantarum 
WCFS1 while another low-MW fraction polymer of 18 kDa enhanced the production of IL-12p70 
[28]. This data suggests an interplay of EPS-recognizing CLRs with other PRRs stimulated by L. 
plantarum cells and this interplay can result in distinct immune responses. 
Figure 4. Concanavalin A lectin blots of whole cell 
extracts derived from L. plantarum WCFS1 wild type, 
ΔtagE1, ΔtagE2E3, and ΔtagE4 strains. On the left side 
of the blot the protein sizes (kDa) are indicated based on 
the Precision Plus Protein™ Dual Color Standards (Bio-
Rad) molecular marker.
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We and others have shown that the EPS produced by different strains is highly diverse in quantity, 
glycan-composition and structure, i.e. glycan bonding types (chapter 6), which in combination 
with glycosylated protein moieties exposed on the bacterial cell surface and their collective role 
in glycan-mediated modulation of CLR signaling and host-cell responses are important targets for 
future research. Immune cells that express a large number of CLRs, such as DCs and macrophages 
[14], can be suitable to study the immunomodulatory effect of EPS. In addition, in vitro reporter 
systems, analogous to the TLR-transfected HEK NF-κB reporter cell lines [29], are useful to screen 
potential CLR ligands. However, the downstream signaling cascades of CLRs are largely unknown 
[14, 30]. Analysis of the gene expression modulated in these immune cells upon contact with 
EPS may be useful to identify the CLR(s) involved in their recognition and possible downstream 
signaling pathways elicited by EPS immunomodulation.            
Structural and immunomodulatory diversity of surface molecules  
Cell envelope molecules of Gram-positive bacteria, including peptidoglycan, LTA, proteins, and 
polysaccharides, play important roles in bacterial physiology and bacterial interaction with the 
environment. In this section, we compared the common and distinct features of these molecules in 
pathogenic and probiotic bacteria, especially focusing on LTA, lipoproteins, and polysaccharides. 
Lipoteichoic acids
Structural analyses of LTA revealed a substantial degree of structural diversity of these molecules 
in different bacteria, allowing the grouping of LTAs into 5 types based on the structure [31, 32]. 
Most LTAs that have been studied to date belong to type-I, including the LTA from S. aureus, 
B. subtilis, and L. plantarum. Type-I LTA are composed of an unbranched 1–3 linked glycerol-
phosphate (GroP) backbone decorated with d-alanyl and glycosyl-substitutions to a variable 
degree, which is anchored to the cell membrane by a glycolipid. Within this type, the structure 
of LTA may still vary in backbone chain length, degree and glycan-specificity of its substitutions, 
and the chemical structure of the anchoring glycolipid moiety [32-34]. More specifically, type-I 
LTAs were found to be glycosylated with N-acetylglucosamine (GlcNAc) or glucose, and the 
glycolipid glycan structure could range from mono- to tetra-saccharides. The type-II to type-V 
LTAs have more complex and sugar-containing repeating units instead of the ‘simple’ GroP 
repeating unit in the type-I backbone. Type-II LTA, found in Lactococcus garvieae strain Kiel 4217 
[35], and Type III LTA, found in Clostridium innocuum [31], have a proposed backbone composition 
consisting of α-Gal(1–6)-α-Gal(1–3)-GroP and α-Gal(1–3)-GroP–repeating units, respectively. 
The backbone of type-V LTA, found in Peptostreptococcus anaerobius [36] and Clostridium difficile 
[37], are proposed to encompass α-D-GlcNAc(1–3)-α-D-GlcNAc repeating units linked through 
phosphodiester bridges. The type-IV LTA, found in S. pneumoniae [38]; [39], have an α-1-4-linked 
pseudopentasaccharide repeating units consisting of 2-acetamido-4-amino-2,4,6-trideoxy-D-
galactose (AATGal), glucose, ribitol-phosphate, and two GlcNAc residues. These structural 
variations are likely to have profound effects on the signaling capacities of the different LTA 
molecules, placing the canonical assumption that LTA is recognized by TLR-2 complexes in the 
mammalian cell into a more refined context. This is further illustrated by a study that compared 
type-IV LTA from S. pneumoniae and type-I LTA from S. aureus, and concluded that type-IV LTA 
displays more potent pro-inflammatory properties in human mononuclear cells as compared to 
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type-I LTA [38]. Importantly, this study isolated LTA from lgt deletion derivatives that produce 
no lipoproteins to avoid lipoprotein contamination of the purified LTA [38]. The LTA from 
the Δlgt derivative of S. aureus did not activate human mononuclear cells, which is in apparent 
contradiction with previous studies that reported on pro-inflammatory properties of LTA from S. 
aureus [40, 41]. Modifications of LTA other than their complete deletion (ltaS mutation) have also 
been employed to evaluate the host-modulation by LTA. In particular the use of dlt mutants, which 
produce modified LTA that lacks d-alanyl substitutions, has shown that the d-alanyl depletion of 
LTA in L. plantarum NCIMB8826 enhances the strain’s anti-inflammatory properties in a mouse 
colitis model [12] and reduces visceral pain perception in a rat colorectal distension model [42]. In 
contrast, the dlt mutant of Lactobacillus rhamnosus GG did not display enhanced anti-inflammatory 
properties in vitro [43], but still suppressed disease symptoms in a mouse colitis model [44].  
Although some correlations have been made between LTA structure and its role in 
immunomodulation, the results are strongly confounded by large differences in LTA purification 
procedures that are bound to influence the level of lipoprotein contamination. Moreover, the large 
variety of in vivo and in vitro models used to test the role of LTA in host response modulation, as well 
as the immune response readouts employed enhanced the inconsistences in the results obtained. 
Therefore, it is of great importance to systemically perform structural and immunological 
comparison of the LTA obtained from different bacteria to pinpoint the structural determinants 
involved in their immunomodulation properties.   
Lipoproteins 
The first biochemical evidence of bacterial lipoproteins was reported by Hantke and Braun in 
Escherichia coli; an abundant lipoprotein Lpp, later named Braun’s lipoprotein, contains an N-terminal 
S-glycerylcystein residue modified with 3 acyl chains (N-acyl-S-diacyl-glyceryl-cysteine; figure 
5) [45]. The biosynthesis pathway of bacterial lipoproteins was also determined in E. coli, which 
consists of 3 steps catalyzed successively by 3 enzymes: prolipoprotein diacylglyceryltransferase 
(Lgt), lipoprotein signal peptidase (Lsp), and lipoprotein N-acyl transferase (Lnt) [46]. Further 
studies have identified other lipoproteins in Gram-negative bacteria as tri-acyl form, including 
Brucella spp. [peptidoglycan-linked lipoprotein (Pal)] [47], Haemophilus influenza type b strain Minn 
A [outer membrane protein (OMP) P6] [48], and Porphyromonas gingivalis (lipoprotein PG1828) 
[49]. Based on these studies as well as the presence of the three conserved enzymes responsible 
for tri-acyl lipoprotein biosynthesis (Lgt, Lsp, and Lnt), it is widely accepted that the tri-acylated 
lipoproteins are the common structure in Gram-negative bacteria [50]. Nevertheless, di-acylated 
lipoproteins in Gram-negative bacteria have also been reported. The cytochrome c subunit in 
the photosynthetic reaction center of Blastochloris viridis (formerly known as Rhodopseudomonas 
viridis) is a di-acyl lipoprotein (S-diacyl-glyceryl-cysteine; figure 5) [51]. Since no orthologous 
protein of the tri-acyl-catalizing E. coli-type lnt was found in the genomes of Mycoplasma species, 
in combination with the detection of di-acylated lipoproteins [52-54], led to the general 
assumption that Gram-positive bacteria possess only di-acylated lipoproteins [50]. Analogously, 
recent studies reported lipoproteins of Listeria monocytogenes to be di-acylated [55]. However, 
recent studies have also identified a tri-acylated SitC lipoprotein in four S. aureus strains and one 
Staphylococcus epidermidis strain [56, 57], although these species also do not encode an E. coli-type 
lnt orthologues in their genomes. Furthermore, three novel lipoprotein structures were identified 
in Gram-positive bacteria. First, the lyso type lipoproteins (N-acyl-S-monoacyl-glycerylcysteine; 
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figure 5) found in several Gram-positive bacteria, including Enterococcus faecalis, Bacillus cereus, 
Streptococcus sanguinis, and Lactobacillus bulgaricus [55]. In addition, N-acetyl type (N-acetyl-S-diacyl-
glycerylcysteine, figure. 5) lipoproteins are found in food-associated Bacilli (Bacillus subtilis and 
Bacillus icheniformis) and in Bacillus-related extremophiles (Oceanobacillus iheyensis and Geobacillus 
kaustophilus) [55]. Finally, an unconventional di-acyl lipoprotein structure, termed peptidyl type 
(Figure 5), was found in two lipoproteins of Mycoplasma fermentans, of which two additional amino 
acid residues are attached in the N-terminal side of lipidated cysteine. Lipoprotein MBIO_0319 
has additional alanyl-serine residues and lipoprotein MBIO_0661 has alanyl-glycine residues [55]. 
While two other lipoproteins, MBIO_0763 and MBIO_0869, in M. fermentans are di-acyl form, 
this conventional di-acyl structure is not detected in the MS analysis of peptidyl MBIO_0319 and 
MBIO_0869, suggesting the lipoprotein structures are specific for certain lipoproteins [55]. The 
authors speculate that peptidyl lipoproteins in M. fermentans may result from a unique specificity 
for cleavage sites of Lsp compared to that of other bacteria [55]. Importantly, Kurokawa et al. have 
reported that lipoproteins, including SitC, SA1659 and SA2079, of S. aureus switches to a di-acyl 
form instead of its tri-acyl form when the cells are cultured in more acidic (pH 6) conditions and 
reach a stationary-growth phase [58]. Additionally, high-temperature and high-salt conditions also 
enhance di-acyl lipoprotein accumulation in S. aureus [58]. This is the first evidence of structural 
alteration in bacterial lipoproteins upon environmental changes. Interestingly, since environmental 
conditions alter lipoproteins structures in S. aureus [58], it may be feasible to compare gene 
expression profiles in these conditions to accelerate the identification of a functional equivalent 
of Lnt in Gram-positive bacteria. Taken together, recent structural analyses have expanded the 
possible variations in bacterial lipoproteins.
Di- and tri-acyl lipoproteins are well-known TLR2 ligands and are recognized by TLR2/6 and 
TLR1/2 heterodimer, respectively [59]. The lyso-type lipoproteins were shown to have a 
different reactivity toward TLR2 heterodimers, where B. cereus OppA signals via both TLR2/6 
and TLR1/2 while E. faecalis PrsA is only recognized by TLR2/6 heterodimer [55]. OppA and 
PrsA differ in their acyl chains and protein sequences [55], which may lead to this different 
reactivity toward TLR2 heterodimers. Further comparisons of other lyso-form lipoproteins 
and their TLR2 heterodimer selectivity are required to identify the determinative structures for 
TLR2 heterodimer recognition. On the other hand, acetyl-type lipoproteins are recognized, as 
Figure 5. Different structural forms of bacterial lipoproteins.
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expected, via TLR2/6 [55]. The TLR2 signaling capacity of peptidyl-type lipoproteins has not 
yet been determined due to the difficulties to obtain sufficient amounts native lipoproteins [55]. 
Although signaling through TLR2/6 or TLR1/2 heterodimers was initially considered not to 
contribute to differential immune responses, but merely to expand the repertoire of bacterial 
ligand recognition [60], recent studies illustrated that the downstream signaling may depend on 
the type of TLR2 heterodimers. This is illustrated by the observation that in mouse bone marrow-
derived macrophages (BMDMs), TLR2-mediated β-amyloid peptide (Aβ; the main component of 
amyloid deposits in the brain of Alzheimer’s disease patients)-induced inflammation is enhanced 
by TLR1 but inhibited by TLR6 [61]. The authors suggested that the distinct responses between 
TLR1/2 and TLR2/6 might be caused by differences in Aβ recognition, in combination with 
differences in the cytoplasmic domains of TLR1 and TLR2 [61]. Moreover, distinct intracellular 
adaptors have been reported for TLR1/2 and TLR2/6 heterodimers. TLR2/6 is bridged by Toll/
IL-1 receptor (TIR) domain-containing adapter protein (TIRAP), also known as MyD88adapter-
like (Mal), to phosphoinositide 3-kinase (PI3K), whereas TLR1/2 depends on a different but 
unidentified adaptor [62]. However, the distinctive functioning of TLR1/2 and 2/6 heterodimers, 
is not yet resolved, because the application of inhibitory peptides that block TIRAP/Mal adaptor 
functioning, could block the cellular signaling of activated TLR1/2 but not of TLR2/6, which is 
in apparent contradiction to the reported adaptor dependency [63]. Irrespective of the unclarities 
that remain, these results support a distinctive role of TLR1/2 and TLR2/6 in immune signaling. 
The environmental modulation of lipoprotein acylation in S. aureus may offer possibilities to 
decipher in detail the immune responses elicited by di-acyl or tri-acyl lipoproteins of this species. 
Our results suggest that the lipoproteins of L. plantarum WCFS1 are tri-acylated based on TLR2 
heterodimers selectivity (chapter 4) and these results require further biochemical analysis to 
confirm the structure. We also searched for candidate genes that could encode the Lnt functional 
equivalent in strain WCFS1. Following identification of the Lnt-like function in Gram-positive 
bacteria, mutation of that function would facilitate the comparison of the immunomodulatory 
properties elicited by specific di- and tri-acyl lipoproteins derived from the same species and 
strain, which would be instrumental to determine whether TLR1/2 and TLR2/6 activation can 
lead to distinct immune responses in the host.    
Extracellular polysaccharides
EPS have the most diverse structural properties among bacterial surface components. Most EPS 
molecules produced by lactic acid bacteria belong to the heteropolysaccharides with repeating 
oligosaccharides units that contain 3 to 8 monosaccharides, which commonly consist of d-glucose, 
d-galactose and/or L-rhamnose, and in some cases N-acetylglucosamine, N-acetylgalacotsamine or 
glucuronic acid [64], and are arranged in variable sugar-linkages and -branching, and non-glycan 
modifications [65, 66]. The EPS diversity is reflected by the variability of the glycosyltransferases 
in the gene clusters involved in EPS biosynthesis and is exemplified further by multiple 
polysaccharide biosynthesis encoding gene clusters [67, 68]. For example, the L. plantarum 
WCFS1 genome encodes 4 CPS biosynthesis gene clusters [11, 19]. We have illustrated that EPS 
production has variable and strain-specific impacts on surface properties and immunomodulation 
in individual L. plantarum strains (chapter 6). Moreover, recent findings have supported the 
direct contributions of EPS in host interaction (discussed above), strengthening the role of EPS 
as a strain-specificity determinant. Notably, two structurally distinct EPS molecules (polymer 
163
7
General Discussion
L900/2 and L900/3) were isolated from L. rhamnosus LOCK 0900, which were shown to possess 
distinct immunomodulatory properties [28]. The high-MW (average 830 kDa) branched polymer 
L900/2 contains a heptasaccharide repeating unit, consisting of one d-galactose, four d-fucose, 
one d-mannose, and one d-glucose, and pyruvic acid. The low-MW polymer L900/3 (average 1.8 
kDa) is contains a pentasaccharide repeating unit, consisting of two d-glucose, one d-galactose, 
one N-acetylmannosamine, and one N-acetylgalacotsamine and a phosphate group. Immuno-
modulation assays showed that L900/2 could enhance L. plantarum WCFS1-induced IL10 production 
in BM-DCs, while L900/3 stimulated the production of IL-12p70 [28]. These results imply the 
structures of EPS can determine their immunomodulatory properties. It will be interesting to 
investigate the immunomodulatory property of intact L. rhamnosus LOCK0900, which contains 
both polymers, in combination with L. plantarum WCFS1-induced cytokine productions in mouse 
BM-DCs. A recently-developed lectin microarray that applies fluorescent-stained bacteria onto 
lectins-coated glass slides can efficiently profile surface glycome of bacteria [69]. This method 
has been applied to L. casei/L. paracasei strains. A probiotic strain, L. casei Shirota (Yakult) bound 
dominantly to CSL, a rhamnose-specific lectin [70] although EPS of strain Shirota contains not 
only rhamnose, but also glucose, galactose, N-acetylglucosamine, and N-acetylgalactosamine [69, 
71]. This observation could imply that within the EPS structures, the different glycan moieties 
may be differentially accessible. Furthermore, single-molecule atomic force microscopy (AFM), 
which can map on nanoscale distribution of single molecular recognition sites on biosurfaces [72], 
combined with fluorescence microscopy has been applied to image the distribution of WTA on the 
surface of L. plantarum [73]. This technology can deliver high resolution imaging views of probiotic 
surface properties, including glycan moieties detected by lectin-activated AFM tips. Emerging 
technologies like lectin microarrays and AFM in combination with immunomodulation assays 
in CLR-expressing cells, such as DCs and macrophages, can provide novel avenues in research 
aiming to unravel structure-function relationships of EPS in the context of immune system-
interaction.    
Concluding remarks and future perspectives 
In this thesis, we have focused on the molecules on bacterial cell surface, including LTA, lipoproteins, 
glycoproteins and EPS, in the probiotic strain L. plantarum WCFS1. We have shown that these 
molecules not only play important roles in bacterial physiology, but also in the interaction with the 
host mucosa through pattern recognition receptors (PRRs) expressed by the host cells. Although 
these molecules are commonly present in Gram-positive bacteria, evidence is accumulating (see 
above) that substantial structural diversity of these canonical cell envelope compounds exists 
between species and strains of the same species. Another example of such diversity in L. plantarum 
can be found in a study that revealed that 6 distinct types of repeating units of wall teichoic acids 
(WTA) exists [74]. In addition, although L. plantarum WCFS1 only produces glycerol-type of WTA 
under laboratory conditions, the strain possesses the genetic capacity to synthesis ribitol-type 
WTA [75]. Interestingly, ltaS deletion led to elevated expression of the genes involved in this 
ribitol-type WTA accompanied with suppressed expression of the genes involved in glycerol-type 
WTA, which could imply that LTA synthesis influences WTA synthesis (chapter 3). On top of the 
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strain specific structural features of cell envelope components, the S. aureus example of growth-
phase and culture-conditions dependent alterations in lipoprotein structures illustrates an even 
further dimension of diversity [58]. Intriguingly, an in vivo study revealed that consumption of L. 
plantarum WCFS1 from different growth-phase induced distinct gene expression profiles in human 
duodenal mucosa [76]. These results indicate that different physiological states of the bacteria 
can induce different responses in the host, which may be depending on differences in bacterial 
surface structures. Another important notion is that although Lactobacillus salivarius Ls33 and L. 
acidophilus NCFM possess the same peptide-bridging their peptidoglycan, these strains release 
different muropeptide fragments due to differences in their peptidoglycan modulating enzyme 
repertoire [77, 78]. L. acidophilus NCFM releases exclusively a muropeptide GlcNAc-MurNAc-
L-Ala-d-Glu-L-Lys-d-Asn (M-tri-N), carrying an epsilon-linked d-Asn, whereas Lactobacillus 
salivarius Ls33 produces an additional muropeptide without d-Asn [GlcNAc-MurNAc-L-Ala-d-
Glu-L-Lys (M-tri)] [77]. This Ls33-specific additional muropeptide is responsible for the protective 
effect of Ls33 in a mouse model of colitis, which is not seen with the NCFM strain [77]. This 
example further complicates the notion of variation between cell envelope structural properties 
of bacteria of a genus or species, it underpins that even with identical molecules to start with, the 
bacterial background and processing capacities may determine which structural properties are 
exposed to the environment and the host cell. Taken together, we are slowly obtaining a clearer 
picture of the way that surface molecules are influenced by genetic background, physiological 
status, environmental factors, and other biological processes to form a unique molecular signature 
associated with each strain that consequently elicit different responses when interacting with host 
cells.  
How host cells perceive the molecular signature of specific bacteria brings the host-bacteria 
interaction to another multi-level of complexity. For example, intestinal epithelial cells express 
multiple PRRs, including TLR1 to 9, and multiple nucleotide oligomerization domain-like 
receptors (NLRs) and CLRs [79]. These PRRs share several key components in downstream 
signaling pathways, such as adaptor protein myeloid differentiation primary response 88 (MyD88), 
mitogen-activated protein kinases (MAPKs), and nuclear factor (NF)-κB [79]. How a cell 
integrates the multiple-stimuli presented by a complete bacterium, or even by several bacteria, 
into a decisive response of the downstream signaling pathways that determine cellular response is 
still largely unclear. Moreover, intestinal mucosa encompass a variety of different cells, including 
several epithelial cell lineages like enterocytes, Goblet cells, Paneth cells, and enteroendocrine 
cells, as well as several immune cell lineages like DCs, macrophages, T and B cells. These cells 
communicate via cytokines, chemokines, and other effectors to the overall response of the 
mucosal tissue [80, 81]. Moreover, the cellular and molecular make-up of the mucosa from 
different healthy human volunteers is quite variable, suggesting that several ‘solutions’ exist to 
accommodate health and homeostasis. This degree of individuality is also very much apparent in 
the analysis of transcriptional profiles of mucosal biopsies from individual volunteers and has led 
to the proposition of what was designated “the band-width of health” [80]. Nevertheless, dietary 
interventions have illustrated that conserved, and biologically coherent responses can be measured 
in mucosal transcriptomes upon the consumption of a probiotic product [76, 82]. However, 
whether these responses to probiotics are having a relevant impact on the health status of an 
individual is likely to depend very strongly on the baseline situation (i.e., the individuals starting 
situation / transcriptional profile). The basis for the observed cellular and molecular individuality 
can be multifactorial, and could include components of the host genotype, the dietary habits, or 
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the endogenous microbiota of the intestinal tract. 
The complexity of host-microbe interactions indicated above, and our (very) limited understanding 
of the molecular details involved, imply that this domain requires substantially more research 
to unravel structure-function relations in bacterial molecules that are of importance to their 
role in host communication. It seems unavoidable that we abandon the relatively naïve view of 
conserved ligands of host receptors like LTA, LPS etc., which is denying the substantial chemical 
diversity hidden under those generic names. Molecular and structural details play a critical role 
in species and strain specific host-microbe interactions, and the future challenge is to determine 
which molecular signatures are more or less important in the hierarchy of host interactions and 
the responses that drive cellular and tissue responses, and finally influencing the function of the 
complete organism.  
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Summary 
Lactobacillus plantarum is found in various environmental habitats, including fermentation products 
and the mammalian gastrointestinal tract, and specific strains are marketed as probiotics, which 
are defined as ‘live microorganisms which when administered in adequate amounts confer 
a health benefit on the host’. Throughout the studies of the mechanisms underlying probiotic 
activity, it became apparent that the probiotic effects are often species and/or strain specific. This 
situation has led more researchers to focus on the molecular characteristics of probiotic strains 
intending to link specific molecular structures to specific probiotic functions, and thereby deduce 
the mechanisms of molecular communication of probiotics. This thesis focuses on potential cell 
envelope effector molecules involved in interaction with the mammalian host cells, including 
lipoteichoic acid (LTA), lipo- and glyco-proteins, and extracellular polysaccharides (EPS), of L. 
plantarum WCFS1, a model strain for probiotic lactobacilli with a well-annotated genome sequences 
and sophisticated genetic engineering tools. First, existing research regarding the potential roles 
in probiotic functionality of Lactobacillus surface molecules in terms of their biosynthesis pathways 
and structure variations as well as interaction with host Pattern Recognition Receptors (PRRs) 
and immunomodulatory properties of these molecules are summarized and compared to provide 
an overview of the state-of-the-art in probiotic effector molecule research. Subsequently, specific 
molecules that reside in the cell envelope of L. plantarum WCFS1 were study for their role in 
bacterial physiology, as well as their role as ligands in Toll-like receptor (TLR) 2 signaling and 
immunomodulatory properties using human-cell co-incubation models. Our results showed that 
the deficiency of LTA had a drastic impact on cell division, cell morphology and growth in L. 
plantarum WCFS1, while LTA-deficient cells also elicited more pro-inflammatory responses in 
PBMCs rather than the expected loss of pro-inflammatory capacity as was observed with similar 
mutants of Lactobacillus acidophilus NCFM. Further studies on the signaling capacity of the purified 
LTA from L. plantarum WCFS1 revealed that these molecules are poor TLR2 activators, which is in 
clear contrast to the highly potent TLR2 stimulatory capacity of LTA obtained from Bacillus subtilis, 
implying that structural differences of the LTA produced by different bacteria are prominent 
determinants of their TLR2 signaling capacity and immunomodulatory properties. Lipoproteins 
of L. plantarum WCFS1 were studied using a derivative strain that is deficient in prolipoprotein 
diacylglyceryltransferase (Lgt), which transfers acyl chain moieties onto lipoproteins. The lipid 
moiety was shown to be important for proper anchoring of lipoproteins and TLR1/2 signaling 
capacity, but did not affect TLR2/6 signaling, suggesting that lipoproteins of L. plantarum WCFS1 
are predominantly (if not exclusively) triacylated. The Lgt deficient strain elicited more pro-
inflammatory responses in PBMCs as compared to the wild type, indicating that the native 
lipoproteins could play a role in dampening inflammation upon host-probiotic interaction. In 
addition, we explored the protein glycosylation machinery in L. plantarum WCFS1, responsible 
for the glycosylation of the major autolysin (Acm2) of this bacterium, which was previously shown 
to be O-glycosylated with N-acetylhexosamine conjugates. Using sequence similarity searches in 
combination with a lectin-based glycan detection and mass spectrometry analysis, two glycosyl-
transferases, GtfA and GtfB (formerly annotated as TagE5 and TagE6, respectively), were shown to 
be required for the glycosylation of Acm2 and other unidentified L. plantarum WCFS1 glycosylated 
proteins. These results provide the first example of a general protein-glycosylation machinery in 
a Lactobacillus species. Finally, extracellular polysaccharides (EPS) in L. plantarum were studied in 
two strains that produce large amounts of EPS: L. plantarum SF2A35B and Lp90, in comparison 
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to the lowly producing model strain WCFS1. Based on genome sequence comparison, both of 
the high producer strains were found to possess strain-specific and unique polysaccharide gene 
clusters. These gene clusters were deleted and the mutants were shown to have lost the capacity 
to produce large amounts of EPS, and were studied in relation to their properties in host-bacteria 
interaction. The results illustrate strain-specific and variable impacts of the removal of the EPS in 
the background of individual L. plantarum strains, supporting the importance of EPS in L. plantarum 
strains as a strain-specific determinant in host interaction. Overall, this thesis showed that surface 
molecules not only play important roles in bacterial physiology, but also in the interaction with the 
host mucosa through pattern recognition receptors expressed by the host cells. With the growing 
amount of evidence of structural variations in surface molecules, which are influenced by genetic 
background, physiological status, environmental factors, and other biological processes, these 
molecules form a unique signature associated with each strain that as a consequence elicits a 
strain-specific response when interacting with host cells.  
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Lactobacillus plantarum wordt aangetroffen in verschillende omgevingen, onder andere in 
fermentatie producten en in de darm van zoogdieren. Specifieke stammen van deze bacteriesoort 
worden verkocht als probiotica; levende micro-organismen die wanneer ze in voldoende 
hoeveelheid worden geconsumeerd een gezondheidsverbeterend effect geven in de gastheer. 
Tijdens het bestuderen van de mechanismes die ten grondslag liggen aan probiotische activiteit 
is het duidelijk geworden dat probiotische effecten vaak soort of zelfs stam specifiek zijn. Deze 
bevinding heeft onderzoekers geïnspireerd om probiotische stammen moleculair te karakteriseren 
om daarmee specifieke moleculen van de probiotica te koppelen aan probiotische functies, met als 
doel om vanuit die kennis het moleculaire mechanisme van communicatie met de gastheer bloot 
te leggen. 
Dit proefschrift concentreert zich op celwand moleculen die een rol kunnen spelen in 
die moleculaire communicatie met de cellen van de gastheer, waarbij gekeken is naar 
lipoteichoinezuren (LTA), vetzuur- (lipoproteïnen) en suiker- (glycoproteïnen) geconjugeerde 
eiwitten en extracellulaire polysachariden (EPS) van de Lactobacillus plantarum stam WCFS1, een 
organisme dat fungeert als model voor probiotische lactobacillen. Voor deze bacterie zijn zowel 
een goed geannoteerde genoom sequentie als geavanceerde methoden voor genetische modificatie 
beschikbaar. Als eerste wordt een overzicht gegeven van het wereldwijd lopende onderzoek dat 
zich richt op de potentiele rol in probiotische functionaliteit van Lactobacillus celwand moleculen, 
hoe de biosynthese van deze moleculen verloopt en de structurele verschillen die zijn gevonden. 
Ook wordt beschreven hoe de verschillende celwand moleculen interacties kunnen aangaan met 
receptoren in gastheercellen die structurele patronen in dit soort moleculen van micro-organismen 
kunnen herkennen en welke immuun systeem modulaties door deze moleculen kunnen worden 
veroorzaakt. Hiermee wordt een overzicht gegeven van de status van het onderzoek dat zich 
richt op de moleculen die verantwoordelijk zijn voor probiotische effecten. Vervolgens worden 
verschillende moleculen die zich bevinden in de celwand van L. plantarum WCFS1 onderzocht 
om te bepalen welke rol ze spelen in de bacteriële fysiologie, maar ook welke rol ze spelen als 
liganden in de door Toll-like receptor (TLR) 2 gecontroleerde signalering en immuun modulatie, 
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waarbij gebruik is gemaakt van humane-cellen in co-incubatie modellen. De resultaten laten zien 
dat LTA deficiëntie drastische gevolgen heeft voor celdeling, morfologie en groei van L. plantarum 
WCFS1. LTA deficiënte bacteriën veroorzaken een meer pro-inflammatoire reactie in humane 
immuun cellen (PBMCs) in tegenstelling tot het verwachte verlies aan pro-inflammatoire reacties, 
zoals eerder is gezien met soortgelijke mutanten van Lactobacillus acidophilus NCFM. De hierop 
volgende studies richten zich op de signaal capaciteit van gezuiverd LTA van L. plantarum WCFS1, 
en tonen aan dat deze moleculen weinig TLR-2 activerende werking hebben, hetgeen duidelijk 
verschillend is ten opzichte van de sterke TLR-2 stimulerende rol die gemeten kan worden voor 
het gezuiverde LTA van Bacillus subtilis. Deze resultaten impliceren dat structurele verschillen in 
de LTA moleculen die gemaakt worden door verschillende bacteriën belangrijke determinanten 
zijn voor de TLR-2 activerende en immuun systeem modulerende rol van deze moleculen. 
Lipoproteïnen van L. plantarum WCFS1 zijn bestudeerd door gebruik te maken van een mutant die 
deficiënt is voor het enzym dat verantwoordelijk is voor de vetzuur koppeling aan lipoproteïnen, 
pro-lipoproteïne diacylglyceryltransferase (Lgt). De vetzuurkoppeling blijkt belangrijk te zijn voor 
de juiste membraan-verankering en de TLR1/2 signalerende werking van lipoproteïnen, maar 
heeft geen invloed op de TLR2/6 signalerende werking, hetgeen suggereert dat de lipoproteïnen 
van L. plantarum WCFS1 voornamelijk (zo niet volledig) drie vetzuur conjugaties bevatten. De 
Lgt deficiënte bacteriestam geeft versterkte pro-inflammatoire reacties in PBMCs vergeleken 
met de wild-type stam, wat aangeeft dat de oorspronkelijke lipoproteïnen een rol kunnen 
spelen in het dempen van inflammatoire reacties in bacterie gastheer interacties. Ook is de eiwit 
glycolsylering machinerie onderzocht in L. plantarum WCFS1, die betrokken is bij de koppeling 
van suikers aan het belangrijkste autolysine van deze bacterie (Acm2), waarvan in eerder werk 
is aangetoond dat het eiwit geconjugeerd is via O-glycosylering met N-acetylhexosamine. Door 
sequentie vergelijking gecombineerd met lectine gebaseerde glycoproteïnen detectie en massa 
spectroscopie analyse, zijn twee glycosyl-transferases, GtfA en GtfB (voorheen geannoteerd als 
TagE5 en TagE6, respectievelijk) geïdentificeerd die noodzakelijk zijn voor de glycosylering van 
Acm2 en andere niet geïdentificeerde glycoproteïnen in L. plantarum WCFS1. Deze resultaten 
leveren het eerste voorbeeld van een algemene machinerie betrokken bij eiwit glycosylering in 
een Lactobacillus soort. Tot slot, worden de extracellulaire polysachariden (EPS) in L. plantarum 
bestudeerd in twee stammen die grote hoeveelheden EPS produceren; L. plantarum SF2A35B 
en Lp90, en vergeleken met een stam die kleinere hoeveelheden EPS produceert, WCFS1. Op 
basis van genoom sequentie vergelijking van de beide stammen die veel EPS produceren werden 
stam-specifieke en unieke clusters van genen gevonden die coderen voor EPS productie. Deze 
clusters werden verwijderd en de mutant stammen bleken geen grote hoeveelheden EPS meer 
te produceren en de eigenschappen van deze stammen in communicatie met gastheercellen is 
bestudeerd. De resultaten geven aan dat de uitschakeling van EPS productie stam-specifieke en 
variabele consequenties heeft die afhankelijk zijn van de achtergrond van de individuele stam 
waarin dit wordt bestudeerd waarmee het belang van EPS als determinant van L. plantarum stam-
specifieke gastheer interacties wordt onderstreept. 
Resumerend, dit proefschrift toont aan dat oppervlakte moleculen van bacteriën niet alleen 
een belangrijke rol spelen in de bacteriële fysiologie, maar ook in de interactie met de mucosa 
van de gastheer doordat ze herkent worden als liganden door specifieke receptoren die door 
gastheercellen tot expressie worden gebracht. Het toenemende bewijs dat er structurele varianten 
bestaan van deze oppervlakte moleculen, die worden beïnvloed door de genetische achtergrond, 
de fysiologische status, verschillende omgevingsfactoren en andere biologische processen, geeft 
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aan dat deze moleculen een unieke, stam-specifieke structurele signatuur vormen die stam-
specifieke reacties teweeg brengen in de interactie met gastheercellen. 
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